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The effect of the menstrual cycle on the breast was investigated
in nulliparous and parous women.
Breast volume was measured by water displacement in four nulliparous
women. Volumes were least in the week after menstruation, and
increased by 20% to a maximum just before menstruation.
From 174 women of reproductive age 212 specimens of normal breast
tissue were obtained during biopsy or mammoplasty. Menstrual and
reproductive histories were taken, and plasma progesterone and
oestradiol concentrations were measured. Histological examination
of lobules, ductules, and ductule epithelium was carried out. There
was much variation between specimens. Parous women had a greater
density of lobules than nulliparae, and parity caused a change in
ductule epithelium: clear basal cells were much more numerous among
nulliparous than parous women. Increased epithelial height during
the luteal phase of the menstrual cycle was noted among both parous
women and nulliparae, but the cycle produced no other changes.
Lobule density was less within ten years of the menarche, but age
was associated with no other lobular changes.
DNA synthesis by epithelial cells was studied in 52 specimens by
organ culture with labelled thymidine followed by autoradiography.
Among nulliparae there was no cyclical variation, but among parous
women synthesis was greatest during the luteal phase of the cycle.
Synthesis of Immunoglobulin A was studied in 80 specimens by
immunofluorescence and by in vitro culture with labelled amino acids
followed by radioimmunoelectrophoresis. Among nulliparae there were
no cyclical variations, but among parous women synthesis was
greatest during the luteal phase of the cycle.
It is suggested therefore that the nulliparous breast is less
sensitive to progesterone than is the parous breast. Before first
pregnancy oestrogen stimulation of mammary epithelium may be
inadequately opposed by progesterone, and this may explain the
increased incidence of breast cancer among nulliparae.
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The research described in this thesis aimed at defining the
structural and functional changes that occur in the human female
mammary gland as a result of the menstrual cycle, both in nulliparous
and in parous women. The reasons for undertaking this research are
as follows.
Although the human mammary gland has been the subject of a great
deal of research, most of the investigation has concentrated on
either the gland which has undergone malignant change or the gland
which is the seat of benign disease. There has been relatively
little investigation of the healthy, non-lactating gland, and
controversy still exists on the most funadmental questions about
its structure. In particular, there is no consensus on the question
of whether or not changes occur in the structure of the breast as a
result of the menstrual cycle. Although several investigations have
addressed this question, their conclusions differ markedly from one
another. (The investigations are discussed in detail in Chapter 2).
On reviewing these studies, it became clear that none had examined
separately nulliparous and parous women. The first hypothesis to
be tested, therefore, was that the breast of the nulliparous woman
responds differently to the menstrual cycle from that of the parous
woman. In other words, the experience of pregnancy may alter the
mammary gland's response to the menstrual cycle. This may be the
reason that previous investigators of breast histology had failed
to agree on the effects of the cycle.
Since an understanding of the normal is a prerequisite for studying
the abnormal, clarification of this point would be of value in further
investigation of the diseased gland. However, the experience of
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pregnancy is of particular relevance to the mammary gland.
Nulliparous women have a higher risk of developing breast cancer
than do parous women. Large-scale epidemiological investigations
published early in the 1970s confirmed this fact, and showed also
that the earlier in her life a woman experiences her first full-
term pregnancy, the smaller her risk of developing breast cancer
later in her life. (These investigations are discussed in detail
in Chapter 7.) Thus the experience of one full-term pregnancy
alters the susceptibility of the breast to the development of
malignant change.
For a variety of reasons - discussed in Chapter 7 - ovarian
hormones are now thought to be implicated in the development of
malignant change in the breast. The importance, for example, of
the age at menarche and the age at menopause is now recognised as
partly determining a woman's risk of developing breast cancer.
Therefore an understanding of the response of the normal breast to
the hormonal changes of the menstrual cycle becomes particularly
important. Breast cancer is the commonest malignancy affecting
women, and some 10,000 British women each year are affected by the
condition. The results of treatment have not improved over the
years, and more attention is now being paid to the causes of the
disease, in the hope of identifying avoidable or preventable factors.
If the hypothesis (that the breast before first pregnancy differs
in its response to the menstrual cycle from the breast of a parous
woman) appears tenable, then further hypotheses could be developed
with direct clinical relevance. For example, if the breast of a
nulliparous woman responds to the cycle, but no cyclical changes
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occur among parous women, then it could be suggested that the
cyclical changes among nulliparae represent a "stress" to the
breast, which could be connected with its increased tendency to
develop malignant change. If such changes could be abolished
(for example, by continuous use of oral contraceptives) then the
increased risk of breast cancer among nulliparous women might be
reduced.
Before such testable theories can be elaborated in any detail,
the first step is to find out whether cyclical changes occur in
the breast, and then whether they occur equally in nulliparous
and parous women. The changes investigated fall under four headings:
macroscopic, histological, DNA-synthesis, and immunological. Each
is described in a separate chapter in this thesis.
In Chapter 2 previous investigations of the structural development
of the breast and its endocrine control are reviewed. In Chapter 3
an investigation of gross morphological changes during the cycle is
described. Chapter 4 described the histological investigation of
normal breast tissue from 174 women. Chapter 5 describes organ culture
work investigating DNA synthesis, and Chapter 6 describes work on
in vitro immunoglobulin synthesis. In the final chapter, (7), the
epidemiology of breast cancer is reviewed in the light of the results
of this work, and a new hypothesis is put forward to explain the
connection between ovarian hormones and breast cancer.
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The female mammary gland consists of glandular tissue and ducts,
surrounded by a stroma of fibrous tissue and fat. The relative
proportions of these components vary depending on the stage of the
woman's reproductive life. This variation occurs partly as a result
of hormonal influences, the most important being the effects of
ovarian steroids.
The first experiments on the effect of the ovary on the mammary
gland were described early in this century. In 1914 Ott and Scott
ground up bovine corpora lutea and injected them into rabbits. They
noted that the glands increased in size and contained milk, and that
under the microscope there was a marked increase in the number of
glandular structures. The importance of the pituitary was also
recognised (Ott, 1910). Since that time many hormones have been
implicated in the control of breast development, and lactation.
Most of the experimental work has been done on a variety of animal
species and this is a potential source of confusion, though Anderson
(1974) points out that there are an estimated 19,000 species in the
class mammalia and investigation has been carried out in relatively
few of these.
A Embryonic and fetal development
The "milk streaks" appear before the sixth week in the embryo, as
two broad zones of skin on the antero-1ateral aspects of the thorax
and abdomen, characterised by taller epithelial cells and an increased
vascularity of subepidermal tissue (Dawson 1934). The streaks disappear
by the tenth week of fetal life, leaving only the nipple area, and at
about the 15thweek this epithelium starts budding downwards. 15 - 20
cords of epithelial cells pass into the subjacent connective tissue
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and after about the 20th week they become canalised: the ducts thus
formed are said to have a wall consisting of a two-layered epithelium -
an outer, basal layer of flattened cells and an inner layer of columnar
cells next to the duct lumen. Mitotic figures are rare in fetal
breast epithelium (Dawson 1934).
Embryonic mammary development appears to be independent of hormonal
control (Vorherr 1974; Anderson 1974), though stimulation of the
fetal breast by placental steroids does occur during the last
trimester of pregnancy. Experimental work has been done on mouse
embryos (Lasfargues and Murray 1959) by cultivation of the mammary
apparatus in artificial media. Growth proceeded to the stage of
secondary duct development without the addition of hormones, but
growth and differentiation were enhanced by the addition of growth
hormone or prolactin. Growth of the epithelium itself was affected
only by growth hormone, while prolactin was said to affect differentiation.
Steroid hormones were also tested, and the interesting observation
was made that oestradiol stimulated the adipose tissue but not the
epithelium. Progesterone promoted breakdown of ground substance and
Cortisol enhanced changes which were indicative of secretion. The
effects of testosterone were investigated by Raynaud (1949), and this
steroid is thought to promote the separation of the mammary bud from
the epithelium - an event in rats and mice which occurs only in the
male. No such separation occurs in the human, and there is no
evidence for androgens having an effect on human embryonic breast
tissue.
Later in fetal development, however, an inhibitory effect of
androgens has been shown on mammary development in organ culture of
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rat and mouse tissue (Ceriani 1970; Turkington and Topper 1967).
Similar work has shown that various hormones are required for in
vitro mammary growth: insulin, prolactin, aldosterone and progesterone.
Ceriani (1970) has suggested that these hormones are not all
necessary to development of all parts of the ductal "tree" - for
example, only insulin is required for the main duct to develop,
while the development of the smallest ductules requires all four
hormones. Ceriani found that oestradiol-17B and growth hormone had
no effect on fetal gland development in vitro.
Development of mammary tissue will proceed slowly in organ culture
systems without the addition of any hormones. It is difficult to
extrapolate these in vitro findings to the normal situation in vivo,
and the fact that the effect of a hormone can be shown in an organ
culture system does not, of course, mean that the effect is necessarily
exerted in vivo. The lack of effect of oestradiol, however, would
appear to indicate that this hormone does not play a significant part
in pre-natal mammary development.
B Development from birth to puberty
According to Dawson (1934), at the time of birth an elementary system
of ducts exists without lobular structures or true secreting tissue.
However, Dabelow (1957) and Bassler (1970) describe "lobulo-alveolar
structures resembling endvesicles" containing colostrum. These are
seen in both sexes, and an elevation of the mammary discs is also
seen. The end-vesicles are said to regress and are not seen in child¬
hood. According to Vorherr (1974) the connective tissue of the breast
at the time of birth consists of three layers: (1) a superficial
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layer under the nipple, (2) an intermediate zone which surrounds
the ducts and extends into peripheral connective tissue septa, and
(3) an inner connective tissue layer which envelops the deepest
epithelial elements. The significance of this layering is not
explained, and it is not clear from the literature whether the
connective tissue near the ducts is loose (as it is in the mature
gland) compared to the remainder of the stroma.
There is histological evidence of stimulation of the glandular
epithelium at the time of birth, and according to Vorherr (1974)
the colostral secretion seen in some 90% of newborn infants is
caused by the withdrawal of sex steroids allowing prolactin to
stimulate the mammary epithelium. This stimulation is maximal at
4-7 days post-partum, and subsides within 3-4 weeks. However,
Vorherr quotes no evidence to show that a rise in prolactin levels
does in fact occur. Neonatal colostrum secretion occurs also in
other species, such as rabbit, cat, goat, and horse (Tucker 1974)
and Tucker points out that fetal glucocorticoids may be involved in
its production as their levels rise around the time of parturition.
The traditional view is that the secretion is stimulated by placental
transfer of maternal hormones (Vaughan 1969): other tissues of the
neonate also show evidence of hormonal stimulation which settles down
soon after birth.
During the period from birth to puberty, only sufficient growth to
keep pace with general body growth takes place. There are no lobules,
and the two-layered structure of the duct wall is still seen. Normally
there is no evidence of specific hormonal effects, but in cases of
precocious puberty breast development occurs with stromal and glandular
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development as in normal physiological puberty (Dawson 1934).
Therefore the breast in childhood appears capable of responding
to hormones, and the lack of breast development before puberty is
a consequence only of low hormone levels.
C Puberty
Breast development is the first sign of puberty (Marshall 1970),
beginning at a mean age of 11 and being completed at a mean age of
15^ (Marshall and Tanner 1974). The menarche occurs somewhat later:
the age at menarche has been falling steadily over the last ten years
but now seems to have stabilised at a mean of 13.2 years in Britain
(Dann and Roberts 1973; Roberts and Dann 1975). (It is probable,
though not proven, that this fall is a result of better nutrition of
the population, allowing children the maximum opportunity of attaining
their genotypic height and weight as early as possible.) The
macroscopical development of the breast around puberty has been well
illustrated by Tanner (1962). He divides it into five phases: first,
the preadolescent elevation of the nipple, followed by (2) the beginning
of mamillar growth and sprouting of subalveolar ductular breast tissue
leading to the formation and protrusion of a small "breast hill" and
an increase in the diameter of the areola. The next two stages are
firstly a further growth of the nipple and secondly an accelerated
growth of subareolar tissues. The fifth stage is the development of
the shape of the mature breast.
The light-microscope appearance at the onset of puberty shows a
development of both the glandular tissue and the surrounding stroma
(Dawson 1934). Initially solid epithelial buds are formed from the
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terminal part of the existing ducts, and these form branches. For
the first time a surrounding loose connecting tissue around the
ducts is described at this stage, and this stroma, as well as being
looser than the rest of the supporting connective tissue, is also more
cellular. The branching ductules are at this stage grouped into
recognisable lobules. Dawson found that no corresponding glandular
changes occur in the human male at puberty.
The hormonal changes at puberty begin with an alteration in the
sensitivity of the negative feedback mechanism at the hypothalamus:
in childhood the very low levels of circulating oestrogens are
sufficient to prevent secretion of hypothalamic releasing factor
(HRF) for follicle-stimulating hormone (FSH) and luteinising hormone
(LH). At puberty the hypothalamic sensitivity to oestrogen is reduced,
and secretion of HRF stimulates the production of FSH and LH, which
in turn stimulate oestrogen production by the ovary (Short 1976). The
stimulus which initiates this change is not known: the onset of
menstruation has been correlated with body weight (Frisch and McArthur
1974), but other factors are thought to be involved.
The age at which hormonal changes begin is not known, and we do not
know the precise endocrinological status (in terms of FSH and oestrogen
levels) at the age of 11, when breast development first starts.
However, it is known that ovulation does not occur before the menarche
and indeed does not begin until several months after this event.
According to Doring (1969), who investigated this question using basal
■%
body temperature record, 60% of menstrual cycles in the 12-14 age group
are anovulatory, and 45% of cycles in the 15-17 age group are. Since
progesterone is only produced by the corpus luteum after ovulation,
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breast development will be well advanced before progesterone is
first secreted,and indeed at the mean age of 15 breast development
will be completed (in terms of gross morphology) without a substantial
contribution from progesterone stimulation. Vorherr (1974) points
out that progesterone is involved in the final stage of macroscopic
maturation (Marshall's "fifth stage"), but it is doubtful if this
contribution is essential.
Studies on other species have shown that cyclic gonadotrophin
activity in the rat begins well before puberty (Baker and Kragt 1969)
and that ovarian oestrogen production may cause rapid prepubertal
growth of the mammary gland (Sinha and Tucker 1969a). A study of
DNA, RNA and hydroxyproline content of the mammary gland in heifers
(Sinha and Tucker 1969b) showed that mammary growth began at three
months of age, which is three months before puberty in the breast
studied. Animal studies show also that in some species mammary
development is not "completed" at puberty, but proceeds during each
oestrus cycle until pregnancy occurs. This has led to conjecture
that a similar phenomenon may occur in the human: this is discussed
in the next section.
Mean levels of circulating prolactin do not increase greatly at the
time of puberty (Vorherr 1974), and it seems that the gross morphological
development of the breast which is completed at puberty is the result
of oestrogen stimulation (with a theoretical possibility of a contribution
directly from pituitary gonadotrophins).
Although the development of the stromal component of the mammary gland
is complete at the end of puberty, only partial development of the
glandular component has occurred, compared with the full development
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required for lactation. By far the greater part of the volume of
the non-lactating breast is made up of fibrous tissue and fat.
Morris (1977) has suggested that this difference in the development
of the two components reflects the function of the non-lactating
breast, which has no nutritive function (since pregnancy has not yet
occurred) but functions to signal to the male that the female is
sexually mature. Among other apes the female's receptivity is
signalled by a swelling or colour change in the perineal area, and
Morris suggests that when the human (the "naked ape") assumed the
upright posture the function of sexual signalling moved from the
perineal area to the mammary area. The hormone-dependent stroma
of the breast - which appears to have nothing to do with the nutritive
function of the glandular component - may therefore be directly
analogous to the hormone-dependent perineal tissue of other species
of ape. The probability that the stromal component has nothing to
do with nutrition is discussed further below, during the discussion
of pregnancy changes.
D Effects of the menstrual cycle on the breast
1 Light microscopy
Over the last fifty years various investigators have studied the
lobules of the human mammary gland with a view to detecting cyclical
changes, but there is no agreement on the influence of successive
menstrual cycles on the detailed histology of the lobules and ducts.
It is noteworthy that none of the investigations has looked separately
at parous and nulliparous women.
The first worker to try to analyse the effects of the menstrual cycle
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on the mammary gland was Rosenburg (1922), although earlier studies
(Ott and Scott 1910; Ott and Scott 1914) had revealed that the corpus
luteum could influence the development of the mammary gland in animals.
Rosenburg performed post-mortem examinations on at least 56 women of
reproductive age, in an attempt to correlate the appearance of the
ovary with the histology of the breast. Most of the cases that he
illustrates are nulliparae, although some had borne children, and he
makes no distinction between the groups. It is of interest that much
of his material came from the influenza epidemic of 1919: all the cases
examined had died of infectious disease - some from tuberculosis.
Rosenburg1s conclusions were that the corpus luteum brings about a
sprouting of the ductules of the breast, which explains the feeling of
fullness that many women experience at the premenstrual phase. He
concluded that the proliferation occurs in both parous women and
nulliparae, and does not occur if the corpus luteum is absent. He
described four phases - the pre-menstrual, menstrual, post-menstrual
and interval phases - and illustrated spectacular proliferation during
the first two, followed by involution (which he did not illustrate)
progressing to a very sparse system of ducts in the interval phase.
This description, he pointed out, differed from the standard anatomical
teaching of his day: it is of interest that Rosenburg1s 1922 description
is the standard anatomical teaching of the present day.
In the same year McFarland (1922) published a study of the normal
breast: he did not look for cyclical changes but was interested in the
effects of pregnancy. He concluded that "there was no difference
between the lobules of virgin breasts and those in the mammae of
parous women".
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Rosenburg's paper was followed by several reports in the German
literature agreeing with his findings (Polano 1924; Ernst 1925;
Litten 1926; Luchsinger Y Centeno 1927). Ernst (1925), confirming
Rosenburg's findings, added that the involution after the menses
resembled the involution after pregnancy (which is described in the
next section). Litten (1926) agreed, and stated that secretion was
present in the premenstrual phase.
However, three years after Rosenburg's report, Dieckmann (1925)
re-analysed Rosenburg's material. The total number of cases
described by Rosenburg was in fact only 25 (6 premenstrual, 9
menstrual and 5 each in the postmenstrual and interval phases).
The average age of cases in the premenstrual phase was 29.8, in the
menstrual phase 34.4, in the post-menstrual phase 24, and in the
interval phase 22.6. Dieckmann illustrated cases of women dying after
several months amenorrhoea, who had no corpus luteum on the ovary and
yet who had lobules typical of Rosenburg's "menstrual" phase. Dieckmann's
conclusions were that the corpus luteum is not essential for finding
lobules in the breast, and that sprouting of the ductules is a
function of age rather than the menstrual cycle. Menstrual changes
such as the subjective feeling of fullness he attributed to oedema of
the lobule. He did not, however, study the effects of parity, and
again his subjects were post-mortem cases, the cause of death in most
cases being chronic disease such as tuberculosis, nephritis, multiple
sclerosis, etc.
Luchsinger Y Centeno (1927) agreed with Rosenburg rather than
Dieckmann, but emphasised that the cycle did not have the same effect
in all breasts, and said that cyclic changes were more pronounced in
older women.
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Ingleby (1932) also described cyclical changes, but although her
description is very detailed it is not clear whether such changes
had been observed from her own material. She found that tumours
showed a similar cycle to normal breast tissue, and "it was found
possible to diagnose the stage of the cycle from an examination of
the tumour alone". This remarkable claim has never been confirmed,
and the same author ten years later (Ingleby 1942) had modified her
original enthusiasm. Far from claiming, as she had in 1932, that
"premenstrual proliferation is much more rapid than carcinomatous
growth", she remarked (after examining whole breast sections) that
"present knowledge of the sexual cycle is fragmentary. Without a
large number of normal specimens - which I have been unable to
obtain - it would be absurd to dogmatise." While emphasising the
extensive variation in a single breast, Ingleby (1942) still felt that
enormous growth and regression can take place - but "only some lobules
undergo changes in a cycle, and they may not do so simultaneously"
(Ingleby and Gershon-Cohen 1954).
In 1934, EK Dawson of Edinburgh published her classic study of the
normal breast. She found that growth of the lobules begins at puberty
and continues until general bodily maturity is reached. According to
Dawson, "changes associated with the recurring sexual cycle are
superimposed on the general growth initiated with the approach of
puberty, but the actual changes in human mammary tissue during the
cycle have yet to be defined. Such definition would appear to demand
a careful estimate of data which indicate sexual and general maturity,
as well as knowledge of the menstrual phase, and in the absence of
these details, comparison of tissue from different individuals may
be misleading." Dawson was therefore reluctant to make categorical
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statements about the effect of the cycle on the breast, but she
does record that "lobules are always present during the menstrual
interval in tissue which is not yet approaching post-menopausal
involution", contradicting Rosenburg's suggestion that lobules are
re-formed each month. Dawson illustrated lobules at different
phases of the cycle with little difference in glandular content,
but she felt that a typical premenstrual lobule had loose lobular
connective tissue ("physiological oedema") which disappeared in the
intermenstrual phase.
At the same time Lewis and Geschickter (1934) published a study of
44 normal breast biopsies taken at operation for carcinoma or adenoma.
They described the following changes: at mid-cycle there is an expansion
of the duct system and an increase in the epithelial thickness. Just
before the menses there is an increase in acinar elements. At the
time of the menses there is a round cell infiltrate in the stroma, and
desquamation of the duct epithelium. The post-menstrual phase is
characterised by disappearance of this infiltrate, a decrease in the
size of the acini, and the stroma's becoming more compact.
Taylor (1936) reviewed 41 biopsies of normal tissue, and pointed out
that there is much variability between breasts. "The chief feature
of this series was the immediately evident variability of the lobular
development of different breasts, irrespective of the time of the cycle.
This is in direct accord with Dieckmann who recognised a mature and an
immature type of lobule somewhat dependent on the patient's age. This
variability makes difficult attempts to prove the occurrence of premenstrual
proliferation of the ducts by comparing single sections from different
individuals, but makes it readily possible to arrange sections to
2-13
illustrate any special morphological process that one may expect to
find. Taking Figs 1 and 2 one has the evidence to demonstrate the
Rosenburg theory, but the reverse can as readily be shown using
Figs 3 and 4." He was able to take consecutive biopsies at day 14
and day 28 from one patient (who was, however, suffering from marked
painful hypertrophy of the breasts) and he found no change. In
general, he felt that acini became slightly dilated before menstruation,
and the cells became more distinct in outline. He also felt that the
intralobular connective tissue fibres were widely separated before
menstruation, and that there was "obvious" premenstrual hyperaemia,
but these were the only changes seen.
Grynfeltt (1938) agreed that proliferative changes occurred in the
premenstrual phase, though his main interest was centred on the
appearance of secretion in the breast, and he appears to have accepted
the idea of premenstrual proliferation uncritically. He examined
tissue only from nulliparae (the source of the tissue is unclear, as
is the number of subjects examined), and concluded that a secretion
appears in the epithelial cells during the premenstruum, apparently
similar to colostrum. He pointed out that there is no indication
in the literature as to when in pregnancy functional changes start
appearing in the breast, and contended that secretory activity begins
during the luteal phase.
In a large study of 300 cancer-containing breasts and 200 specimens
of noncancerous breast tissue, Foote and Stewart (1945) attempted to
find structural differences between the breast of women who have breast
cancer and those who do not have the disease. In their description
of the mammary lobules, they remark that "examination of the character
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of the mammary lobules has offered more difficulties than any other
aspect of this morphological analysis". They found it impossible
to find a survey of normal material taken from patients without
chronic disease, but after studying a large amount of material
they concluded that "certain lobule patterns are more characteristic
of one phase of the cycle than another". Their findings were, they
reported, more or less in agreement with those of Rosenburg and
Dieckmann, but they emphasised the considerable heterogeneity of
appearances within a single breast. The characteristic lobule patterns
that they describe are as follows.
On day 0 of the cycle, acini are numerous and closely spaced, and
lumina are open and contain secretion. Lining cells are orderly,
cuboidal to columnar, and the cytoplasm is rather abundant and pale.
On day 4 there are still numerous acini, but some lumina are narrowed
and many are closed. There are fewer columnar cells, and contracture
of acini leads to obliteration of lumina, and cells piling up in a
disorderly fashion. The stroma shows early condensation, decreased
vascularity and increased numbers of lymphocytes. On day 8 there are
still more lymphocytes, collapsed acini, smaller acinar cells with
nuclear pyknosis and a dense stroma. By day 12 involution is nearly
complete: there are few acini, collapsed with hyaline connective tissue
condensation around them. The lymphocytic infiltration has cleared.
Reactivation occurs at 15 days: the stroma loosens, the connective
tissue cells become larger and acinar lumina are re-established. By
day 22 the acini have multiplied, the lining cells are larger and taller,
with more abundant cytoplasm and pale nuclei. There are occasional
mitoses, and the lumina are present but not yet crowded with secretion.
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Foote and Stewart are clearly unhappy about the heterogeneity of
the lobules in their material, and record that it was possible to
predict the phase of the menstrual cycle correctly in only 10% of
these cases. They suggest that this might be due to the primary
condition requiring surgery, and so they examined the breasts of
27 women who were victims of sudden death, to see if "normal"
breasts showed a similar heterogeneity. They report that the
heterogeneity among this group was much less: 22 of the subjects
were suitable for analysis (the remainder being post-menopausal or
having advanced post-mortem changes) and of these 22 the phase of
the menstrual cycle was correctly predicted in 16 (72%). Details of
this prediction (eg. how many phases the cycle was divided into) are
not given, but the prediction was apparently made by two independent
observers working "blind".
Engel (1947) studied 100y sections of whole human breast and
commented on "alveolar sprouting in the premenstruum", which he said
only occurred in breasts which already consisted of well-differentiated
glands. He pointed out that neither size nor palpation gives any
correct indication of the functional capacity of a breast. Asking
the question, "Do menstrual changes occur in the breast?" he replied,
"Because of the natural variations in the glandular equipment of
different breasts it can be said that there is no rule and menstrual
changes may or may not occur".
Dabelow (1957), summarising the work of various investigators,
including his own earlier work, also draws attention to the fact that
changes in a gland are not uniform and that some parts of the gland
are not affected at all. He describes partial lobular degeneration
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after the menses, of varying intensity, and states that cellular
infiltration occurs during degeneration and regeneration. According
to Dabelow, all authors agree that stromal oedema, lobular enlargement
and partial new formation occur, and he states further that over a
period of years each cycle adds more differentiation and some lobuli,
since not all lobuli degenerate. Later, after describing involution,
Dabelow states that "the degree of involution never quite resembles
that state of the virgin breast", but he does not explain how the
virgin and the post-involution breasts differ.
Huseby and Thomas (1954) studied the effect of exogenous oestrogen
(given for breast cancer) in 36 patients all of whom were more than
five years past the menopause. 34 of them showed stimulation of the
epithelial cells, which were enlarged and showed signs of increased
activity. There was proliferation of ductules and new lobule formation,
and an increase in interlobular connective tissue. The oestrogen did
not, however, restore breast histology to a normal pre-menopausal
appearance.
Ozzello and Speer (1958) studied normal breast tissue obtained from
42 patients (20 from patients with carcinoma, 17 with fibrocystic
disease, and 5 with fibroadenomata). These investigators were
particularly interested in the stroma of the breast, which they studied
with special stains (haematoxylin and eosin; the Ritter-Oleson method
for neutral polysaccharides; periodic acid-Schiff stain for neutral
polysaccharides; and toluidine blue). They found that the fibres
forming the basement membrane formed a tight network in close contact
with the myoepithelial cells. The stroma surrounding the basement
membrane was RO positive, but the interlobular stroma was predominantly
PAS positive. The interlobular stroma did not change its reaction to
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any of the stains during the cycle, but the intralobular stroma
showed characteristic cyclic alterations. During the intermenstrual
phase it was in part PAS and in part HS positive, the former pre¬
dominating somewhat over the latter. The premenstrual phase was
characterised by an increase in the HS positivity, and increased
metachromasia: this increase was concomitant with an increase in the
looseness of the stroma and in the number of fibroblasts. The PAS
positive material disappeared, and at the end of the premenstrual
phase PAS positive secretory granules appeared within the acinar
cells and PAS positive material appeared in the lumina of the ductules.
After menstruation these changes were reversed.
CD Haagensen, in his textbook on diseases of the breast (Haagensen
1971), noted that there was no consensus on histological changes that
are supposed to occur during the cycle. In an effort to settle the
controversy he carried out a histological study of surgically removed
breast tissue, counting the numbers of lobules and acini in ten
representative microscopic fields of each of 100 specimens. (The
diagnosis of the primary condition is not recorded). He found no
difference in the menstrual, premenstrual and interval phases. Nor
could he see any variation in numbers of mitoses, compactness of acini,
cellularity of the stroma or intralobular oedema. The only change he
found was that vacuo!isation of the basal layer of cells was present
in 33% of cases in the premenstrual phase and 12% of cases in the
interval phase: its significance, he felt, was questionable. Unfortunately,
the parity of the subjects examined is not recorded. Remarking that
the change in size of breasts in the premenstrual phase (well documented
by several investigators, and discussed in Chapter 3) must have some
basis, he suggests that it must be due to blood or lymph engorgement,
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or to increase in the extracellular fluid tension - changes not
demonstrable by conventional microscopic techniques.
Nizze (1972) studied the intralobular connective tissue in 99
healthy breasts obtained at autopsy and 54 at biopsy. He noted a
loosening of the fibres, which he attributed to oestrogen and
progesterone - the oedema of the connective tissue was progesterone-
induced with apa-missive effect from oestrogen, but oestrogen alone
produced increased density of connective tissue. These conclusions
were inferred from the varying ages of the subjects, rather than from
plasma hormone assays.
Other methods of investigating cyclical changes in the breast are
worth mentioning here. Pickles (1950) developed a baroplethysmographic
method of measuring blood flow in the breast, and made measurements
on one subject during the normal cycle as well as during pregnancy
and lactation (Pickles 1953). He found that blood flow increased
during the luteal phase to a maximum just before menstruation, and
then fell to its lowest point at about the 10th day of the cycle.
The change was of the order of 40% of the units he used, but his
method did not allow calculations to be made of the amount of blood
flowing. Papanicolau (1958) in a study of exfoliative cytology of
nipple secretion found that among women aged 20-39 secretion could
be aspirated from 23.8% in the second week of the cycle and from 55%
in the fourth week: details of parity are not given, but the cyclical
change was not seen in women over forty. Petrakis (1975) stated that
secretions could be aspirated from approximately 75% of non-lactating
premenopausal women. In a study of 606 women in San Francisco, he
found that parity did not affect the number of women from whom
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secretions could be obtained (68.9% of nulliparous women and 71.6%
of parous women) and the menstrual cycle did not affect the proportions
either (70.8% in week 1; 83.9% in week 2; 75.8% in week 3; and 82.8%
in week 4). However, the proportion fell to 60% after the menopause.
2 Ultrastructure
The ultrastructure of the normal human breast was first studied in
the late 1950s, and none of the early reports on normal tissue suggested
cyclical changes (Tannenbaum et al 1969; Ozzello 1971) although these
were looked for carefully in 18 patients by Waugh and Van der Hoeven
(1962), who also found no effect of parity. In a detailed electron
microscope study of the epithelial-stromal junction Ozzello (1970)
suggested that it might play a functional role in regulating the
transfer of substances from the bloodstream to the mammary epithelium
and from the latter to the lymphatics, possibly by varying the
concentration or the chemical configuration of its acid mucopoly¬
saccharides. However, there was no evidence of a change in its
structure during the cycle.
A study in 1974 of 21 women of reproductive age (Fanger and Ree,
1974) suggested that ultrastructural changes do occur in the
epithelial cells. Nine of the patients examined were parous, but
parous and nulliparous women were not analysed separately. All
their subjects had benign breast disease, and the tissue studied was
histologically normal. Fanger and Ree found "characteristic" light
microscopic changes between the follicular and luteal phases of the
cycle - in the preovulatory phase acini were numerous, closely-spaced
and had nearly obliterated lumina. Epithelial cells were small,
crowded together and had irregular dark nuclei: their cytoplasm was
pale and "vacuolar fixation artefact" more frequent. The stroma was
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compact with common lymphocytes. In the postovulatory phase the
acini were larger, with re-established lumina. Epithelial cells
were taller, less crowded and had paler larger nuclei. Rare mitoses
were seen, cytoplasm was abundant, and the stroma was oedematous.
"Lobulo-acinar organisation" was at its maximum.
Under the electron microscope Fanger and Ree were able to divide
the cycle into two phases, I and II, and subdivide each phase into
two, according to the appearance of the epithelial cells lining the
ductules (which were the only structures examined in this study). A
phase I cell (soon after the menses) had a moderately wavy plasmalemmal
outline with occasional widening of intercellular spaces: microvilli
were not prominent, and nuclei varied from pear shaped to irregular.
The cytoplasmic appearances - ribosomes, polysomes, rough endoplasmic
reticulum and golgi complexes - were poorly developed, suggesting
relative inactivity. The Phase IA cell was swollen with straight
plasmalemmal outlines obliterating intercellular spaces: microvilli
were at their smallest. The nuclei were swollen, but otherwise the
cells seemed inactive - the difference between I and IA being the
swelling of the IA cells, possibly due to increased intracellular
fluid content. Phase 11A follows: the plasmalemmal outline is very
irregular, as is the nucleus. The cytoplasm is denser, with dispersed
glycogen particles. Phase 11A starts at day 15, but there is still
little evidence of activity in the cytoplasm, apart from the increased
density. Phase II cells, by contrast, have a slightly irregular
outline, with microvilli at their most prominent and numerous. The
nuclei are enlarged and less irregular, and the nucleoplasm is moderately
dense, suggesting increased activity. The density of the cytoplasm is
variable, with the glycogen leached out, but electron-opaque material
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present. The rough endoplasmic reticulum, ribosomes, polysomes
and golgi apparatus are enlarged and suggest potential secretion.
Fanger and Ree state that all the cells in a particular specimen
do not show the same type, but the predominant type in most cases
corresponds to the stage outlined above. They suggest that the
phase I cells, apparently inactive, correspond to the low ovarian
hormone levels of the menstrual phase, and the phase IA cells, which
are swollen, correspond with raised oestrogen levels in the follicular
phase - oestrogen influences cellular water and electrolyte metabolism.
They suggest also that their phase IA cells may correspond to Bassler's
B cells (Bassler 1970), and that the appearance of progesterone in the
blood stimulates glycogen production (progesterone causes glycogen
production in endometrial cells). However, they did not confirm that
their patients were ovulating. The changes in glycogen content of
endometrial cells during the luteal phase of the cycle have been
described by Armstrong (1973): glycogen and mitochondria appear between
the 13th and 20th days and an accumulation of glycogen occurs in the
cell from the 23rd to 28th day: the nucleus of the endometrial cell is
smooth in the proliferative phase and irregular in the secretory phase.
The changes described by Fanger and Ree are the appearances which would
be expected, but it should be noted that they give no figures on the
frequency of their "typical" cells in any particular specimen, and so
their observations should be treated with some caution.
E Pregnancy
The macroscopic changes in the breast in pregnancy are an enlargement
of the breast, with the blood vessels becoming more obvious, an increase
in size and pigmentation of the areola, and a change in consistency to
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a firmer and slightly less regular organ. Subjectively, "breast
tenderness" is one of the first signs of pregnancy, and is said to
begin during the fifth to sixth weeks after the last menstrual period.
The volume change during pregnancy has been fully studied by Hytten
(1954). Using a water-displacement technique which involved a
specially-made bell-shaped apparatus, he measured breast volume
during pregnancy in 86 subjects, and then measured the subsequent
milk yield. He found that the main increase in volume occurred in
the middle trimester of pregnancy (though the increase during the very
first weeks, before the women came under his care, is not known). He
also found that the subsequent milk yield does not correlate with the
total breast volume, but correlates much more closely with the increase
in volume during the pregnancy. This finding emphasises the point which
was made earlier, that the existence of a stroma, increasing the volume
of the breast, is not important to its nutritive function, since the
nutritive role of the breast seems to be best served by an increase
in size caused by the proliferating glandular component during pregnancy.
The histological changes in pregnancy are said to begin within the first
3-4 weeks gestation, with an increased ductular sprouting. The
proliferation of the ducts continues until halfway through pregnancy
(Vorherr 1974) and is then gradually replaced by a proliferation of
lobules and a hypertrophy of existing lobulo-alveolar structures.
During the third trimester of pregnancy the breast consists mainly of
enlarged lobules, with only a little supporting stroma between them.
Dabelow (1957) states that the amount of connective tissue is relatively
decreased, but Dawson (1935) states that there is an actual decrease
in the amount of connective tissue, though she points out that there is
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much variation between individuals. The development during the latter
stages of pregnancy consists of differentiation and maturation of
secretory cells: the alveoli lose their two-layered structure during
the second half of pregnancy, though the milk ducts retain a two-
layered epithelium throughout pregnancy and lactation. As the end
of the pregnancy approaches, fat droplets are seen within the secretory
cells, and there is an increasing accumulation of colostrum within the
lumina of the alveoli. The increase of breast size towards the end
of pregnancy is thought to be due to an increase in the dilation of
alveolar lumina by secretion (Vorherr 1974): this would fit in with
Hytten's (1954) finding that the increase in breast volume during
pregnancy is correlated with subsequent milk yield.
During pregnancy the levels of circulating oestrogen, progesterone
and prolactin (Friesen 1972) increase steadily to achieve maximum
values near term. Chorionic gonadotrophs reaches its maximum value
at the tenth week of pregnancy and then declines to a steady level
after the sixteenth week. The histological development of the breast,
which continues throughout pregnancy, thus correlates more closely
with the steady increase in steroid levels than with the early peak
of chorionic gonadotrophs. Human placental lactogen, however, also
shows a steady increase during pregnancy, and the pituitary gland
undergoes changes in pregnancy which involve a 30-50% increase in
its weight and volume (Vorherr 1974), mainly due to "prolactin cell"
hyperplasia (Goluboff and Ezrin 1969). The secretion of pituitary
gonadotrophins and growth hormone decreases during pregnancy (Jaffe
et al 1969; Hanson et al 1970), but serum corticosteroid levels are
increased in late pregnancy (Scholz and Huther 1971).
2-24
Work on hypophysectomised animals showed that the pituitary
synergises with oestrogen and progesterone in stimulating mammary
development (Turner 1939). Later work suggested that prolactin
alone could produce full mammary development in rats (Meites 1965).
However, the DNA content of the gland in hypophysectomised rats is
lower than in ovariectomised rats (Hahn and Turner 1966). Mammary
development can be achieved by injection of oestrogen and progesterone
(Moon et al 1959) but more complete development requires growth
hormone, insulin and Cortisol (Kumaresan 1967).
It seems, therefore, that most hormones can be implicated to some
extent in the mammary proliferation of pregnancy, but the exact
contribution of each remains unclear. The classical view that
oestrogens stimulate duct growth while progesterone produces lobulo-
alveolar development was in vogue before the importance of prolactin
or human placental lactogen was realised. The latter hormone is
very similar in structure to human growth hormone (Sherwood et al
1971) and its concentration steadily increases during pregnancy
(Varma et al 1971). Its function is unclear, as the lactogenic
activity that it shows in some experimental situations must be inhibited
during pregnancy, when it is produced: whether it also has a role in
stimulating mammary development is not known.
F Lactation
A full account of milk production will not be given here: the
mechanisms of secretion of fat, protein, carbohydrate, ions and
water have been reviewed by Linzell and Peaker (1971). To summarise
the relevant points in the human: colostrum is produced during the first
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3-5 days after parturition, before the milk "comes in". Colostrum
is a cloudy yellowish fluid with a specific gravity slightly higher
than that of milk. It is rich in protein and in some ions such as
sodium and potassium, and is particularly rich in immunoglobulin,
especially IgA. The importance of this to the neonate, particularly
in respect of the passive transfer of immunity, has been appreciated
only relatively recently, and is discussed in Chapter 6.
Around day 2-5 postpartum, there is a transitional phase, during
which the concentration of protein in the secretion falls and that of
lactose and fat rises. The secretion of fat droplets into milk
involves the pinching off of part of the apical membrane of the
secretory cell, but whole cells are not lost during milk production.
During lactation, therefore, the histological structure of the breast
remains static, with the alveolar cells having the appearance of
actively secreting epithelium: they have microvilli on the luminal
surface, a large Golgi apparatus near the basal nucleus, and prominent
mitochondria and rough-surfaced endoplasmic reticulum. The lumina of
the alveoli are distended with secretion: storage of milk is effected
in the human mainly by the alveoli, with very little contribution from
the lactiferous sinuses near the nipple. Engel (1947) studying whole-
breast sections, noted that the lactating gland has alveoli lined by
a single layer of cells (unlike the two-layered arrangement in the non-
lactating breast). He felt that the outer layer of cells was the
precursor layer, in the non-lactating breast, and the inner layer "a
kind of protective covering".
The alveoli are surrounded by a basket-shaped network of myoepithelial
cells, which are the effector organs in the suckling reflex. The
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suckling reflex is initiated by stimulation of the nipple and areola,
though conditioning allows milk ejection to be produced purely by
psychological stimuli such as the sound of the infant's crying. The
afferent component of the reflex stimulates oxytocin release from the
posterior pituitary by a neuronal pathway involving the supraoptic and
paraventricular nuclei of the hypothalamus. The oxytocin acts on the
myoepithelial cells to stimulate contraction: no innervation of these
cells has been demonstrated, and they are said to be 10-20 times more
sensitive to oxytocin than myometrial cells (Vorherr 1974). The
structure of the myoepithelial cells under the light microscope has
been described by Richardson (1950): they are very elongated cells with
branching processes, and lie external to the basement membrane. They
are irregular in shape and orientation, and are usually regarded as
modified epithelial cells. Controversy about the exact role of
myoepithelia continues, but doubts about their ability to function as
contractile tissues were ended with the advent of electron microscopy,
which demonstrated the presence of myofibrils (Hamper! 1970; Hoi 1 man
1974).
The endocrine control of lactation has two aspects: induction of
lactation and its maintenance. Induction - the sudden appearance of
milk within a few days of parturition - is thought to be the result
of the interaction of several hormones. Prolactin is essential, and
hypophysectomy during pregnancy means that lactation will not occur.
However, highly purified prolactin is ineffective in initiating
lactation in experimental animals unless combined with adrenal gluco¬
corticoids. Oestrogens can produce lactation also, but this is
thought to be mediated via prolactin (Tindal and Knaggs 1966). In
humans the secretion of oestrogens, progesterone and prolactin is
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increased in late pregnancy and the levels of steroid secretion fall
after parturition. It is thought that progesterone has an inhibitory
effect on the secretory tissue, and that the initiation of lactation
is caused partly by the removal of this progesterone effect
(Turkington and Hill 1969; Kuhn 1969; Herrenkohl 1971). Progesterone
is also said to inhibit the stimulatory effects of oestrogen and
prolactin secretion in rats (Chen and Meites 1970). In vitro
induction of lactation requires a specific sequence of hormones:
insulin and hydrocortisone are used first to induce mammary cell
division, and following this prolactin in combination with insulin
and hydrocortisone will induce casein production (Topper 1970).
Stimulation of a-lactalbumin synthesis can be blocked by progesterone
(Turkington and Hill 1969).
For the maintenance of lactation, both suckling and adequate hormone
levels are required, though suckling is not necessary for the
initiation of milk synthesis. Again, a number of hormones have been
shown to affect the maintenance of lactation (fully reviewed by Cowie
et al 1980): in animal experiments hypophysectomy causes cessation of
milk synthesis (Selye 1933) and hormone replacement with prolactin
and ACTH will partially restore lactation in hypophysectomised rats
(Cowie 1957). In goats lactation can be completely restored using a
combination of prolactin, growth hormone, adrenal corticosteroids, and
tri-iodothyronine (Cowie 1969a). Prolactin alone will restore lactation
in rabbits (Cowie et al 1969). Suckling causes prolactin secretion
(Tucker 1971) but the levels steadily decline as lactation progresses
(Kaprowski and Tucker 1973a). Animal studies have also shown the
importance of ACTH and adrenal steroids, of the thyroid and parathyroid,
and of insulin (Tucker 1974): since these hormones are essential to
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life, it is not surprising that their removal will affect lactation.
Oestrogens are not essential to lactation: the circulating levels
of ovarian oestrogens are low during lactation, and ovariectomy in
various animal species does not affect lactation (Folley and Kon
1938; Griffith and Turner 1962). Oestrogens have in fact an inhibitory
effect on lactation in several species (Cowie 1961), and synthetic
oestrogens have been used to suppress lactation in women (Watson 1969).
Progesterone does not affect lactation, even if large doses are given
(Folley 1942), but will enhance the suppression of lactation produced
by oestrogen (Griffith and Turner 1962). Progesterone may interfere
with the milk ejection reflex: Griffith and Turner found that exogenous
oxytocin did not empty the gland after progesterone administration -
an observation which suggests an action of progesterone on the myo¬
epithelial cells themselves.
Although ovarian steroids do not have important physiological effects
on lactation, lactation affects their production. In the human,
lactation produces a state of amenorrhoea which lasts for a variable
length of time but is usually several months. It has been suggested
that the inhibition of ovulation which is produced by lactation has
been the main factor regulating population growth until relatively
recently in human history (Short 1976). The inhibition of ovarian
activity appears to be achieved at a hypothalamic level by neural
stimuli: denervation of the mammary glands of animals prevents the
inhibition of reproductive activity as well as preventing the surge
of prolactin induced by suckling (Kann and Martinet 1975). If the
afferent neural stimuli do act at a hypothalamic level, then the
secretion of releasing factors for the gonadotrophins could also be
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inhibited: on the other hand it has been shown that prolactin itself
can inhibit ovarian activity in vitro (McNatty, Sawers and McNeilly
1974), and the suckling-induced surges of prolactin may therefore act
directly on the ovary.
G Involution
If suckling is discontinued for more than 48 hours, the rate of milk
synthesis and milk secretion rapidly begins to decrease (Dabelow 1957).
Bonnar et al (1975) showed that plasma prolactin concentration falls
to normal within three weeks of delivery if breast feeding is
discontinued, but remains raised for six weeks if breast feeding is
proceeded with. In both groups of women oestrogen levels fall at
delivery and FSH rises, but in non-breast feeders oestrogen rises
after 17 days in response to FSH. Bonnar suggests that prolactin
inhibits ovarian response to FSH. Engel (1947), measuring milk output
by test-feeding, stated that menstruation only returns after lactation
has begun to fail.
Dawson (1935) in her histological study of the breast describes six
stages in involution, beginning with distension of the alveoli with
retained secretion, which may actually rupture the alveolar wall.
There is flattening of the epithelial cells, and then phagocytic cells
migrate into the alveolar lumen. Secretion is removed, distension
diminished, and the alveolar wall desquamates:the cells are pushed into
the lumen, and gradually disintegrate. The process is irregular and
does not proceed uniformly even within the same lobule, but Dawson
felt that the alveoli at the periphery of a lobule seemed to disintegrate
first. The next stage is one of fibrosis, with the re-growth of
fibrous tissue, and the last stage is the reappearance of fatty tissue.
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Vorherr (1974) describes an essentially similar process, with the
addition that intracel1ular lysosomal enzymes are induced near the
Golgi apparatus to remove intracellular secretory material.
The duration of involution obviously depends on whether lactation
is stopped suddenly or gradually: Vorherr (1974) quotes a time of
three months, and Dawson 9-12 months. According to Holmann (1974),
the myoepithelial cells are the structures least affected by the
disorganisation of involution.
H The gland after the menopause
At the time of the menopause, which occurs around the age of 50,
ovarian activity ceases and circulating levels of oestrogen and
progesterone fall. There is a reduction of the amount of glandular
tissue in the breast: according to Vorherr (1974) this begins prior
to the menopause, around the age of 35, and the process speeds up
after the age of 45. Loss of lobular and alveolar structures occurs,
and ultimately only fat, connective tissue and the mammary ducts remain.
Reduction in the amount of stroma is said not to occur. Thus the
menopause does not produce a dramatic change in breast structure:
the loss of glandular tissue is a long-term process continuing over
the decades after the age of 45. This tends to contradict those who
believe that the ovary exerts an immediate effect on breast histology.
SUMMARY
This brief outline of the appearances of the human mammary gland
during a woman's lifetime indicates that although lactation and its
endocrine control have been well investigated, there remains uncertainty
about the effects of endogenous hormones on the non-pregnant and
non-lactating gland. Some investigations have shown cyclical changes
in the breast lobules during the normal menstrual cycle, but these
changes have not been quantified and have not been related to measure
ment of hormone concentrations. Other investigators have found no
cyclical changes, while still others have compromised by suggesting
that in any one cycle changes occur in some lobules but not in others
None of these previous studies has investigated cyclical changes
separately in nulliparous and parous women.
Before the present study of breast histology is described in
Chapter 4, Chapter 3 will present the results of a study of breast









Many women report a feeling of fullness in the breasts during the
premenstrual phase of the cycle. There has, however, been only
one previous attempt to measure breast volume changes directly
(Ingleby, 1949). No previous investigation had addressed the
question of whether or not oral contraception produces similar
changes in breast volume. In the previous investigation by Ingleby,
the parity of her subjects was not recorded. It was therefore
thought worthwhile to repeat the direct measurement of breast
volume changes, and also to measure breast volume in women taking
the oral contraceptive pill.
This study was conducted by a student in the Honours Zoology course
at Edinburgh University, Miss Dorothy Milligan. She was under the
supervision of Professor Short and myself
II METHODS
A Subjects
Four women were studied, all of them nulliparous healthy women aged
21 years.
Subject 1: Measurements were made for one normal cycle followed by
one contraceptive-control led cycle. The oral contraceptive was
Norinyl 1 (mestranol 50yg and norethisterone 1 mg), taken for 21 days
followed by seven tablet-free days. This subject had taken Norinyl 1
before the study and measurements were begun during the second normal
cycle after stopping the contraceptive.
Subject 2: Measurements were made for one contraceptive-controlled
cycle, followed by a normal cycle and then another contraceptive-
controlled cycle. The oral contraceptive used was Ortho-Novin 1/50
(mestranol 50yg and norethisterone 1 mg), and measurements were begun
on the sixth day of treatment. Ovulation was confirmed during the
normal cycle, by serial progesterone determinations.
Subject 3: Measurements were made for three consecutive contraceptive
controlled cycles. The contraceptive used was Gynovlar 21 (ethinyl-
oestradiol 50 ug and norethisterone acetate 3 mg) taken in the usual
regime of 21 days treatment followed by seven tablet-free days.
Subject 4: Measurements were made for one normal 29-day cycle. This
subject had not taken oral contraceptives.
B Method
1 Measurement technique A glass mixing bowl 7 inches in diameter
(17.8 cm) standing inside a container on the floor was filled to the
brim with water. The woman, kneeling on the floor, lowered one breast
into the bowl, displacing the water into the surrounding container.
The volume of water displaced was measured in a 1-litre graduated
cylinder. Variability due to postural changes was controlled by
marking positions for the container, hands, knees and elbows on a
sheet of plastic. Each woman made three consecutive measurements on
each breast every day at the same time, using water of about the same
temperature. Repeated measurements were also taken from one woman
throughout one day, and the results related to previous posture. A
series of consecutive measurements was also made over 40 minutes on
the right breast of one woman at water temperature ranging from 45 -
15°C.
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2 Reliability of technique: A measure of the precision of the
technique was obtained from the correlation between measurements
made on left and right breasts for each day of the cycle. The
correlation coefficient was highly significant (P<0.001) for all
individual cycles (Table 3:1). The "error" in the method was
calculated by expressing the variation between consecutive measure¬
ments made on one breast on any one day as a percentage of the
total change in volume during the cycle. Table 3:1 shows the error
for each subject expressed as a coefficient of variation.
TABLE 3:1





















A Effect of previous posture
Posture had an effect on breast volume, as shown in Table 3:2 below.
This effect was significant (P<0.001).
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TABLE 3:2
Variations in breast volume after consecutive changes in posture
Horizontal for
4 hours 11.5 hours
Vertical for
4 hours 11.5 hours
Right breast (ml)






B Effect of water temperature
There was a decrease in volume with decreasing water temperature and
this decrease was significant (0.05>P>0.02). The figures are given
below in Table 3:3.
TABLE 3:3
Variation in breast volume with consecutive decreases in water temperature
Temperature (°C) 45 40 35 30 25 20 15
Breast volume (ml) 542 564 571 514 525 505 518
C Cyclical changes
Breast volume increased significantly during the second half of both
normal and contraceptive-controlled menstrual cycles. Fig 3:1 shows
consecutive cycles in a single subject, the first being normal and
the second contraceptive-control 1ed. The difference between the mean
volumes in the first and second halves of both cycles is significant
(P<0.001). In the cycles illustrated in Fig 1 the smallest volumes
are found on days 9-17 of the normal cycle, with a steep rise until
the maximum volume is reached on day 25. The difference between the




Fig 3:1 Subject 2: absolute volume changes with time throughout
a normal cycle and the subsequent contraceptive controlled
cycle. (From Milligan, Drife and Short, 1975).
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In the contraceptive-controlled cycle in Fig 1, the minimum volumes are
found during menstruation, with a steady increase during the 21-day
course of tablets until the withdrawal bleed, when there was a sharp
fall.
Fig 3:2 shows the volume changes in all three normal cycles studied.
Although the peak volumes occur in the second half of the cycle, their
relationship to menstruation is not consistent, with two of the
subjects showing peak volumes at the start of the menses, and the
third showing the peak volume during the luteal phase.
Fig 3:3 shows all six contraceptive-controlled cycles studied.
Although the decrease in breast volume in these cycles started on
different days in different women, in every case the main decrease
occurred during the week when the pill was not taken. Breast volumes
increased again with the start of a new course of treatment, and maximal
volumes were found at the time of withdrawal bleeding in two subjects,
and during the latter part of the treatment cycle in the three cycles
from the third subject. Minimum volumes appear to occur a week earlier
in contraceptive-controlled cycles than in normal menstrual cycles.
IV DISCUSSION
The first investigators to measure morphological variations in the
breasts during the menstrual cycle were Reiman and Seabold (1933).
They took a series of X-rays of the breast and measured the area of
the breast shadow using a planimeter. They found that the breasts
were largest 7-10 days before the menses, although they noted that
there was a variation between different individuals, between different
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Fig 3:2 Volume changes throughout all complete normal cycles
expressed as percentages of mean volume for each cycle,
and plotted backwards from the first day of the menses.
(From Milligan, Drife and Short, 1975).
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Fig 3:3 Volume changes throughout all complete contraceptive-
controlled cycles expressed as percentages of mean
volume for each cycle, and plotted backwards from
first day of menses. (From Milligan, Drife and
Short, 1975).
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same breast. The variation in size found by these workers was up to
40% of the smallest volume, and they also apparently found that a
benign tumour varied in size with the cycle. This type of investigation
has of course never been repeated because the dangers of repeated
X-rays are now recognised. Reiman and Seabold felt that their
investigation gave an indication of volume change only, and that
accurate measurement of breast volume was impossible.
However, Geschickter (1945) used a water displacement technique and
observed an increase in volume in the second half of the cycle.
Ingleby (1949) made weekly plaster casts of the breasts of volunteers,
and then weighed the wax impressions made from these casts. She
found the smallest breast volumes in the follicular phase of the cycle
in seven out of nine women, with an increase of 8-44% above minimum
values during the second half of the cycle.
Although a simple one, the technique of measurement used here seems a
reliable one, as judged by the high correlation coefficients obtained
by each woman for measurements on the right and left breasts.
The changes described in this chapter are around 20% of the minimum
breast volume, the mean total change in normal cycles being 100 ml.
The mean change in Pill cycles was 66 ml. There have been no previous
studies on breast volume changes in response to oral contraceptives.
The results described here indicate that the change in breast volume
is a response to progesterone rather than oestrogen. Volumes in the
normal cycles are lowest around the 9th day of the cycle, when oestrogen
concentrations are highest. Fig 3:1 and Fig 3:3 show that in contraceptive-
controlled cycles the increase in volume begins earlier than in the
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normal cycle - in a contraceptive-controlled cycle a progestogen
is taken from day 7, whereas during a normal 28-day cycle progesterone
appears in the circulation only after day 15.
The mechanism of the change in breast volume is not clear. The
histological study described in Chapter 4 indicates that marked
histological changes do not occur during the normal menstrual cycle.
The most likely explanation of the volume changes is that of fluid
retention, allied to vascular changes. During the normal menstrual
cycle there are overall changes in the amount of fluid retained in
the body tissues, but the total change in body weight during the
cycle is no more than 1 kg in most women (Parboosingh et al 1973;
Thorn et al 1938). The 20% change in breast volume is therefore not
merely a reflection of generalised fluid retention.
Vascular changes in the breast have been studied by various methods.
Thermography is employed clinically to study the vascular pattern of
the breast, and Isard and Shi 1o (1968) performed weekly thermograms
on ten healthy volunteers, aged 20-43. The parity of the subjects is
not stated. Correlation of vascular changes with the cycle was poor
in this study, but in five of the women there was increased vascularity
during the week before menstruation. Parry et al (1972) studied nine
healthy women by thermography: again the parity of the women is not
recorded, but from the fact that they were student radiographers it
seems likely that most of them were nulliparous. No cyclical changes
were found in the thermograms. Parry et al attribute this negative
finding to the fact that they compensated for the change in basal
body temperature that occurs in the second half of the cycle: previous
investigators had not compensated for this rise, and Parry et al suggest
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that this explains the apparent changes found.
Zeppa (1969) studied the vascular response of the rabbit mammary
gland to hormones, using a technique of vascular labelling of whole
mounts of breast tissue. If the breast were pre-treated for two
days or more with oestrogen, a submammary injection of oestrogen
caused increased vascular permeabi1ity. This response was abolished
by antihistamines. The response to other hormones such as progesterone
was not studied.
Masters and Johnson (1966) reported a 20-25% increase in breast volume
during intense sexual excitement, and attributed this change to
vasocongestion. The method of measuring this change is not given,
but if it is genuine then it demonstrates that vascular changes alone
could explain this amount of volume change. The volume changes
measured by Hytten (1954) during pregnancy are likely to have a different
basis, being associated with glandular development during the mid-
trimester of pregnancy (Chapter 2) and being correlated with the amount
of milk yield during later lactation.
It is unfortunate that parous women were not also studied. Parous
women report similar breast symptoms to those experienced by nulliparae
(Chapter 4), but as yet there is no objective proof that their breast
stroma responds to the cycle in the same way as the nulliparae studied
in this chapter.
Summary
Four nulliparous women measured the volume of their right and left
breasts daily during the normal menstrual cycle and during contraceptive-
controlled cycles. In both normal and contraceptive-controlled cycles
the breast volume increased in the second half of the cycle. The
increase was around 20% of the minimum volume, the mean change being
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The main purpose of this project was to study normal breast histology,
in order to find out whether differences exist between nulliparous
and parous women as far as the response of their breast tissue to
the menstrual cycle is concerned. Certain difficulties are immediately
obvious. It is not possible to take tissue from the same woman before
and after pregnancy. Nor is it possible to obtain serial specimens
of tissue from a woman during a single cycle (though this has been
carried out in Rhesus monkeys (Speert 1948). Needle biopsy, used
in the diagnosis of malignant disease, does not provide enough tissue
for histological analysis.
Therefore, as discussed in Chapter 2, most investigators have found
it necessary to obtain tissue either at biopsy of a breast lump or
at post-mortem. Because there is much variation between individuals,
large numbers of specimens are required, and these can only be
accumulated by using biopsy material. The advantages of using such
material are that a history can be obtained from the patient, blood
can be taken for hormone estimation, and fresh tissue is obtained
suitable for organ culture. The disadvantages are that only a single
small specimen can usually be obtained, and that because a breast lump
is present the breast cannot be regarded as truly normal. These points
are discussed in more detail in Section IV of this chapter, which also
contains an account of my attempt at using post-mortem material.
Despite the imperfections, therefore, there was no alternative to the
use of tissue obtained at breast biopsy. The help of several surgeons
(who are acknowledged elsewhere in the thesis) was therefore sought
and was most willingly given.
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II PATIENTS AND METHODS
Specimens of tissue were obtained from 174 patients. Of these, 156
were undergoing surgery for biopsy of a breast lump: these operations
were performed in the Royal Infirmary (Wards 7 & 8), Chalmers Hospital,
Longmore Hospital and the Deaconess Hospital, Edinburgh. The remaining
18 were undergoing reduction mammoplasty at Bangour Hospital, Broxburn,
West Lothian. All the patients were interviewed by me before operation,
except for five patients who were interviewed by the medical or nursing
staff in my absence. The purpose of the study was explained to them,
and they all agreed to allow normal tissue to be taken.
A History
The data form used for recording the patient's history is given in
Appendix 1. The patient's age, age at menarche, parity and dates of
pregnancies were recorded. The date of the last menstrual period was
noted, along with the regularity of the menstrual cycle. A note was
taken of the times that the patient had taken oral contraceptives in
the past. In case anxiety over her condition might have upset the
regularity of the menstrual cycle, a note was made of the date when
she first saw a doctor about the breast lump. From 118 patients
details were taken about premenstrual breast tenderness or other
premenstrual symptoms. To check that the next period came at the
expected date, 112 patients were asked to fill in a note giving the
date of their next period after the operation, and post it to me in
a prepaid envelope. The rate of return of these envelopes was high
(103 out of 112: 92%). Patients taking oral contraceptives, and those
who turned out to have cancer, were not asked to do this.
Tables 4:1 to 4:8 give a summary of the histories obtained.
TABLE 4:1































SD: 9.6 SE: 0.7
SD: 9.7 SE: 0.7
SD: 7.6 SE: 0.7
SD: 7.9 SE: 0.7
SD: 11.3 SE: 1.5
SD: 11.3 SE: 1.5
"Menstrual age" means the age of the patient minus her age at menarche
SD means Standard Deviation
SE means Standard Error of Mean
In all subsequent Tables in this chapter, Standard Errors are given





0 + 1 3
1 + 0 14
1 + 1 4
1 + 2 1
1 + 4 1
2 + 0 41
2 + 1 13
2 + 2 1
2 + 3 1
3 + 0 13
3 + 1 8
3 + 2 3
3 + 3 1
3 + 5 1
4 + 0 4
4+1 2
4 + 2 1
5 + 0 2
6 + 0 1
TOTAL 174
The first figure refers to the number of pregnancies of more th
28 weeks' gestation. The second figure refers to the number of
miscarriages (ie. less than 28 weeks' gestation).
TABLE 4:3a
Menstrual cycles of nulliparous patients studied (Total: 49)
Length of menses Lengths of cycle Irregular cycles
2 days 1 23 days 1 21-28 days •• 1
3 days 2 24 days 0 14-45 days •• 1
4 days . 11 25 days 2 28-56 days •• 1
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6 months








Nulliparae on oral contraceptives (Total 10)
Length of menses
3 days .. 3
4 days .. 5
28 day cycle .. 10
5 days .. 1
7 days .. 1
In Table 4:3a and Table 4:3b the length of cycle and length of
menses are those given in the patient's history.
Table 4:4 shows the accuracy of the history as indicated by the
letters patients sent notifying me of the date of their next period.
TABLE 4:3b
Menstrual cycles of parous patients studied (Total: 95)
Length of menses Length of cycle Irregular cycles
2 days 2 21 days .. 8 14-21 days .. 2
3 days 9 22 days .. 0 14-42 days .. 1
4 days 10 23 days . 1 14-49 days .. 1
5 days 34 24 days . 1 14 days -
3 months
6 days 14 25 days . 3
21-35 days .. 1
7 days 16 26 days . 5
28-35 days .. 1
8 days 4 27 days . 3
28-42 days .. 1
9 days 1 28 days . 52
6-8 weeks .. 1
10-15 days .. 1 29 days . 2
35-42 days .. 1
Not known .. 1 30 days . 5
Post- ^3-7 days .. 1 35 days . 2 menopause
Post- ? 3 months . 1
menopause
• • C-
Parous patients on oral contraceptives (Total 20)
Lengths of menses
1 day 1
2 days .. 1
3 days .. 3 26 day cycle
4 days .. 11 28 day cycle





Confirmation of stage of cycle
























































3 Nulliparae and 2 parous patients on oral contraceptives confirmed
that their periods arrived at the right time. One parous patient
on oral contraceptives had a period one day late. One nullipara
confirmed that she was post-menopausal.
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TABLE 4:5
History of oral contraceptive ("Pill") use
"Pill"refers to combined oestrogen-progestogen oral contraceptives,
of various types.
Never on Pill
On Pill in past
Less than 1 year .. 28
1-2 years .. 15
2-4 years .. 12
5 years .. 3
6-8 years .. 3

























TABLE 4:6 Breast Feeding History in 112 Parous Patients
Not known 10
No breast feeding 42
Breast feeding 60
Fed first baby but not second 13



















Fed more than one baby
1 week & 2 weeks
2 weeks & 1 week
1 month x 4
6 weeks & 2 weeks
6 weeks/0/6 weeks/0
6 weeks & 2 weeks
6 weeks x 3
3 months & 6 weeks
3 months & 2 months
3 months x 2
0/3 months x 2
3 months & 4% months
4 months/2 months x 2
5 months x 2/2 months
5 months & 6 months
6 months & 2 months
6 months & 3 months
6 months & 3 months x 2
6 months & 6 months
6 months/4^ months/1 month
7 months & 2 months
7 months & 4 months
7 months x 2
7 months x 3
8 months & 6 months
8 months x 2
0 & 9 months
9 months & 6 weeks
9 months & 8 months
TOTAL
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TABLE 4:7 Menstrual symptoms
a) Breast symptoms during the cycle among 115 patients asked
Tenderness (91 patients were specifically asked about this)
None 42
1-2 days before menses 14 )
3 days - 1 week before menses 30 ) 49
1-2 weeks before menses 5 )
Swelling 32
Swelling only on Pill 1
Lumpiness 1
Mastitis 1
b) OTHER Menstrual Symptoms
Pre-menstrual tension (96 patients specifically asked)
None 43
1-2 days before menses 27 ) ^







"Feels great" (2 days before menses) 1
"Swelling" includes: bloatedness, heaviness, fullness, hard, and tight
(Totals are not given because some patients had more than one symptom.
For totals see Table 4:8)
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TABLE 4:8
Correlation between breast symptoms and pre-menstrual tension (PMT)
Neither 24
Breast symptoms but no PMT 31




No breast symptoms 24 18 42
Breast symptoms 31 42 73
55 60 115
2
Correlation: X : 1.75 Not significant
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B Hormone estimation
A sample of 10 ml of venous blood was taken either at the time
that the patient was interviewed (which was within 24 hours of
operation) or by the anaesthetist during the operation. Blood
was centrifuged and the plasma was stored in the deep freeze
(-20°C) within a few hours of being obtained.
Plasma progesterone was estimated by radioimmunoassay using a
modification of the method of Neal et al (1975).
Plasma oestradiol was estimated by radioimmunoassay using a
modification of the method of Cameron et al (1972).
C Biopsy technique
All biopsies were taken under general anaesthesia. Since many
different anaesthetists were involved over the series of 174 patients,
the techniques of anaesthesia varied.
Through a single incision, first the clinically abnormal lump was
removed and sent for examination by the pathologist. Then a piece
of macroscopically normal tissue was removed by the surgeon from a
site as far away as possible from the clinically abnormal lump.
With reduction mammoplasty specimens, glandular tissue was selected
from the excised tissue soon after its removal. The selection was
usually random, though in some cases it was possible to record the
quadrant from which the tissue was taken.
With biopsy specimens, the site of the biopsy was checked by noting
the silde, quadrant, and distance from the nipple, of the scar after
operation.
The dates and sites of the biopsies are given in Tables 4:9 and
4:10. From some patients multiple specimens were taken, and details
of these are given in Table 4:11.








































Not known 1 3
Post-menopausal 2 2




Plasma progesterone concentrations during the cycle in parous
and nulliparous women (ng/ml)
Day of cycle Nul1iparae Parous women
1 - 7 0.460 + 0.199 0.968 + 0.298
(n: 7) (n: 23)
8-14 1.460 + 0.589 1.688 + 0.517
(n: 14) (n: 28)
15 - 21 6.165 + 1.724 6.452 + 1.011
(n: 6) (n: 21)
22 - 28 8.921 + 1.734 7.010 + 1.261
(n: 7) (n: 16)
29+ 6.993 + 2.976 7.933 + 5.118
(n: 4) (n: 3)
During the follicular phase of the cycle, 7 of the 21 nulliparae
and 15 of the 51 parous women had plasma progesterone concentrations
greater than 1 ng/ml (3.2 n mol/1).
During the luteal phase of the cycle, 1 of the 13 nulliparae and
3 of the 37 parous women had plasma progesterone concentrations less
than 1 ng/ml (3.2 n mol/1)
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TABLE 4:11
Plasma oestradiol-17g concentrations during the cycle in parous
and nulliparous women (pmol/1)
Day of cycle Nulliparae Parous women
1 - 7 530 + 141 363 + 53
(n: 8) (n: 21)
00 1 h-* -pi 572 + 99 737 + 104
(n: 14) (n: 24)
15 - 21 413 + 94 593 + 63
(n: 4) (n: 17)
22 - 28 597 + 169 418 + 78
(n: 6) (n: 11)
29+ 423 + 153 346 + 227
(n: 4) (n: 2)
In this and the previous table, the "day of cycle" is that given
by the menstrual history.
TABLE 4:12 Sites of Biopsies
a) Quadrant Nul1iparae Parous patients
R upper outer 12 22
R upper inner 3 12
R lower outer 5 3
R lower inner 0 3
L upper outer 12 15
L upper inner 3 11
L lower outer 2 3
L lower inner 2 8
Not known 12 33
Multiple specimens 8 5
TOTAL 59 115
Distance from nipple
1 cm 2 8
2 cm 8 14
3 cm 2 15
4 cm 4 10
5 cm 5 10
6 cm 15 13
7 cm 1 2
8 cm 0 1
Not known 14 37











6 or more 13 16






Total 118 36 82
The distribution is not significantly different among parous
women and nulliparae.
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TABLE 4 : 14 Patients from Which multiple specimens were obtained
Parity Diagnosis Area biopsied
Number of
specimens
Parous Fibroadenoma R & L breasts 2
Parous Fibrocystic disease R upper inner quadrant 2
Null ip Fibroadenomata R & L breasts 2
Nullip Mammoplasty R med & lat sides 2
Nullip Mammoplasty R med & lat sides 2
Nullip Mammoplasty R med & lat sides 2
Null ip Mannoplasty R & L breasts 2
Parous Fibroadenomata R & L breasts 2
0+1 Mammoplasty 4 from each breast 8
Parous Mammary dysplasia R & L upper outer quadrants 2
Null ip Mammoplasty 3 from each breast 6
Nullip Fibroadenomata R & L breasts 2
Nul1ip Mammoplasty 2 from each breast 4
Parous Mammoplasty 5 from one breast 5
Nullip Mammoplasty 10 from one breast:
2 central and 2 from each
10
of four quadrants (one
from central and one from
peripheral part of each
quadrant)
(Normally with mammoplasty specimens it was impossible to identify
the quadrant or distance from the nipple from which the tissue was
obtained, as tissue was taken randomly from the specimens removed
by the surgeon).
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The size of the biopsy of normal tissue varied but it was usually
a cube of around 0.5 to 1.0 cm side. It was immediately placed
in 4% neutral buffered formaldehyde.
At the same time smaller specimens were obtained from most of the
patients for fixation in glutaraldehyde, and samples of tissue were
frozen on solid CC^.
Some of the patients also provided specimens for the study of DNA
synthesis and immunoglobulin synthesis. This tissue was obtained
at the same time and was transported separately in different media,
as described in Chapter 5 and Chapter 6.
D Diagnosis of the breast lump
The histopathology of the primary condition for which the biopsy
was undertaken is noted in Table 4:15. The diagnoses in this table
are those made by the routine pathology services to the various
hospitals. The diagnostic labels attached to the benign conditions
vary considerably, and in Table 4:15 they have been grouped into
three groups. Group one consists of conditions involving a discrete
lump such as a fibroadenoma or a lipoma - which may be expected to
leave the rest of the breast entirely normal. This group also includes
the eighteen patients who had normal tissue removed at mammoplasty -
the pathologist checked this tissue in each case and reported it as
normal. Group one also includes four cases in which the apparent lump
removed consisted of normal tissue.
Group 2 consists of benign conditions which may involve more than
one area of the breast (for example, fibrocystic disease).
Group 3 consists of eleven patients who proved to have carcinoma.
These were excluded from further analysis.
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TABLE 4:15 Histopathology of primary condition
Group 1: Localised conditions
Fibroadenoma 36







Normal lymph node 1
TOTAL 66
Group 2: Fibrosing adenosis with or without cyst formation
Fibrocystic disease 17
Cystic disease and fibroadenosis 1
Fibroadenosis and fibrocystic disease 1
Fibroadenosis 43
Fibroadenosis and cysts with epitheliosis 1
Fibroadenoma and fibroadenosis 4
Fibroadenosis with cysts 3
Mammary dysplasia 4
Fibrosing adenosis 2








Fibrosis and cyst formation
Adenosis
Fibroadenomata with epithelial hyperplasia
Sclerosing adenosis with microcysts
Epitheliosis
Epitheliosis and adenosis
Mammary dysplasia (multifocal duct papilloma,
fibroadenosis, fibrosing adenosis, focal epitheliosis)
TABLE 4:15 (continued)
Adenosis, fibrosis, epitheliosis, sclerosing adenosis
Interlobular fibrosis, fibroadenosis, involution
Fibrosclerosis and atypical lobular hyperplasia
Fibroadenoma and cystic epithelial hyperplasia
Cystic epithelial hyperplasia and duct ectasia
Epitheliosis and sclerosis with adenosis
TOTAL





Relationship between parity and diagnosis of the primary benign condition
Group 1
(localised disease) gener^ised disease)
Nul1iparae (n: 56)
Proliferative phase 16 ) 12 )
Luteal phase 10 ) 29 8 ) 27
On Pill 3 ) 7 )
Parous women (n: 107)
Proliferative phase 16 ) 39 )
Luteal phase 11 ) 37 24 ) 70
On Pill 10 ) 7 )
TOTAL 66 97
See text for explanation of "Group 1" and "Group 2".
There is no significant difference between parous and nulliparous
women as regards the type of breast disease. There is no difference
between the phases of the cycle as regards the type of disease.
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III HISTOLOGY
A Preparation of the sections
The tissue blocks were stored in 4% neutral buffered formaldehyde
for several days until a group of about ten specimens was collected.
Sections 4y thick were then cut on a standard rotary microtome.
Multiple sections were taken from some blocks (for comparison with
one another) but normally only one series of sections, each stained
differently, was kept from each specimen.
Cutting and staining of the sections were carried out under the
supervision of Mr R R Hogg of the Research Laboratory of the Department
of Pathology.
Most of the histological analysis (except where stated) was carried
out on sections stained with haematoxylin and eosin. This staining
was performed by the standard method (Drury and Wallington 1967,
p 129) in which nuclei appear blue to blue-black, cytoplasm appears
as shades of pink, and fibrous and elastic tissue also appears pink.
Other stains used were as follows:
Methyl Green-Pyronin: (Drury and Wallington 1967, p 160)
This method uses a mixture of two basic dyes to stain chromatin and
basophilic inclusion bodies (usually RNA). DNA is stained green or
blue-green, and RNA granules stain dark rose red. The cytoplasm of
plasma cells stains purple.
Gomori's Aldehyde Fuchsin Stain (Drury and Wallington 1967, p 179).
This method shows elastic fibres (and also some mucopolysaccharides
and mast cell granules) as a deep purple-violet.
Alcian Blue Stain for acid mucopolysaccharides (Drury and Wallington
1967, p 212). This method, in which acid mucopolysaccharides appear
blue, was combined with the Periodic Acid-Schniff method (Drury
and Wallington 1967, p 204) in which neutral polysaccharides appear
red or magenta.
Best's Carmine Method for Glycogen (Drury and Wallington 1967, p 208)
This stain shows glycogen as bright red granules, while nuclei stain
blue.
Masson's Trichrome Stain (Drury and Wallington 1967, p 167). This
stain for collagen shows nuclei as black, fibrin as red, and collagen
(using the light green counterstain) as green. Reticulin and mucin
also stain green.
Enzyme methods were also used on tissue which had been frozen on
solid CO2 after removal, but satisfactory staining was not obtained
and so no analysis was carried out of this material.
Histological Analysis
All the histological analysis was carried out by myself. Dr I I Smith
and Dr T J Anderson of the Department of Pathology gave helpful advice
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Fig 4:1(a) To illustrate a normal lobule
Mammoplasty specimen obtained from a 21 year-old nulliparous woman
on the tenth day of a 26-day cycle. The plasma progesterone concentration
was "undetectable". Her menarche had been at the age of 11. Objectively
the breasts did not appear grossly over-developed, and she had no breast
symptoms, but she said that breast development had begun at the age of 7,
two years after radiotherapy to a tumour of the orbit.
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Fig 4:l(b) To illustrate a normal lobule.
This is a second normal lobule from the same section
as that illustrated in Fig 4:l(a). Intralobular stromal
oedema is clearly seen.
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The histological analysis is divided into three broad areas: the
breast lobules, the ductules, and the stroma (both intralobular
and extralobular). There is some overlap between these three
headings, but it convenient to describe them separately.
B Examination of the lobules
1 Methods
The structure of a typical breast lobule is shown in Fig 4:1(a & b).
The lobule consists of a number of ductules (also called acini)
embedded in a stroma of loose connective tissue. The ductules arise
from a terminal ductule which can rarely be identified in a section.
The loose connective tissue (the intralobular stroma) is usually
clearly distinguishable from the remainder of the breast stroma (the
extralobular stroma - also called the interlobular stroma). The
variables examined were as follows.
a) Lobules per unit area The number of lobules in each section was
counted. A lobule was defined as three or more ductules in close
apposition. The area of the section was measured using a measuring
eyepiece with a scale. (The units in this scale measured 3.0 mm in
length when used with the lowest-power objective lens (4/0 . 12).
The length and breadth of the section were each measured, and multiplied
together to obtain the area. Although sections were not exactly
rectangular, making this method of measurement slightly inaccurate,
it is felt to be sufficiently accurate for its purpose, which is
comparison of sections with one another. The areas were measured in
square millimetres.
b) Ductules per unit area The number of ductules in each lobule
was counted. The total number of ductules in the section was obtained
by addition, and was divided by the area of the section. When the
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number of lobules in the section was much greater than twenty,
the number of ductules in the first twenty lobules was counted,
and the total number of ductules was obtained by multiplying the
total number of lobules by the average number of ductules in the
first twenty lobules.
c) Percentage area of lobules This figure represents the
proportion of the total section area occupied by lobules. Two
methods were used to obtain this value: direct measurement and
automated analysis.
(i) Direct measurement - The dimensions of each lobule
in a section were obtained using the measuring eyepiece. The
area of each lobule was obtained by multiplying its length
by its breadth - involving an approximation since the lobules
are not rectangular. The areas of all the lobules were added
up to give the total area occupied by the lobules, which was
then divided by the total area of the section (found by direct
measurement as described above) to give a percentage. This was
a time-consuming method, and was used in 21 sections altogether.
(ii) Automated analysis - Because measurement of each lobule
was laborious, an alternative method was sought. Automated image
analysis was available from a commercial research organisation,
Inveresk Research International, using a "Quantimet" image
analyser. The"Quantimet" (Imanco, Cambridge Instruments Ltd,
Melbourn, Royston, Herts) is a machine which consists of a video
screen connected to a microscope. Connected to the video screen
is a computer which can give a point count, using a grid on the
screen of 600 x 450 - ie. 270,000 - points. Detection levels can
be set, and in this case two levels were used: dark areas
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indicated glandular material in the section of breast tissue
being scanned, and the lighter areas were stroma. The method
depended on the fact that the glandular tissue is much more
cellular than the stroma, and the concentrations of darkly-
staining nuclei made the glandular tissue appear dark on the
black-and-white video screen. At the magnification and
resolution used, the point count was a count of whole cells
rather than nuclei only. Only low-power scanning was carried
out, and a green filter was used to clarify the black-and-white
image. Approximately 10 to 20 fields were scanned in each
specimen, and the whole specimen was included. The smallest
section required three fields, and the largest 40, with a mean
of 17. Only haematoxylin and eosin sections were used, and the
analysis was done by myself after suitable training in the use of
the machine.
A comparison between the results of Quantimet analysis and
direct measurement of the lobules is given in the Results section.
d) Average number of ductules per lobule This was found by counting
the ductules in each lobule. When a section contained a very large
number of lobules (more than 25), only the first 20 lobules were
examined. A lobule was defined as being separate from an adjacent
lobule if a distinct line of extralobular stroma could be seen between
them.
e) Area of average lobule This was obtained by measurement (as
described in (c) above) of the total area of the lobules: this figure
was divided by the number of lobules, obtained by direct counting. The
result was expressed in square millimetres.
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f) Ductule density in lobules This figure represents the
number of ductules per unit area of the lobule. It is expressed
in ductules per square millimetre. It was obtained by dividing
the average number of ductules per lobule ("d", above) by the




(a) Reproducibility of Quantimet analysis
When the same section was examined by the "Quantimet" on different
days, some variation in the readings was noted. This variation
is shown below (Table 4:17).
TABLE 4:17 Variation in "Quantimet" readings of lobule area, between










21 Reading on 1st day 244,853 6,993,245 3.5
Reading on 2nd day 346,284 5,319,378 6.5
50 Reading on 1st day 144,753 1,561,587 9.3
Reading on 2nd day 143,770 1,143,894 12.6
80 Reading on 1st day 68,842 1,963,211 3.5
Reading on 2nd day 42,681 1,501,240 2.8
(r for % area of lobules = 0.93)
The variation between the two readings on the same section on different
days occurs because of difficulty in setting detection levels on the
"Quantimet" in exactly the same way at each session. It was not possible
to examine all the sections in the same session, but in an effort to
minimise the variation the whole series of 100 sections was examined
in three sessions.
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(g) Variation between specimens from the same breast
Three pairs of specimens, each pair from a single breast,
were examined using a "Quantimet", and the results are shown
below (Table 4:18).
TABLE 4:18
"Quantimet" analysis - variation between specimens from a single breast
r= 0.54 (NS)
The variation in this series of three pairs is fairly marked. This
is considered further later in this section.
(y) Relation between lobule area measured by "Quantimet" and
measured directly
In nine sections the lobule area was measured directly as described
in the Methods section (part c(i), page 4-30), and also by the
automated method. The correlation between these two methods is
shown in Fig 4:2. The correlation coefficient, r, = 0.807. This
correlation is unsatisfactory, indicating that one or both methods
is subject to an appreciable degree of error. However, it indicates
that the automated analysis gives a guide, if not an accurate
measurement,of the proportion of glandular tissue present.
(ii) Variation in one block - Several sections from a single
block were examined in three cases to assess the amount of
variation over a small area of tissue. The blocks were chosen
by a colleague (TJA) to represent different groups of patients,
Section number % area of lobules










Lobule Area (per cent)
by QUANTIMET
Lobule Area (per cent) by direct measurement
Fig 4:2: Lobule area (per cent). Relationship between direct
measurement and measurement by "Quantimet" automated analysis.
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but were examined "blind" after relabelling. Specimen 171 is
from a nullipara, never on the Pill, at day 13 of her cycle.
Specimen 101 is from a parous woman, on the Pill in the past but
not at the time of biopsy, at day 28. The results are presented
overleaf (Table 4:19).
Table 4:19 shows that there is substantial variation between
sections cut from the same block (although these sections were
not adjacent: every tenth section was examined). Despite this
variation, the difference between patients was still greater than
the difference between sections, and the asterisks in Table 4:19
denote significant differences between specimens 101 and 171 for
the first four factors examined - ie. for all parameters except
the area of the average lobule and the ductule density within the
lobules, both of which seem constant among different patients.
(iii) Variation in one breast - To asses the amount of variation
between different areas of a single breast, ten blocks were taken
from one breast at mammoplasty. Two blocks were taken from close
to the nipple, and two from each quadrant - one from the periphery























































































































































































































































TABLE 4:21 Assessment of lobules










Right Left Right Left Right Left
Lobules/sq mm 1.33 0.54 0.14 0.25 0.17 0.18
Ductules/sq mm 46.6 16.5 2.2 2.4 1.8 2.2
I Area of lobules 10.1 9.6 2.9 7.5 2.6 3.2
Average number of
ductules/lobules 35 30.6 15.5 9.4 10.3 12.2
Area of average
lobule (sq mm) 0.09 0.15 0.21 0.30 0.15 0.18
Ductule density in
lobules (/sq mm) 398 201 75 31 69 68
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Table 4:20 shows that the size of lobules and numbers of ductules
per lobule are relatively constant, but that there is more variation
in other parameters. In particular, there is a greater number of
lobules and ductules per square millimetre in the upper outer
quadrant of this breast. The question of the influence of the site
of biopsy is discussed further in Section c(v).
(iv) Variation between right and left breasts - Bilateral
biopsies were taken in three cases and the right and left breasts
were compared. The results are presented in Table 4:21. From
this table it appears that although there may be variation between
the right and left breasts of one subject, this is less than the
variation between different subjects.
Extreme examples of the variation between subjects are shown in
Figs 4:3 and 4:4
b) Effects of parity and the menstrual cycle
Parity A comparison of the lobules between nulliparous and parous
women is shown in Table 4:22. Most of the aspects studied show no
significant difference between the two groups, although there is a
trend towards higher numbers of ductules/sq mm among the parous women.
However, significant differences were seen in two parameters: the
number of lobules per unit area, and the ductule density in the lobules.
In both these instances the significance of the difference was not
high, P being just less than 0.05. Both, however, showed a similar
trend with the higher values being found among the parous women (a
similar trend to that found for the numbers of ductules/sq mm).
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x 80
Fig 4:3 To illustrate a specimen with large numbers of ductules/sq mm
The specimen was obtained at biopsy (diagnosis of lump: fibroadenosis)
from a 45 year-old woman on the 12th day of a 21-day cycle. The
plasma progesterone concentration was 7.4 ng/ml. Her menarche
had been at the age of 14. She had had two full-term pregnancies,
one when she was aged 27 and one at the age of 30. She had breast¬




Fig 4:4 To illustrate a specimen with small numbers of ductules/sq mm
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenoma) from a 46 year-old woman on the eighth day of
a 25-day cycle. The plasma progesterone concentration was
"undetectable". Her menarche had been at the age of 11.
She had had one full-term pregnancy at the age of 23, and
one miscarriage. She had breast-fed for eight weeks.
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TABLE 4:22 Assessment of lobules: effect of parity
ALL NULLIPARAE ALL PAROUS WOMEN
Lobules/sq mm 0.287 0.428
+ 0.049 " P<0*05 " + 0.036
(n: 40) (n: 87)
Ductules/sq mm 6.05 9.1
+1.18 - NS - +1.06
(n: 36) (n: 67)
% area of lobules 8.23 7.50
+ 1.41 - NS - + 0.66
(n: 31) (n: 62)
Average number of 20.7 22.0
ductules/lobule
+2.2 - NS - +1.1
(n: 34) (n: 66)
Area of average 0.227 0.229
lobule (sq mm)
+ 0.026 - NS - + 0.025
(n: 24) (n: 62)
Ductule density in 112 178
lobules (/sq mm) _ p n n(. _
+ 20 r<u.uo + 19
(n: 22) (n: 45)
In this and subsequent Tables showing Mean + Standard Error,
statistical analysis was by Student's "t" test.
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Menstrual cycle and oral contraception
Separate studies were made of women taking oral contraceptives,
women in the follicular phase of the cycle, and women in the luteal
phase of the cycle (as shown by a plasma progesterone concentration
of over 1 ng/ml). Nulliparous and parous women were examined
separately. The results are summarised in Table 4:23.
There is no significant difference between the phases of the cycle
in either parous or nulliparous women, for any of the parameters
studied. Nor do women taking oral contraceptives show any significant
difference from either those in the follicular phase or those in the
luteal phase.
Coded specimens
To eliminate possible bias in assessment of the specimens, 20 sections
were selected by a colleague (TJA) and relabelled. The sections were
selected to represent approximately equal numbers of parous and
nulliparous women in each phase of the cycle. Assessment was then
carried out by myself, "blind", and the code was not broken until the
assessment was complete.
The results are set out in Tables 4:24 and 4:25.
TABLE 4:23 Assessment of lobules
Effects of parity, stage of cycle and oral contraception
NULLIPARAE PAROUS WOMEN
II Pro!if Luteal Q p.,, Pro!if Luteal
phase phase phase phase
Lobules/sq mm 0.35 0.27 0.27 0.37 0.41 0.47
+0.15 +0.06 +0.07 +0.07 +0.06 +0.05
(n: 10) (n: 16) (n: 14) (n: 12) (n:43) (n:32)
Ductules/sq mm 4.7 8.3 4.6 7.4 9.2 9.8
+1.9 +2.4 +1.5 +2.0 +1.8 +1.1
(n:8) (n:14) (n:14) (n:10) (n:35) (n:22)
I area of lobules 8.29 8.77 7.77 7.23 7.55 7.84
+3.63 +2.15 +2.11 +2.46 +0.99 +0.97
(n:8) (n:10) (n:13) (n:7) (n:29) (n:26)
Average number of 20.27 26.54 15.9 21.93 22.44 21.28
ductules/lobule
^A5 ^4>44 ^2 8J ^1<8] ^ >51
(n:8) (n: 12) (n:14) (n:9) (n:35) (n:22)
Area of average 0.221 0.238 0.220 0.358 0.213 0.195
lobule (sq mm) +0.051 +0.049 +0.039 +0.101 +0.041 +0.025
(n:6) (n:9) (n:9) (n:8) (n: 28) (n:26)
Ductule density in 121 113 103 135 178 189
lobules (sq mm) ±43 ±36 ±3, ±6, ±24 ±36
(n:7) (n:6) (n:9) (n:6) (n:22) (n: 17)
There are no significant differences between the subgroups.
4-45
TABLE 4:24 Assessment of lobules




Q p.,, Follic Lutealphase phase phase phase
Lobules/sq mm 0.291 0.481 0.582 0.604 0.347 0.861
+0.011 +0.140 +0.293 +0.168 +0.084 +0.242
Ductules/sq mm 5.03 10.18 7.16 16.67 6.15 16.33
+3.19 +6.49 +4.16 +12.92 +3.37 +5.00
% area of lobules 6.4 9.4 6.7 17.7 5.1 13.1
+4.4 +3.8 +2.4 +11.1 +2.8 +4.0
Average number of 18.2 16.2 11.7 23.3 16.0 18.8
ductules/lobule
+g>g +1 >9 +2o.8 +5.3 +1.6
Area of average 0*233 0.239 0.146 0.263 0.133 0.156
lobule (sq mm) +0.127 +0.05 +0.045 +0.112 +0.043 +0.029
Ductule density 81.5 93.1 102.4 78.9 120.2 136.1
(/sq°mm)eS ~6-2 i46-4 i26,0 i23-3 i2,5 i22-6
TOTAL 23 (n:2) (n:5) (n:5) (n:2) (n:3) (n:6)
Differences between subgroups are not significant
TABLE 4:25 Assessment of lobules
Coded specimens: Effects of stage of cycle and parity
SIMPLIFIED TABLE
All All 1,? ! „ follic lutealmil lips parous phase phasp
Lobules/sq mm 0.49 0.67 0.425 0.738
+0.13 +0.12 +0.092 +0.183
Ductules/sq mm 8.05 13.6 8.61 12.19
+3.08 +3.5 +4.10 +3.47
% area of lobules 7.8 11.8 7.8 10.2
+1.9 +3.0 +2.5 +2.6
Average no of 14.7 18.9 16.1 15.6
ductules/lobule +2J +2>g +3_g +]>6
Area of average 0.199 0.169 0.199 0.152













Differences between subgroups are not significant
c) Other factors
i) Menstrua] age (Table 4-26)
The "Menstrual age" is the patient's age minus her age at menarche.
Patients were divided into four groups as shown in Table 4:26, each
group covering ten years of menstrual age.
Although there is variation between groups regarding some of the
parameters studied, no general trend is seen. The numbers of
lobules/sq mm and ductules/sq mm are smaller in the youngest age
group than in the others, and this difference is significant (P<0.05).
ii) Birth interval (Table 4:27)
"Birth interval" is defined here as the age at first full-term
pregnancy minus the age at menarche. Obviously, therefore, it applies
to parous women only.
Patients were divided into five groups as shown in Table 4:28, with
each group covering a five-year birth interval.
If lobule development continued before first pregnancy but was arrested
after first pregnancy, a trend would be seen in Table 4:27, but no such
trend is present. The numbers of specimens in some of the groups are
small, but in spite of this the results are fairly constant, and
differences are not significant.
iii) Breast-feeding history among parous women (Table 4:28)
Parous women in whom the history of breast-feeding was known were
divided into five groups according to whether or not they had breast¬
fed, and for how long. The groupings according to duration of
breast-feeding were chosen simply in order to provide approximately
equal numbers of women in each group. The results, summarised in
Table 4:28, show no trends and no significant differences, either
according to length of breast-feeding, or between those who breast¬
fed and those who did not.
4-48
TABLE 4:26 Assessment of lobules
Effect of menstrual age
Menstrual age (years)
1 - 9 10-19 20-29 30+
Lobules/sq mm 0.27 0.49 0.33 0.42
+0.07 +0.06 +0.04 +0.07
(n: 21) (n :37) (n: 44) (n:29)
\
Ductules/sq mm 4.3 10.6 7.7 6.9
+1.0 +2.0 +1.2 +1.6
(n : 17) (n:29) (n:37) (n:18)
l area of lobules 7.06 8.57 7.45 8.70
+1.61 +1.04 +1.21 +1.27
(n : 17) (n:28) (n:31) (n:20)
Average no of 20.7 23.0 20.1 19.3
ductules/lobules
±2g ±1 g ±UJ ±ZA
(n: 15) (n :29) (n:36) (n:18)
Area of average 0.194 0.263 0.192 0.236
lobule (sq mm) +0.028 +0.039 +0.030 +0.051
(n :13) (n: 28) (n:26) (n:19)
Ductule density 165 147 147 168
)" lobul,es +51 +25 +23 +40(/sq mm) - - - —
(n : 11) (n:22) (n:23) (n: 11)
Differences between the youngest age group and the others are significant,
for lobules/sq mm and ductules/sq mm (P<0.05). Otherwise differences
are not significant.
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TABLE 4:27 Assessment of lobules
Effect of birth interval among parous women
Birth interval (years)
2 - 5 6 - 10 11 - 15 16 - 20 21 +
Lobules/sq mm 0.64 0.36 0.45 0.45 0.83
+0.22 +0.04 +0.06 +0.11 +0.82
(n:6) (n: 34) (n:35) (n:9) (n:2)
Ductules/sq mm 3.5 7.6 10.9 7.0 9.9
+0.1 +1.2 +2.0 +2.1 +9.9
(n:2) (n: 26) (n:29) (n:7) (n:2)
% area of lobules 11.36 6.33 7.91 7.60 5.72
+3.78 +1.03 +0.89 +1.70
(n:5) (n:20) (n:27) (n:6) (n: 1)
Average no of 23.7 20.7 22.7 19.8 12
ductules/lobule
±9_? ±, g ±, g ^ ,
(n:2) (n:24) (n:31) (n:7) (n:l)
Area of average 0.208 0.206 0.269 0.173 0.035
lobule (sq mm) +0.064 +0.042 +0.045 +0.048
(n:5) (n:20) (n:27) (n:7) (n:l)
Ductule density 303 171 158 166 343
in lobules
+2g7 +24 +2g +5g
(/sq mm)
(n:2) (n:15) (n:22) (n:5) (n:l)
"Birth interval": age at first full-term deliver minus age at menarche.
There are no significant differences between the groups.
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TABLE 4:28 Assessment of lobules
Effect of breast-feeding history among parous women
Length of breast-feeding
Never 1-6 8-20 24-26 52-84




Lobules/sq mm 0.44 0.34 0.35 0.48 0.49 0.41
+0.06 +0.06 +0.13 +0.10 +0.09 +0.05











6.6 6.0 10.8 7.6 8.1
+1.8 +1.9 +2.8 +2.8 +1.3
(n:7) (n : 11) (n: 13) (n:5) (n:36)
5.77 7.77 7.05 10.54 7.34
+1.40 +2.95 +0.76 +2.30 +0.85
(n:10) (n:6) (n: 10) (n:5) (n:31)
24.0 18.9 23.8 17.5 21.5
+4.4 +3.0 +2.5 +3.0 +1.6
(n:7) (n:10) (n: 12) (n:5) (n:34)
Area of average 0.262 0.201 0.314 0.215 0.205 0.228
lobule (sq mm) +0.046 +0.041 +0.146 +0.666 +0.046 +0.037









There are no significant differences between the groups
iv) Diagnosis of the lump biopsied (Table 4:29)
Patients were divided as described in Section I ID of this chapter
(Table 4:15) into those whose primary pathological condition was likely
to be localised (or was non-existent) and those whose primary
pathological condition might have been generalised or patchily
distributed throughout the breast.
Only those parameters which had shown a significant variation in
relation to parity were studied.
The difference between the two groups were not significant, although
for each parameter (lobules/sq mm; ductules/sq mm; and ductule density
within the lobules) the figures were higher in Group 2 - ie. the
patients whose disease might have been widespread
v) Influence of the site of biopsy (Table 4:30)
A possible effect of the site of the biopsy was mentioned earlier
(Section 2a(iii)). Patients were divided into groups according to the
disease of the biopsy site from the nipple, and also according to the
quadrant of the breast from which the biopsy was taken. Only the
numbers of lobules per sq mm and the numbers of ductules per sq mm
were studied.
Table 4:30 shows that there were no significant differences between
the groups. In particular, this study does not confirm the trend
shown in Table 4:20, in which greater numbers of lobules were present
in the upper/outer quadrant of the breast. (If anything, the trend
in Fig 4:30 is in the opposite direction).
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Differences between the groups are not significant
TABLE 4:30 Lobules: Influence of site of biopsy
a) Distance from 2 3 4 5 ^nipple (cm) or more
Lobules/sq mm 0.41 0.46 0.51 0.44 0.33 0.37
+0.08 +0.07 +0.14 +0.11 +0.06 +0.08
(n:8) (n:18) (n:11) (n:13) (n:13) (n:24)
Ductules/sq mm 7.92 8.34 8.30 10.62 6.62 7.39
+2.08 +1.58 +2.63 +4.11 +1.94 +1.53
(n:6) (n:15) (n:7) (n: 11) (n:10) (n:20)
b) Quadrant Upper/outer Upper/inner Lower/outer Lower/inner
Lobules/sq mm 0.369 0.439 0.429 0.683
+0.043 +0.082 +0.125 +0.160
(n :42) (n:25) (n:8) (n: 12)
Ductules/sq mm 8.197 7.483 9.063 11.71
+1.169 +2.525 +2.091 +2.498
(n :34) (n:18) (n:8) (n:10)
Differences between the groups are not significant
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C Examination of the ductules
1 Methods
Examination of the ductules involved only the ductules within the
lobules, and no assessment of large extralobular ductules was made,
as they were seen in only a few of the sections. The examination
concentrated on three areas. First, the size of the ductules, and
the size of their lumina. Second, the type of cells present in the
epithelium of the ductules. Third, the presence or absence of
secretion in the lumen.
a) Ductule size Preliminary examination showed that there is
great variation between specimens in the dilatation of the lumina
of the ductules. This was assessed in two ways. First, a subjective
assessment allowed rapid assessment of a large number of specimens.
Second, direct measurement, a more time-consuming procedure, gave
detailed information on a smaller number of specimens.
(i) Assessment of ductule dilatation - Sections were assessed
subjectively according to whether the majority of ductule lumina were
"very small", "small", "moderate", "dilated", or "very dilated". Two
intermediate categories, "moderate/small" and "moderate/dilated", were
also necessary, because ductule dilatation was rarely completely uniform
over a section. The number of categories was therefore seven. The
number of specimens examined by this method was 121.
(ii) Measurement of ductule diameters - Using the measuring
eyepiece and the medium high-power objective lens, the diameter of the
ductules could be measured directly. In each measurement, the outer
diameter was measured and then the diameter of the lumen (as shown in
Fig 4:5), giving the height of the epithelium when the difference between
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x 800
Fig 4:5 To illustrate the measurement of ductule diameters
The shortest diameter of the ductule was measured, using the
measuring eyepiece.
Total ductule diameter: This measurement ("A" above) was from
one basement membrane to the basement membrane on the opposite side.
Diameter of lumen: Along the same line as the above measurement,
the distance between the inner borders of the epithelia was
measured ("B" above).
Epithelial height: The difference between these two measurements
("A" - "B"), divided by two, gave the epithelial height.
This figure illustrates "Type 1" epithelium. The specimen was
obtained from a 20 year-old woman in the seventh week of her
first pregnancy. Further patient data are given at Fiq 4:6
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these two measurements was divided by two. To avoid artefacts due to
ductules being cut at an angle, the smallest diameter of the ductule
was measured. Usually 25 ductules were measured, and always at least
20. The measurement was made in arbitrary units on the eyepiece scale,
and when the average diameter for each specimen was found in these
units, the figure was converted to microns (y) - the conversion factor
having been found using a measuring slide. (One unit on the measuring
eyepiece was equivalent to 23.5y). A total of 47 sections was examined
by this method.
b) Ductule epithelium After examination of a number of specimens,
it became clear that there were two types of cell in the epithelium of
the ductules. These were cells whose cytoplasm remained clear on
staining with haematoxylin and eosin, and cells with pink cytoplasm.
The cells with pink cytoplasm are usually situated near the lumen of
the ductule, while the clear cells are basal in position. (The clear
cells are often thought to be myoepithelial cells (Hamperl 1970), but
are sometimes present in larger numbers than other epithelial cells
(Haagensen 1971) - a fact which casts doubt on their role as myoepithelial
cells (Bassler 1970).) Both the numbers of the two types of cell, and
the size of the cells, were examined.
(i) Epithelial types - The relative numbers of the two types
of cell were used to grade the epithelium into different types, depending
on which cell type was predominant. Initially a division into five
epithelial types was attempted, but since observer agreement on five
types was very difficult to achieve, a simpler classification into
three types was used.
Type 1: The epithelium is two-layered, with an inner layer of "pink
cells" and a complete (or almost complete) outer layer of "clear cells".
(Fig 4:5 and Fig 4:6).
x 200
To illustrate "Type 1" epithelium
(See also high-power view at Fig 4:4)
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenoma) from a 20 year-old women seven weeks after her
last menstrual period. She had had a positive pregnancy test
and the pregnancy was terminated for social reasons under the
same anaesthetic while the breast biopsy was done. The plasma
progesterone concentration was "over 21.08 ng/ml". She had
never been pregnant before. Her menstrual cycle was usually
regular, 5/35 days. She had never been on the Pill. Her
menarche had been at age 14.
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Type 2: The two cell types are present but are intermingled and do
not form discrete layers. (Fig 4:7 and Fig 4:8).
Type 3: Only "pink cells" are present, and there are no "clear cells".
(Fig 4:9 and Fig 4:10).
(ii) Size of epithelial cells - Separate assessments were made
of the size of the "pink cells" and the "clear cells". Each specimen
was graded into one of three types depending on whether the pink cells
were "large", "medium" or "small", and a separate grading was carried
out based on the clear cells, which were divided into similar categories.
Because of variation between ductules and lobules, such gradings are
only approximate, but no intermediate gradings were used.
c) Secretion in lumina of ductules Secretion appears as pink-
staining material in the lumina of some ductules on haematoxylin and
eosin stained sections. Sections were graded as when none was
present; "+" when secretion was present in only a few ductules; "+"
when secretion was present in some ductules in several lobules; "++"
when secretion was present in most ductules in many lobules; and "+++"
when secretion was present in all, or almost all, ductules.
2 Results
a) Assessment of ductule dilatation
(i) Variation (Table 4:31) - In five cases two specimens from
the same breast were compared, and in three cases specimens from right
and left breasts were compared. The results are summarised in Table 4:31,
and show fairly good correlation between specimens. In six of the eight
cases assessment was identical in the two specimens. In one case, two
specimens from one breast differed by one "grade". In the remaining
case, two specimens (one from each breast) differed markedly, with ductule
lumina graded as "moderate/dilated" in one specimen and "small" in the other.
4-59
x 200
Fig 4:7 To illustrate "Type 2" epithelium
(See also high-power view at Fig 4:8)
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenosis) from a 40 year-old woman on the 25th day of
a 26-day cycle. The plasma progesterone concentration was
4.55 ng/ml. Her menarche had been at age 13. She had had
two full-term pregnancies, one when she was 20 years old,
and the other at age 21. She had breast-fed for 10 days
after the first pregnancy, but not at all after the second.
She had no breast tenderness during the cycle.
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Fig 4:8 To illustrate "Type 2" epithelium
This illustration is of the same soecimen seen in lower-Dower
view in Fig 4:7. The patient data are given at Fig 4:7.
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x 200
Fig 9: To illustrate "Type 3" epithelium
(See also high-power view at Fig 4:10)
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenosis) from a 28 year-old women on the second day of
a 26-day cycle. The plasma progesterone concentration was
"undetectable". Her menarche had been at age 14. She had had
two miscarriages and four full-term pregnancies, the first when
she was 19 years old and the most recent full-term pregnancy
at age 22. She had breast-fed her first and third babies for
six weeks each, but had not breast-fed the other two. She had
no breast symptoms during the cycle.
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x 800
Fig 4:10 To illustrate "Type 3" epithelium
This illustration is of the same specimen seen in lower-power
view in Fig 4:9. The patient data are given at Fig 4:9.
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TABLE 4:31 Assessment of ductule lumina


























(ii) Effects of parity and the cycle (Table 4:32) - 121
specimens were divided into groups first according to whether the woman
was parous or nulliparous, and then according to whether she was taking
oral contraceptives or was in the proliferative or luteal phase of a
normal cycle. (The luteal phase was defined as a plasma progesterone
concentration of over 1 ng/ml). The results are presented in Table 4:32.
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TABLE 4:32 Assessment of ductule lumina







On Pill Follic Luteal
phase phase








Very smal1 (1) 1
Small (48) 3 8 7 3 12 15
Mod/small (5) 3 2
Moderate (43) 4 4 4 5 17 9
Mod/dilated (8) 1 1 2 2 2
Dilated (13) 1 4 1 4 3
Very dilated (3) 1 2
Total number of specimens examined: 121
NOTE: Among nulliparous patients there is a trend to greater numbers
of dilated ductules in the luteal phase compared with the follicular
phase. Its significance was tested as follows:-
Fol 1 icular phase Luteal phase
"Small" (including moderate/small g j
and "very small) u '
"Moderate" 4 4
"Dilated" (including moderate/dilated 7
and "very dilated")
Chi-square applied to these figures = 3.86 (not significant]
4-66
Table 4:32 shows no effect of parity. When the results for nulliparae
are totalled and compared with those for parous women the pattern is
identical. There is also no effect from oral contraception. Among
parous women the pattern is similar in the two phases of the cycle ,
but among nulliparae there are more "dilated" lumina during the luteal
phase of the cycle than during the proliferative phase. This trend
is not significant when the Chi-square test is applied as shown in the
footnote to Table 4:32.
(iii) Other factors (Tables 4:33 4:34 4:35) -
Menstrual age The patients were divided into groups according to
menstrual age, as described previously (Section Bc(i), page 4-<V7) and
as shown in Table 4:33. There is no trend and no significant effect
of menstrual age.
Birth interval When the patients were divided into groups according
to birth interval, as described previously (Section Bc(ii)), no effect
was seen (Table 4:34).
Breast-feeding history Table 4:35 shows no effect of breast-feeding
compared with women who never breast-fed, and no effect according to
the length of time for which they breast-fed.
b) Measurement of ductule diameters
(i) Variation (Tables 4:36 and 4:37) - Table 4:36 shows the
variation in total ductule diameter, luminal diameter and epithelial
height between ten sections from the same block of tissue. Variation
is smallest with the measurement of epithelial height (coefficient of
variation = 1.5) and is larger with the measurements of the diameter
of the lumen (coefficient of variation = 14.2)
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TABLE 4:33 Assessment of ductule lumina
Effect of menstrual age
MENSTRUAL AGE
1 - 9 10 - 19 20 - 29 30+
(n:19) (n:32) (n : 41) (n:
Very small (1) 1
Small (45) 10 11 17 7
Moderate/small (5) 1 3 1
Moderate (43) 5 15 10 13
Moderate/dilated (7) 1 1 4 1
Dilated (13) 3 2 5 3
Very dilated (3) 1 2
Total number of specimens examined 117
In each age group the distribution is similar
TABLE 4:34 Assessment of ductule lumina







































Total number of specimens examined 77
There are no significnat differences between groups of patients
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TABLE 4:35 Assessment of ductule lumina





1-6 8-20 24-46 52-84



























Total examined 70 28 12 13 42
The groups of patients show no significant differences
TABLE 4:36 Measurement of ductule diameters:






















Mean 245 77 84
SD 14.3 11 .0 4
SEM 4.5 3.5 1 .3
Coefficient of variation 5.8 14.2 1.5
The patient was a parous woman in the luteal phase of the cycle
4-71
TABLE 4:37 Measurement of ductule diameters:
Variation between different specimens from the same patient
a) TOTAL DUCTULE DIAMETER (y)
Right breast Left breast
Specimen A Specimen B Specimen A Specimi
Patient data
Nullip, follic 158 134
Nullip, on Pill 230 273
Nullip, luteal 221 212
Nullip, on Pill 296 247 218 252
249 266
b) DIAMETER OF LUMEN (y)
Patient number
Nullip, follic 35 28
Nullip, on Pill 80 103
Nullip, luteal 82 73
Nullip, on Pill 120 66 54 82
66 94
c) EPITHELIAL HEIGHT (y)
Patient number
Nullip, follic 61 80
Nullip, on Pill 75 85
Nullip, luteal 70 70
Nullip, on Pill 88 90 82 85
92 86
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Table 4:37 shows the variation between specimens in each of the
parameters, in four cases. Two of the cases each had two biopsies
from one breast, one case had bilateral biopsies, and the fourth
had three samples taken from each breast at mammoplasty.
Epithelial height shows little variation within one breast, but
slightly more variation between right and left breasts. The
diameter of the lumen shows greater variation, both in a single
breast and between right and left breasts.
(ii) Effect of parity and the menstrual cycle (Table 4:38) -
As before, the patients were divided into groups according to parity,
use of oral contraception and stage of the cycle. The results are
shown in Table 4:38. There is no overall difference between parous
and nulliparous women. As in section 2a(ii), there is a trend
among nulliparous women to have greater ductule luminal diameters
during the luteal phase of the cycle, but this trend does not reach
statistical significance. No such trend is seen among parous women.
Epithelial height, though showing no difference between nulliparae
and parous women, shows variation with the cycle in both groups. The
height is greater in the luteal phase of the cycle, and this difference
is significant (among parous women P<0.01 ; among nulliparae P^0.05).
Oral contraceptive use shows no effect on luminal diameter, but
epithelial height is greater among nulliparous users of oral
contraceptives than among normally cycling nulliparae (P<0.05). No
such effect of oral contraceptive use is seen among parous women.
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TABLE 4:38 Measurement of ductule diameters:
Effects of parity, stage of cycle and oral contraception
NULLIPARAE
On Pill Prolif Luteal
Phase Phase
PAROUS WOMEN



















(n:2) (n: 12) (n :15)
b) DIAMETER 83

























Total: 42 (n:9) (n: 4) (n:3) (n:2) (n: 12) (n:12)
Differences in epithelial height between nulliparous women in the
proliferative phase and the other two groups of nulliparous women are
significant (P<0.05). The difference in epithelial height between the
proliferative phase and the luteal phase among parous women is significant
(P<0.01). Other differences are not significant.
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iii) Other factors (Tables 4:39 4:40 4:41) - The effect
of menstrual age is shown in Table 4:39. There is a trend towards
decreasing luminal diameter with greater age, and this trend is
statistically significant (P<0.05). There is also a slight trend
towards decreasing epithelial height with greater age, but this
trend is not significant.
The effect of birth interval is shown in Table 4:40. Because of
low sample numbers some groups have one or no results, and the
trend (towards lower figures with increasing birth interval) is not
significant.
The effect of breast-feeding history is shown in Table 4:41. Although
patients who had breast-fed for more than a year in total had greater
luminal diameters and epithelial heights than other groups, the
numbers are again small and the difference is not significant. There
is no overall difference between women who breast-fed and those who
did not as regards epithelial height. There is a slight difference
as regards luminal diameters, with those who had breast-fed having
greater diameters than those who did not, but this trend is not
statistically significant.
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4:39 Measurement of ductule diameters:
Effects of menstrual age
MENSTRUAL AGE
1 - 9 10 - 19 20 - 29 30+
years years years years
TOTAL DUCTULE DIAMETER (y) 253 229 194 172
+24 +10 +12 +13
Total: 43 (n: 4) (n: 19) (n: 12) (n: 8)
DIAMETER OF LUMEN (y) 101 74 62 45
+17 +5 +8 +5
Total: 38 (n: 4) (n: 19) (n: 9) (n: 6)
EPITHELIAL HEIGHT ( v) 76 79 61 62
+5 +3 +4 +7
Total : 38 (n:4) (n:19) (n:9) (n:6)
The trend towards decreasing luminal diameter with increasing
menstrual age is significant (P<0.05).
4 - 76
TABLE 4:40 Measurement of ductule diameters:
Effects of birth interval among parous women
BIRTH INTERVAL
2 - 5 6 - 10 11 - 15 16 - 20
years years years years
TOTAL DUCTULE DIAMETER (y) 174 218 177 195
+14 +11
Total: 27 (n:l) (n: 1) (n: 13) (n: 1)
b) LUMEN DIAMETER (y) 54 67 50
+8 +6
Total: 24 (n:l) (n:ll) (nl2)
c) EPITHELIAL HEIGHT (y) 60 75 62
+5 +4
Total: 24 (n: 1) (n: 11) (n: 12)
Differences between groups are not significant
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TABLE 4:41 Measurement of ductule diameter:














breast¬ 1 - 6 8 - 20 24 - 46 52 - 84 breast-
fed weeks weeks weeks weeks feeders
187 191 149 183 252 197
±15 +14 +13 +40 +5 +n
(n: 7) (n:6) (n:5) (n:4) (n:6) (n: 21)
48 51 43 61 82 61
+5 +16 +6 +15 +3 +6
(n:5) (n: 4) (n:5) (n:4) (n:5) (n:18)
66 66 53 62 85 68
+6 +9 +4 +7 +1 +4
(n: 5) (n: 4) (n: 5) (n : 4) (n:5) (n:18)
Differences between groups are not significant
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c) Epithelial types
(i) Variation - Observer variation: 23 specimens were assessed
independently by two observers (TJA and myself). The specimens had
been selected to represent different groups of patients, and had been
relabelled to ensure that the assessment was "blind". The results
are shown in Table 4:42.
This table shows complete agreement between observers in only four
cases. In another 14 cases there was agreement about the predominant
type of epithelium present, but disagreement over the amount of
other type also present. In the remaining five cases (numbered h, m,
n, o and s) there was disagreement about the predominant type of
epithelium. In these five cases the disagreement was limited to a
single grade - ie. a specimen assessed as "Type 2" by one observer
was assessed as "Type 3(2)" by the other, for example. In no case
was an epithelium assessed as Type 1 by one observer and Type 3 by
the other.
Variation between specimens from the same patient: In five cases
two specimens were available from the same breast, and in another
six cases bilateral biopsies were available. Three more patients
had two or more specimens taken from each breast at mammoplasty.
The assessment of these 14 patients is shown in Table 4:43, along
with data on the patients.
In seven cases there was complete agreement or almost complete
agreement ("almost complete" meaning that there was agreement about
the types present but slight disagreement about their proportions -
ie. 2X3 as compared with 2»3).
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In two of the remaining seven cases there was agreement on the
predominant type of epithelium present but another type was also
present in only one of the pair of specimens. In the remaining five
cases there was agreement on which types of epithelium were present,
but disagreement over which type was predominant.
In no case did the disagreement involve more than one grade - ie.
no patient had Type 1 in one specimen and Type 3 in another (apart
from the single section in which types 1 and 3 were found together).
Agreement tended to be slightly better between pairs of specimens
taken from the same breast (as compared with bilateral biopsies, but
the difference was very slight.
(ii) Effect of parity and the menstrual cycle - The patients
were divided into groups according to parity and according to oral
contraceptive use and stage of the cycle. The detailed results are
presented in Table 4:44, with a simplified version of the table on
the same page.
Parity: When the overall pattern in nulliparae is compared with that
in parous women, it is seen that there is a predominance of Type 1
epithelium among nulliparae, while Type 3 epithelium is relatively
more common among parous women. In the simplified table, "Type 1
present" means that type 1 epithelium was in some cases not the
predominant type present, and in most cases was mixed with Type 2
epithelium in varying proportions. The same applies to "Type 3
present" in the simplified table. The effects of parity are presented
in graph form in Fig 4:11. The difference between parous women and
nulliparae is highly significant (Chi square 38.47; p<0.001).







































1 & 2 (3)
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2 > 3 > 1
means the types were present in equal numbers
( ) means that only a small proportion of lobules had this type.
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TABLE 4:43 Epithelial types:




Specimen A Specimen B
2
Left breast














Parous, follie phase 2»3 2 >3
Nul ip, follie phase
Nul ip, on Pill 1 >2
Nul ip, luteal phase 1 >2 1 >2
Nul ip, luteal phase 2»1 2»1
Nul ip, luteal phase
Nul ip, luteal phase 1 >2
Nul ip, on Pill 2
Nul ip, follie phase 1 >2 2 >1
Nul ip, follie phase 3>2
Nul ip, on Pill 2 »1 1 >2
1 & 2 & 3
Nul ip, follie phase 2
Nul ip, follic phase 2»1 2»1
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On Pill Prolif Luteal
phase phase
Parous
On Pill Prolif Luteal
phase phase
1 only (3) 1 1 1
1 »2 (6) 1 1 2 2
1 >2 (17) 4 4 5 1 2 1
2>1 (15) 3 4 3 5
2 »1 (32) 2 10 6 1 10 3
2 only (45) 2 7 2 7 17 10
2 »3 (6) 1 1 3 1
2>3 (15) 1 2 1 2 2 7
3 >2 (8) 5 3
3 » 2 (10) 1 2 7
3 only (17) 1 2 3 7 4
3 & 1 (2) 1 1
1&2&3 (2) 1 1




































The overall difference between nulliparous and parous women is highly
significant (x^ = 38.47; P<0.001)
Other differences are not significant
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Fig 4:11 Epithelial types: distribution among parous and
nulliparous women.
The histogram shows the freguency with which the
three types of epithelium shown in Figs 4:5 to 4:10
were seen in 178 biopsies of normal breast tissue.
Type 1 epithelium was seen mainly in nulliparous women,
and Type 3 epithelium was commoner in parous women.
Compare Table 4:44
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Oral contraception arid the menstrual cycle: Table 4:44 shows that
the pattern among oral contraceptive users was very similar to that
among normally cycling women. In both parous and nulliparous women
there was no difference between the follicular and luteal phases of
the cycle.
Coded specimens: The distribution of epithelial types among the
coded specimens was also checked, in an attempt to eliminate observer
bias. The code was not broken until the assessments had been made.
The results are shown below (Table 4:45)
TABLE 4:45 Frequency of predominant epithelial type among coded specimens
Predominant type
Nulliparae Parous women
Follic phase Luteal phase Follic phase Luteal phase
Type 1 22 11
Type 2 45 25
Type 3 12 0 2
Total number of specimens examined = 23 (in four specimens two epithelial
types were equally distributed).
From the small numbers no trend is apparent, and this small series neither
confirms nor refutes the trend in the previous table.
(iii) Other factors (Tables 4:46 to 4:52) - Menstrual age: Patients
were divided into four groups as before, each group covering a ten-year
menstrual age range. The results are presented in Table 4:46. The
simplified table at the bottom of the page shows a trend, with the
youngest age range having a greater frequency of Type 1 epithelium.
In order to separate this effect from the effect of parity, the effect
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TABLE 4:46 Epithelial types:
1 - 9
1 only (3) 2
1»2 (6) 3
1>2 (16) 3
2> 1 (15) 4
2»1 (30) 10





3 only (17) 2
3 & 1 (2)
1 & 2 & 3 (2)
Total examined 172 33


















Type 1 present (70) 22 23 16 9
Type 2 only (43) 412 18 9
Type 3 present (55) 7 16 14 18
Other (4) 3 1
33 54 48 37
Younger menstrual age is associated with a greater frequency of
Type 1 epithelium. See separate examination of parous and nulliparous
women in Tables 4:47 and 4:48
4-86
TABLE 4:47 Epithelial types: Effect of menstrual age among nulliparae
Menstrual age group
1-9 10-19 20-29 30+
1 only (2) 2
1»2 (4) 3 1
1>2 (12) 3 3 5 1
2>1 (10) 4 3 3
2»1 (18) 10 7 1
2 only (10) 3 2 2 3
2>>3 O) 1
2>3 (4) 3 1
3>2 (0)
3>>2 (0)
3 only (3) 1 1 1
3 & 1 (1) 1
1&2&3 (2) 2
Total examined 67 30 19 12 6
SIMPLIFIED TABLE:
Type 1 present (46) 22 13 9 2
Type 2 only (10) 3 2 2 3
Type 3 present (8) 5 1 1 1
Other (3) 3
30 19 12 6
The distribution of epithelial types is similar in each age group
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TABLE 4:48 Epithelial types: Effect of menstrual age among parous women
Menstrual age group
1 - 9 10 - 19 20 - 29 30+
1 only (1) 1
1»2 (2) 1 1
1 >2 (4) 4 1
2>1 (5) 4 1
2»1 (12) 5 2 5
2 only (33) 1 10 16 6
2»3 (5) 1 4
2>3 (11) 3 4 4
3>2 (8) 1 2 5
3»2 (9) 1 3 4 1
3 only (14) 1 7 3 3
3 & 1 (1) 1
Total examined 105 3 35 36 31
SIMPLIFIED TABLE:
Type 1 present (24) 10 7 7
Type 2 only (33) 1 10 16 6
Type 3 present (47) 2 15 13 17
Other (1) 1
3 35 36 31
Differences in the distribution of epithelial types in the different
age groups are not significant
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of menstrual age was examined separately in nulliparous and parous
women (Table 4:47 and 4:48). When the simplified tables for
nulliparae and parous women are compared, no effect of menstrual
age is seen in either group, and it appears that the apparent
effect seen in Table 4:46 is indeed due to the greater numbers of
nulliparae in the younger age group.
Birth interval: The patients were divided into four groups
according to the length of time between the menarche and the first
full-term pregnancy. The results are presented in Table 4:49.
The distribution of epithelial types is similar in each group, and
no trends are seen.
Breast-feeding history: The patients were divided into groups
according to whether or not they had breast-fed, and the total
duration of breast-feeding. The results are presented in Table 4:50.
There is no obvious difference between those who had breast-fed
and those who had not, and there is no obvious effect of the duration
of breast-feeding.
Diagnosis of the primary condition: The patients were divided into
two groups according to the diagnosis of the condition that had
necessitated operation. As described in section 11D, Group 1
consisted of conditions which were localised or non-existent, and
Group 2 consisted of conditions which might have been generalised or
patchy in distribution. The results are shown in Table 4:51. From
the simplified table it is seen that type 1 epithelium was slightly
commoner among Group 1 than Group 2. This trend failed to reach
statistical significance, however, and is most probably due to the
greater proportion of nulliparae in Group 1.
Site of biopsy: The patients were divided into groups according to
the distance between the nipple and the biopsy site, and according to
TABLE 4:49












3 & 1 (1)
Total examined 102
SIMPLIFIED TABLE:
Type 1 present (24)
Type 2 only (33)
Type 3 present (44)
Other (1)
Birth interval (years)






3 13 12 5
1 3 1
5 5




10 41 40 10
1 10 10 2
3 13 12 5
6 18 17 3
1
10 41 40 10
Distribution is similar in each group
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TABLE 4:50
Epithelial types: effects of breast feeding history among parous women
Breast feeding history
Did not 1-6 8-20 24-46 52-84
breast feed wks wks wks wks
1 only (1) 1
1»2 (2) 2
1 >2 (4) 1 2 1
2>1 (5) 3 2
2»1 (13) 6 1 5 1
2 only (30) 13 4 5 6 2
2>>3 (4) 2 1 1
2>3 (10) 3 1 2 3 1
3>2 (6) 1 1 2 1 1
3»2 (6) 1 2 1 2
3 only (15) 9 2 3 1
3 & 1 0) 1




Type 1 present (25) 12 5 1 5 2 13
Type 2 only (30) 13 4 5 6 2 17
Type 3 present (41) 16 7 7 7 4 25
Other (1) 1 1
41 16 13 19 8 56
Distribution is similar in each group of patients
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TABLE 4:51 Epithelial types and diagnosis of primary condition
Group 1 Group 2
(localised disease) (possibly generalised disease)
1 only (3) 2 1
1 »2 (6) 5 1
1 >2 (17) 9 8
2>1 (15) 7 8
2»1 (32) 19 13
2 only (45) 17 28
2>>3 (6) 4 2
2 >3 (15) 7 8
3 >2 (8) 3 5
3»2 (10) 3 7
3 only (17) 7 10
3 & 1 (2) 2 0
1&2&3 (2) 1 1
Total 178 86 92
SIMPLIFIED TABLE:
Type 1 present (73) 42 31
Type 2 only' (45) 17 28
Type 3 present (56) 24 32
2The difference between the two groups is not significant (X :5.13)
TABLE 4:52 Epithelial types: Effect of site of biopsy

















Type 3 seen 12 8 6 5 j 8
TOTAL 114
10 21 18 16 18 31
b) Quadrant of breast upper/outer upper/inner lower/outer lower/inner
Type 1 seen 24 9 4 3
Type 2 only 17 11 3 5
Type 3 seen 16 12 5 9
TOTAL 118 58 32 12 16
In neither table are the differences significant
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the quadrant of the breast from which the biopsy was taken. The
results are shown in Table 4:52.
From these results there appears a slight trend for Type 1
epithelium to be found in the biopsies taken further away from the
nipple, and in the upper/outer quadrant of the breast. However,
this was not a significant trend. It may be that this slight trend
is also explained by the site of biopsy among nulliparous women.
d) Size of epithelial cells
(i) Variation (Table 4:53) - In six cases two specimens were
available for comparison: four pairs each from a single breast, and
two pairs from right and left breasts. The size of clear cells and
pink-staining cells was estimated separately in each pair, and the
results are shown in Table 4:53. Complete agreement is seen in all
specimens except in the estimation of pink-staining cells in one
pair from right and left breasts. In this pair the assessment varied
by only one grade (medium in one specimen and large in the other).
(ii) Effects of parity and the menstrual cycle, and of oral
contraceptives (Table 4:54) -
Patients were divided into groups as before according to parity, and
according to oral contraceptive use and stage of the normal cycle.
The results are presented in Table 4:54.
When "pink staining" cells (ie. those closest to the lumen of the
ductule) were examined, the distribution was similar in all groups
and there was no obvious effect of parity or the cycle. Women taking
oral contraceptives had a similar distribution to that in normally
cycling women, and the small numbers meant that the slight trend towards
larger cells among nulliparae was not significant.
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TABLE 4:53 Size of epithelial cells of ductules:
Variation between specimens from the same patient





B Specimen A Specimen
Nullip, fol1 ic small small
Nullip, on Pill medium large
Nullip, 1uteal small small
Nullip, luteal small small
Nullip, luteal medium medium
Nullip, luteal medium medium
b) "Clear" cells
Nullip, fo11ic large large
Nullip, on Pill medium medium
Nullip, luteal medium medium
Nullip, luteal 1 arge 1 arge
Nullip, luteal large large
Nullip, luteal large 1 arge
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TABLE 4:54 Size of epithelial cells of ductules:
Effects of parity and menstrual cycle, and oral contraceptives
a) "Pink staining" cells
Size of eel 1s
Large Medium Smal1
Nulliparae (34):
Pro!iterative phase (11) 1 6 4
Luteal phase (16) 3 9 4
On oral contracept. (7) 3 4 0
Parous (58):
Proliterative phase (27) 1 16 10
Luteal phase (24) 5 12 7
On oral contracept. (7) 1 4 2






















The difference in distribution of "clear" cells between nulliparae and
2
parous women is highly significant (X : 16.7; P<0.001)
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When "clear cells" were examined, it was found that these were larger
among nulliparae than among parous women. This trend was highly
significant (P<0.001). However, the distribution in the two halves
of the cycle was similar, in both nulliparae and parous women, and
the distribution among Pill-users was similar to that among normally
cycling women. The greater numbers of large clear cells among
nulliparae are associated with the increased amounts of Type 1
epithelium among nulliparae, since Type 1 epithelium is characterised
by a complete or almost complete basal layer of clear cells (as
discussed in the previous section).
(iii) Other factors (Tables 4:55 and 4:56) -
Menstrual age: Patients were divided into groups as before and no
differences were found in the distribution of "pink-staining" cells
among the different groups (Table 4:55). When "clear" cells were
examined, however, the youngest age group (menstrual age 1-9 years)
had a preponderance of large clear cells. Again, this appears to be
due to the greater numbers of nulliparae (with Type 1 epithelium) in
this age group.
Birth interval: When parous women were divided into groups according
to birth interval, no differences in the distribution of either type
of cell were seen (Table 4:55).
Breast-feeding history: Parous women were divided into groups according
to whether or not they had breast-fed, and for how long. The slight
differences in the distribution of "pink-staining" and "clear" cells
shown in Table 4:56 are not significant, although there is a suggestion
that "large" cells of either type are seen less frequently among women
who have breast-fed for longer periods.
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TABLE 4:55 Size of epithelial cells of ductules:
Effects of menstrual age and birth interval




1 - 9 years (19) 2 13 4
10 -19 years (28) 4 17 7
20 -29 years (24) 789
30+ years (16) 1 11 4
TOTAL EXAMINED 87 14 49 24
Birth interval:
2-5 years (5) 0 3 2
6 -10 years (23) 5117
11 -15 years (19) 2 10 7
16 -20 years (6) 0 33
TOTAL EXAMINED 53 7 27 19
b) "Clear" cells
Menstrual age:
1 - 9 years (19)
10 -19 years (28)






11 -15 years (19)












TABLE 4:56 Size of epithelial cells of ductules:
Effect of history of breast feeding among parous women
a) "Pink Staining" cells
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Never breast-fed (21)
Breast-fed for 1 -■ 6 weeks (10)
8 -- 20 II (7)
24 -■ 46 II (11)

















Never breast-fed (21) 6 8 7









3 15 ( 15 (









TOTAL EXAMINED: 54 9 23 22
In each table the distribution of cell types is similar in each group
of patients
e) Secretion in lumina of ductules
(i) Variation - Multiple specimens were obtained in eight
cases. In two of these cases, two specimens were obtained from the
same breast, and in five cases specimens were obtained from right
and left breasts. In the remaining case three specimens were obtained
from each breast at mammoplasty. The results are shown in Table 4:57.
In five cases there is complete agreement, and in each of the three
remaining cases (including the multiple specimen) the disagreement was
by only one grade, (eg. +++ compared with ++, or + compared with +).
(ii) Effects of parity and the cycle, and of oral contraception
(Tables 4:58 and 4:59) -
Patients were divided into groups according to parity, stage of the
cycle and use of oral contraception. The results are shown in Table 4:
Although a slightly greater proportion of parous women than nulliparae
had large amounts of secretion present (++ and +++), this difference
was not significant.
In both parous and nulliparous women there was no difference between
the stages of the cycle, and oral contraceptive users had a similar
distribution of secretion to normally cycling women. The amount of
secretion in the coded specimens was also checked, in an effort to
check for bias. These specimens were chosen to represent different
groups, but the code was not broken until all the assessments had been
made. The results are shown in Table 4:59. There is a trend towards
larger amounts of secretion among parous women, but in neither parous
women nor nulliparae is there any obvious difference between the stages
of the cycle. The large amounts of secretion seen in nulliparae taking
oral contraceptives were not confirmed in the larger series.
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TABLE 4:57 Assessment of secretion in lumina of ductules
Variation between specimens from the same patient
Right breast Left breast
PATIENT DATA:- Specimen A Specimen B Specimen A Specimen B
Parous, follic + +
Nullip, on Pill + +
Nullip, luteal + +
Nullip, luteal +++ ++
Nullip, luteal + +
Parous, on Pill + +
Parous, follic + +
Nullip, on Pill + + + +
+ +
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TABLE 4:58 Assessment of secretion in lumina of ductules
















0 (11) 2 1 3 3 2
± (22) 3 3 4 2 6 4
+ (56) 8 6 6 7 19 10
++ (27) 1 1 3 1 12 9
+++ (13) 1 1 2 2 3 4













45 (100%) 84 (100%)
The difference between nulliparae and parous women is not significant
(x2 = 5.41).
TABLE 4:59 Assessment of secretion in lumina of ductules
Coded specimens: Effects of parity, stage of cycle
oral contraception
Nulliparae
Follicular phase Luteal phase On Pill
(a) + (f) 0 (k) +++
(b) + (g) + (1) +++
(c) + (h) ++
(d) + (i) 0
(e) 0 (j) +
Parous women
(m) ++ (P) ++ (v) +
(n) + (q) ++ (w) +





(iii) Other factors (Table 4:60 and 4:61) - Menstrual age:
Patients were grouped according to menstrual age with each grouping
covering a ten-year age range. The results (Table 4:60) show no
difference in distribution of secretion between any of the groups.
Birth interval: Patients were grouped according to the number of
years between menarche and the first full-term pregnancy, with each
group covering a five-year range. The results (Table 4:60) show no
significant difference in distribution of secretion in any of the
groups.
Breast-feeding history: Parous women were grouped according to
whether or not they had ever breast-fed, and if so, for how long.
The results (Table 4:61) show no difference between breast-feeders
and those who had never breast-fed, and no effect of the total duration
of breast-feeding.
TABLE 4:60 Assessment of secretion in "lumina of ductules
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a) Effect of menstrual age
Amount of secretion MENSTRUAL AGE (years)
(and numbers of patients)
1-9 10-19 20-29 30+
0 (11) 1 3 6 1
+ (22) 4 9 5 4
+ (58) 8 14 20 11
++ (27 2 9 11 5
+++ (13) 3 6 1 3
DTAL 126 18 41 43 24
b) Effect of birth interval among parous women
Amount of secretion BIRTH INTERVAL (years)
(and numbers of patients)
1 - 9 6 - 10 11 - 15 16 -
0 (5) 2 3
+ (11) 3 7 1
+ (33) 1 15 14 3
++ (22) 2 10 7 3
+++ (9) 1 1 5 1
TOTAL 80 4 31 36 8
In each table, distribution is similar in each group of patients
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TABLE 4:61
Assessment of secretion in lumina of ductules:









1-6 8-20 24-46 52-84




0 (5) 2 3 5
+ (12) 3 2 5 2 9
+ (31) 14 4 5 3 5 17
++ (19) 9 1 4 4 1 10
+++ (6) 2 1 3 4
TOTAL 73 28 10 12 15 8 45
Distribution is similar in each group of patients
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D Examination of the stroma
1 Methods
Cyclical changes have previously been described in both the intra¬
lobular and the extralobular stroma.
a) Intralobular stroma Three aspects of the intralobular
stroma had received attention from previous investigators - the
looseness of the stroma (Taylor 1936; Foote and Stewart 1945;
Dabelow 1957; Nizze 1972), the amount of cellular infiltrate
(Foote and Stewart 1945; Lewis and Geschickter 1934; Dabelow 1957),
and the mucopolysaccharide content (Ozzello and Speer 1958). Each
of these three was assessed separately in this investigation.
(i) Cellularity - Using sections stained with haematoxylin
and eosin, sections were graded according to a subjective overall
assessment of the amount of cellular infiltration of the intralobular
stroma. Account was taken of variation between lobules, but a single
overall assessment was made. Five gradings were used: low (Fig 4:13),
low/moderate, moderate, moderate/high, and high (Fig 4:12).
(ii) Oedema - The intralobular stroma frequently stained more
lightly than the extralobular stroma (see Fig 4:1b), and this appears
to be due to a looseness of the fibrous tissue. This looseness was
assessed using five grades. Grade "0" meant that the intralobular
stroma was indistinguishable from the extralobular stroma (Fig 4:14).
Grade "+" meant they were only just distinguishable. Grade "+" meant
they were distinguishable in most lobules. Grade "++" meant that there
was a fairly marked separation of fibres in all lobules. Grade "+++"
meant there was wide separation of fibres in all lobules (Fig 4:1b).
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x 200
Fig 4:12 To illustrate cellular intralobular stroma (graded +++)
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenoma) from a 52 year-old nulliparous woman 14 days
after her period. The date of her subsequent period is not
recorded. The plasma progesterone concentration was
1.71 ng/ml. Her menarche had been at age 13, and her
periods had been regular (3/28) until three months before




Fig 4:13 To illustrate acellular intralobular stroma (graded _+)
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenosis) from a 41 year-old nulliparous woman on the
29th day of a 31-day cycle. The plasma progesterone
concentration was not measured as the specimen tube broke.





Fig 4:14 To illustrate lobules without stromal oedema
The specimen was obtained at biopsy (diagnosis of lump:
fibroadenosis with cysts and epitheliosis) from a 32 year-old
woman on the tenth day of her cycle. The date of her subsequent
period is not recorded. The plasma progesterone concentration
was "undetectable". Her menarche had been at age 11. She had
never taken oral contraceptives.
Compare Fig 4:1b
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(iii) Acid mucopolysaccharide content - When sections were
stained with alcian blue and periodic acid Schiff there was marked
variation in the amount of blue staining of the intralobular stroma -
indicating variation in the amount of acid mucopolysaccharide present.
(There was very little variation in the amount of neutral polysaccharide,
indicated by pink staining with this stain.) The "blueness" of the
stroma was assessed subjectively as follows:
0 no staining
+ Staining only just detectable
+ staining clearly seen in some lobules
++ most lobules showed obvious staining
+++ all lobules showed obvious staining
b) Extralobular stroma The appearance of the extralobular stroma
is said to show cyclical changes (Huseby and Thomas 1954). In the
present investigation, its appearance on haematoxylin and eosin
staining was assessed according to whether it stained deeply, moderately
or lightly, and whether the staining was uniform. Non-uniform staining
appeared to be due to separation of the fibres of the stroma, possibly
an indicator of stromal oedema. The appearance was graded as "thin",
"normal", or "thick" (Fig 4:15) by the intensity of the staining, or
as "fibrous" if the stain was obviously not uniform but was stringy
in appearance (Fig 4:16). There was not much variation of the appearance
over each section, and a single assessment was made.
All the stromal assessments were made without the observer knowing
the parity or stage of cycle of the subjects. The specimens were not,
however, re-numbered for these assessments because the observer's
repeated examinations would have allowed him to recognise sections
even if they had been re-coded between each part of the examination.
The large number of sections involved meant that it was impossible for
the observer to remember details of parity of more than one or two subjects.
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The specimen was obtained at mammoplasty from a 45 year-old
woman on the 24th day of a 25-day cycle. The plasma
progesterone concentration was 4.307 ng/ml. She had experienced
the menarche at age 13, and had had one full-term pregnancy
when she was 22 years old. She had breast-fed for six weeks.
She had taken an oral contraceptive for about four years until
four months before the operation. She complained of breast
heaviness for a week before her periods, but this had now
become continuous and the indication for the operation was
heaviness and lumpiness of the breasts.
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x 200
Fig 4:16 To illustrate extralobular stroma graded as "fibrous"
The specimen was obtained at biopsy (diagnosis of the lump:
fibroadenoma) from a 33 year-old woman on the 22nd day of
her cycle. The date of her subsequent period is not recorded:
her cycle varied in length from 2-3/21 to 2-3/35 days. The
plasma progesterone concentration was 6.79 nq/ml. Her menarche
had been at age 12. She had had two full-term pregnancies,
the first when she was 22 years old and the second at age 23.
She had not breast-fed.
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2 RESULTS
a) Variation (Table 4:62)
Cellularity: Four pairs of specimens, each pair from the same breast,
and three pairs from right and left breasts were studied. Exact
agreement between assessments was found in each pair.
Oedema: Five single-breast pairs of specimens and four pairs from
right and left breasts were studied. Agreement was exact in all but
three pairs: in two right/left pairs there was disagreement by one
grade, and in one single-breast pair, disagreement by two grades
(0 compared with +).
Acid mucopolysaccharide content: Three single-breast and five right/
left pairs were studied, along with multiple samples from each breast
of two patients undergoing mammoplasty. Agreement was exact in all
but one pair: in the remaining pair disagreement was by one grade.
In the multiple specimens, disagreement was by only one grade.
Extralobular stroma: In four single-breast pairs and three right/
left pairs, agreement was exact in five, and differed by one grade in
the remaining two pairs (both of them single-breast pairs).
b) Effects of parity and the cycle
(i) Cellularity (Table 4:63) - Over all patients, the
difference between the follicular and luteal phases was minimal,
but when the week of the cycle was taken into account (Table b), the
2
difference between week 2 and week 4 was significant (X = 6.42;
P<0.05).
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TABLE 4:62 Histological appearance of the stroma:






Pt 8 Pt 51 Pt 94
Mod Mod Mod/low
Mod Mod Mod/low
Pt 35 Pt 53 Pt 74 Pt 92
Low Mod Mod/high Mod
Low Mod Mod/high Mod
b) Oedema Pt 8 Pt 51 Pt 94 Pt 132
Right breast 00+ +
Left breast + 0 + +
Pt 23 Pt 35 Pt 36 Pt 53 Pt,74 Pt 92
1st specimen + 0 ++ 00 ++
2nd specimen + 0 +++ 00 +
c) Acid mucopolysaccharide content
Pt 8 Pt 51 Pt 94 Pt 132 Pt 168
Right breast + 0 + 00
Left breast + 0 + 0 +_
Pt 53 Pt 74 Pt 92
1st specimen 00+
2nd specimen 00+
Pt 150a Pt 150b Pt 150c Pt 163a Pt 163b Pt 163c
Right breast _+ 0 + + 0
Left breast 0 + + + + +
d) Extra!obular stroma
Pt 8 Pt 51 Pt 94
Right breast Fibrous Fibrous Normal
Left breast Fibrous Fibrous Normal
Pt 35 Pt 53 Pt 74 Pt 92
1st specimen Thick Normal Fibrous Normal
2nd specimen Fibrou s Normal Fibrous Fibron s
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TABLE 4:63
Cellular infiltrate in intralobular stroma: effects of parity and cycle
a) All patients (n: 113) Cell counts
High Mod/high Mod Mod/low Lov
Nu11iparae: prolif (12) 1 - 4 2 5
1uteal (17) 1 3 10 2 1
Parous: prolif (37) 5 7 16 6 3
1uteal (30) 2 6 14 6 2
On Pill: nu11ip (7) 1 1 3 1 1
parous (10) 4 2 4
b) All patients except those on oral contraceptives (n:94)
Week of cycle
Week 1 1 3 10 3 2
Week 2 5 0 12 5 7
Week 3 3 1 8 4 0
Week 4 0 13 12 3 2
c) Nulliparae Mod/high Mod Mod/tow
d) Parous
Week 1 0 4 1
Week 2 1 2 5
Week 3 1 0 0
Week 4 3 7 3
Week 1 4 6 4
Week 2 4 10 7
Week 3 3 8 4
Week 4 10 5 2
In Tables (b) and (d) the difference in distribution of cell counts
between week 2 and week 4 are significant (P<0.05).
(X^ = 6.42 and 6.67 respectively)
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There is no obvious difference between parous and nulliparous women
in the amount of cellular infiltrate. Among nulliparae, high counts
were more frequent in the luteal phase of the cycle, and low counts
in the proliferative phase, but the difference was small - perhaps
because of the small numbers of specimens available for examination.
When the week of the cycle was taken into account, the cyclical change
was not any more pronounced, and was not statistically significant.
Among parous women, there was no difference between proliterative
and luteal phases of the cycle, but when specimens were examined
according to the week of the cycle, there was a slight increase in
the number of high counts in week 4. The difference between week 2
2
and week 4 was statistically significant (X = 6.67: P<0.05).
When women taking oral contraceptives were examined, the distribution
of counts among nulliparous women was similar to that among normally
cycling women, but among parous women there was a tendency to higher
cell counts.
(ii) Oedema (Tables 4:64 and 4:65) - No difference emerged
between parous and nulliparous women, or between stages of the cycle
in either group. The fact that "+++" gradings were seen only among
parous women probably reflects the greater numbers of parous women
examined. Women taking oral contraceptives had a similar distribution
of gradings as normally cycling women.
(iii) Acid mucopolysaccharide content (Table 4:66) - Again
all groups showed the same distribution of gradings, and no differences




Oedema of intralobular stroma: Effects of parity, stage of cycle and
oral contraception
+++ ++ + + 0
Nul1iparae: Proliterative phase (18) 1 1 8 8
Luteal phase (15) 1 5 2 7
Parous: Proliterative phase (45) 1 7 13 17 7
Luteal phase (31) 2 5 11 9 4
Taking "Pill": Nul1iparae ( 9) 2 3 1 3
Parous (13) 4 8 1
Total: 131 specimens from 121 patients
+++ : Wide separation of fibres in intralobular stroma in all lobules
++ : Fairly marked separation of fibres
+ : Intralobular stroma distinguishable from extralobular stroma in
most lobules
+ : Intralobular stroma only just distinguishable from extralobular
stroma
0 : Intralobular stroma indistinguishable from extralobular
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TABLE 4:65 Oedema of Intralobular stroma
Coded specimens: Effects of parity,
stage of cycle and oral contraception
Nulliparae
Follicular phase Luteal phase On Pill
(a) +++ (f) +++ (k) +
(b) - (g) - (1) +++
(c) + (h) -
(d) +++ (i) +++
(e) + (j) +++
Parous
(m) +++ (P) + (v) -
(n) + (q) +++ (w) +




"+++" means intralobular stroma clearly seen




Acid mucopolysaccharide content of intralobular stroma: Effects of parity,
stage of cycle and oral contraception
+++ ++ + + 0
Nulliparae: Proliferative phase (25) 1 2 9 13
Luteal phase (19) 1 5 4 9
Parous: Pro!iterative phase (54) 1 7 7 13 26
Luteal phase (34) 6 7 8 13
On Pill: Nul1iparae (16) 1 1 1 6 7
Parous (16 1 1 3 11
TOTAL: 164 specimens from 146 patients
Acid mucopolysaccharide content assessed by subjective grading of blue
staining of intralobular stroma by Alcian Blue/Periodic Acid Schiff stain.
+++ all lobules showed obvious staining
++ most lobules showed obvious staining
+ staining clearly seen in some lobules




Extralobular stroma: Appearance of H & E staining: Effects of parity,
stage of cycle and oral contraception
Thick Fibrous Normal Thin
Nulliparae: Follicular phase (14) 4 3 6 1
Luteal phase (17) 0 4 11 2
Parous: Follicular phase (38) 12 8 13 5
Luteal phase (29) 6 11 9 2
All Follicular phase (52) 16 11 19 6
All Luteal phase (46) 6 16 20 4
On Pill: Nul1iparae (10) 2 2 5 1
Parous ( 8) 1 1 6 0
"Thin": poor staining, but uniform
"Thick": heavy staining, again uniform
"Fibrous": stain broken into strands, with clear areas between
The difference in distribution of "thick" and "fibrous" stroma between
the Follicular and Luteal phases of the cycle approaches statistical
2
significance (X = 3.80) but does not reach significance. (P>0.05)
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(iv) Extralobular stroma (Table 4:67) - Parous and nulliparous
women showed a similar distribution of gradings, but there was a suggestion
of a change during the cycle, with "thick" stroma being seen more
frequently in the proliferative phase in both groups, and "fibrous"
(ie. more oedematous) stroma being seen more frequently in the luteal
phase. This difference is only marginal, when the numbers of specimens
graded as "normal" and "thin" are borne in mind, but it may be a
reflection of the oedema of the breast which can be observed macroscopically
(see Chapter 3) in the luteal phase.
c) Other factors
Effects of menstrual age and birth interval (Tables 4:68 and 4:69) -
The menstrual age of each patient was calculated as her age minus her
age at menarche. Birth interval was the difference between her age
when she had her first full-term pregnancy, and her age at menarche.
Each of these was compared with the distribution of gradings of
cellularity, oedema and acid mucopolysaccharide content, and no difference
could be detected.
When the extralobular stroma was examined, there was a suggestion that
"thick" stroma was more frequently seen among older women (ie. women
of greater menstrual age), but this difference was minimal.
Effects of breast feeding history (Table 4:70) - Among parous women,
the total length of breast feeding as recalled by the patient was
compared with the histological findings. Women who had never breast¬
fed showed a similar distribution of all the gradings as those who
had breast-fed, and the length of time that breast-feeding had continued
did not affect the distribution either.
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TABLE 4:68 Effect of menstrual age on the stroma (ie. age minus age
at menarche)
1 INTRA-LOBULAR STROMA 1-9 yrs 10-19 yrs 20-29 yrs 30+
a) Cellularity: low 1 2 6 1
mod/low 4 4 6 3
moderate 8 15 16 10
mod/high 4 5 7 3
high 2 6 2 4
Total examined: 109 19 32 37 21
Oedema: 0 6 8 10 3
+ 6 14 14 11
+ 6 12 8 10
++ 3 4 7 0
+++ 0 0 1 1
Total examined: 124 21 38 40 25
c) Acid mucopolysaccharide content:
Total examined
0 12 20 25 20
+ 7 16 10 9
+ 7 10 4 2
++ 2 2 7 5
+++ 0 0 1 0













TABLE 4:69 Effect of birth interval on breast stroma
(age at first birth minus age at menarche)
I INTRA-LOBULAR STROMA 2-5 6-10 11-15 16-20 20+
yrs yrs yrs yrs yrs
a) Cellularity: low 2 1 2 0 0
mod/low 0 3 7 1 0
moderate 1 11 14 3 0
mod/high 1 8 4 2 0
high 1 4 3 3 0
Total examined: 71 5 27 30 9 0
b) Oedema: 0 0 2 9 0 0
+ 2 16 11 5 0
+ 3 13 9 2 0
++ 1 3 3 1 0
+++ 0 0 1 1 0
Total examined: 82 6 34 33 9 0
c) Acid mucopolysaccharide content:
0 4 21 14 7 2
+ 1 8 13 1 0
+ 3 5 6 1 0
++ 1 5 5 1 0
Total examined: 98 9 39 38 10 2
II EXTRA-LOBULAR STROMA
Thin 1 1 3 1
Normal 1 13 7 4
Fibrous 2 8 11 2
Thick 1 5 9 2
Total examined: 71 5 27 30 9
—
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TABLE 4:70 Effect of breast-feeding history on the stroma among parous women
I INTRA-LOBULAR STROMA Never 1-6 8-20 24-46 52-84breast-fed wks wks wks wks
a) Cellularity: low 1 1210
mod/low 5 3010
moderate 13 32 4 6
mod/high 6 4320
high 2 1052
Total examined: 67 27 12 7 13 8
Oedema 0 4 3 1 3 0
+ 13 3 8 4 3
+ 7 6 2 5 4
++ 4 0 1 2 1
+++ 1 1 0 0 0
Total examined: 76 29 13 12 14 8
c) Acid mucopolysaccharide content
0 20 7 10 7 4
+ 6 5 1 5 2
+ 7 2 1 4 1
++ 3 3 2 2 1
+++ 1 0 0 0 0
examined: 94 37 17 14 18 8
II EXTRA-LOBULAR STROMA
Thin 3 3 0 0 0
Normal 9 5 2 3 4
Fibrous 9 1 2 5 3
Thick 6 3 3 5 1
examined: 67 27 12 7 13 8
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d) Relationship between stromal changes and breast symptoms
The stromal appearances were compared in patients who had complained
of breast symptoms during or before menstruation, and those who had
no symptoms. The results are presented in Table 4:71. The amount
of stromal oedema did not differ significantly between the two groups,
although there was a slight trend towards more pronounced oedema of
the intralobular stroma among women with symptoms. The difference
between the two groups of women was more pronounced when dilatation
of the ductule lumina was assessed, but the difference was not
significant. Again, however, there was a trend towards greater
dilatation among women with symptoms.
The distribution of gradings of the appearance of the extralobular
stroma was similar in both groups, with a possible trend towards more
"thick" and "fibrous" stroma among women with symptoms.
IV AUTOPSY CASES
Attempts were made to obtain breast tissue from victims of sudden
death, in the hope that this would avoid the problem inherent in the
use of biopsy material - that the patient has some complaint related
to her breasts necessitating operation. Eight specimens were obtained,
with the very kind co-operation of the forensic pathologists acknowledged
at the introduction to this thesis. Details of the eight cases are
shown in Table 4:72. It is apparent from this table that essential
details (such as parity and oral contraceptive use) were unobtainable.
Because of the social circumstances of these patients, many of whom
had comitted suicide, it was impossible to trace details of contraceptive
use from Family Doctor records. Although the ovaries were examined,
accurate staging of the cycle proved impossible (the endometrium had
frequently undergone autolysis). For all these reasons, this source of
material had to be abandoned.
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TABLE 4: 71 Histological appearances in patients with premenstrual
breast symptoms






TOTAL 78 48 30





Srnal 1 14 12
TOTAL 66
43 23





TOTAL 68 46 22
Differences in distribution are not significant
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TABLE 4:72 Autopsy Cases
Case Age Parity Cause of death Contraception Other points
1 25 0? ?drug o/d IUCD
2 35 0? Alcohol o/d ? Mastitis
3 20 1+0 Trauma ? CL present
4 30 2+0 SBE steri1ised CL present
5 29 0 Drowning ? Nullip cervix
6 45 ? Barbiturate o/d ? none
7 24 1+0 Inhaled vomit
after a fit
IUCD







SBE Subacute bacterial endocarditis
IUCD Intrauterine contraceptive device
CL Corpus luteum
V DISCUSSION
A Summary of positive findings
1 Differences between parous and nulliparous women
a) Lobules per unit area Parous women had a greater density of
lobules than did nulliparae (P<0.05). (Table 4:22).
b) Ductule density within lobules The number of ductules per unit
area within lobules was greater among parous women than among nulliparae
(P<0.05). (Table 4:22).
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c) Epithelial types "Type 1" epithelium was commoner among
nulliparae than among parous women, but "Type 3" epithelium was
commoner among parous women than nulliparae (P<0.001). (Table 4:44)
d) Size of "clear" epithelial cells Clear basal epithelial cells
were graded as "large" more frequently among nulliparae than among
parous women (P<0.001). This highly significant difference reflects
the greater frequency of "Type 1" epithelium among nulliparae.
2 Differences due to the menstrual cycle
a) Epithelial height During the menstrual cycle there was a
variation in the height of the ductule epithelium as assessed by
direct measurement. This was greater in the luteal phase of the
cycle than in the follicular phase. The significance of this
difference was greater among parous women (P<0.01) than among
nulliparae (P<0.05).
b) Cellular infiltrate of stroma When the week of the cycle was
taken into account, a cyclical variation in cellular infiltration
of the intralobular stroma was seen. There was a greater number of
cells during week 4 of the cycle than during week 2 (P<0.05).
3 Differences due to menstrual age
a) Lobules per unit area and ductules per unit area The density of
both lobules and ductules was less among women within ten years of
the menarche than among older women (P<0.05). (Table 4:26)
b) Diameter of ductule lumina The lumina of the ductules tended




Sir Astley Cooper said of the milk cells, "Their number is very great;
it varies much and it would be an act of folly and inutility to
endeavour to reckon them". (Cooper 1840). This pessimistic view
has to some extent been justified by the fact that for the last fifty
years controversy has surrounded the question of the breast's response
to the normal menstrual cycle. The variation between specimens,
described in this chapter, partly explains this controversy. The
controversy is unlikely to be explained by the difference between
nulliparous and parous women, since these differences are not marked,
but nevertheless no previous investigators have looked for such changes.
The menstrual cycle appears to have little influence on breast histology,
and other variables even less influence.
1 Variation between specimens
The lobular architecture is the area in which the greatest variation
between specimens occurs. Some variables (such as the percentage area
of lobules) trebled or quadrupled in one specimen compared to another
from the same block (Table 4:19), and there was a slightly greater
variation between different blocks taken from the same breast. Variation
between right and left breasts was no more marked than variation between
different blocks from a single breast. This amount of variability
emphasises the pitfalls of drawing conclusions from a small number of
specimens (as were originally drawn by Rosenburg, 1922). Large numbers
of specimens have to be examined before trends can be discerned, and
when this has been done by previous investigators, the conclusions have
tended to be guarded (Foote and Stewart, 1945) or negative (Haagensen,
1971).
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Although there is marked variation in lobular architecture, it
appears from this study that less variation between specimens occurs
in the structure of the epithelium of the ductules, and in the
stroma (eg. Tables 4:31, 4:43, 4:62).
2 Variation associated with parity
The fact that variations due to parity had not previously been described
(or even, apparently, looked for) was one of the main reasons for
undertaking this study. It has been assumed by others that since the
breast returns after involution to a structure resembling that of the
virgin breast (Dawson 1935), the two must be identical. The results
of the present study suggest, on the contrary, that parity has more
important effects on breast histology than does any other factor -
although even the effects of parity are far from obvious.
The finding that the density of lobules is greater among parous women
than among nulliparae (Table 4:22) suggests that involution after
pregnancy is not always complete. (None of the patients studied had
recently breast-fed, and so the results are unlikely to be influenced
by breasts in the process of involuting). However, the associated
variable (the number of ductules per unit area) did not differ
significantly. Nevertheless, the number of ductules per unit area
tended to be greater among parous women, and although this trend did
not reach significance it tends to support the conclusion that lobule
numbers are greater among parous women.
The density of ductules within lobules also appeared greater among
parous women, suggesting a similar process of incomplete involution.
However, in this case the difference in the associated variables
(average number of ductules per lobule, and area of average lobule)
was only very slight, and this casts doubt on the significance of the
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variation in ductule density. The size of the lobules is not changed
after pregnancy and involution, and if ductules are present in greater
numbers, the difference must be only very slight.
On the other hand, the difference in distribution of epithelial types
is highly significant. Even here, however, the change brought about
by parity is a subtle rather than a sharp one, and the increased
frequency of Type 1 epithelium among nulliparae is seen only when a
large number of specimens is examined (Tables 4:44 and 4:45). This
would explain why this trend has not previously been reported, despite
close attention being paid to the basal clear cells which characterise
Type 1 epithelium (eg Bassler 1970). The reason for the difference in
epithelial types is unknown, because the function of the basal clear
cells is unknown. As discussed above (Chapter 2), it has been assumed
by some workers that these cells are myoepithelial cells, but their
large numbers in some specimens (Fig 4:5) makes this very unlikely.
Since they are basal in position, they may be precursors of the pink-
staining cells: if this is the case then the implication that they
are less differentiated and are capable of proliferation has important
implications when the breast's susceptibility to carcinogenesis is
considered (Chapter 7).
3 Variation associated with the menstrual cycle
In this study the phase of the menstrual cycle was normally decided
by the plasma concentration of progesterone. The advantage of this
method is that it allows ovulatory cycles to be distinguished from
anovulatory cycles, a distinction that has not been made by previous
investigators. It also allows comparison to be made between cycles
of unequal length, since variation in the day of ovulation may have
an important influence on the effect that the cycle has on the breast.
A possible disadvantage of this method of dividing the cycle into two
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rather than four or more, is that a change in one of four phases might
be obscured. If a change were missed it would be likely to be a small
one, or to be compensated for by an opposite change in the same phase
of the cycle. Such a phenomenon seems unlikely, and no previous
investigation has suggested it: changes, if they occur, are said to
be slow in onset and regression, and therefore are likely to be detected
by the method chosen.
The lack of variation attributable to the menstrual cycle was a
striking negative finding in this study. As described in Chapter 2,
investigators studying small series of specimens had described marked
changes, (eg. Rosenburg 1922). (For example, in the present study the
difference in the appearance of Figs 4:3 and 4:4 could be attributed
to the difference in plasma progesterone concentrations, since all
other variables are almost identical). The results of the present study,
however, agree with those investigators who looked critically at large
series - for example, Haagensen (1971), who studied 400 specimens and
concluded that cyclical changes do not occur in the lobules. Other
investigators have suggested that changes occur although not all lobules
respond to them (Foote and Stewart 1945): because of the variability of
histology from different parts of the same breast this theory would be
easy to illustrate, but there has been no supporting data in the form
of quantitation of how many lobules show changes and how many do not.
The theory that cyclical changes occur in some but not all lobules makes
assumptions which are practically impossible to prove or disprove, but
the burden of proof is, I suggest, on those who believe such a phenomenon
occurs.
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The one cyclical change in the ductules that was found in the present
study was a change in epithelial height (Table 4:38). This is greater
during the luteal phase of the cycle, and the difference is seen among
both parous women and nulliparae. The greater significance of the
variation among parous women (P<0.01) than nulliparae (P<0.05) is
probably due to the difference in the number of specimens examined.
The fact that an effect is seen among both parous and nulliparous
women does not agree with the findings in Chapters 5 and 6, in which
cyclical effects were seen among parous women but not among nulliparae.
However, those chapters are concerned with functional aspects, and
the relationship between epithelial height and function is not certain.
The phenomenon observed here is similar to that reported in the
ultrastructural study of Fanger and Ree (1974), who reported that
epithelial cells became more active in the luteal phase of the cycle.
The cellular infiltration of the intralobular stroma appeared to increase
during week 4 of the cycle and was at its lowest during week 2. This
finding agrees with the work of Foote and Stewart (1945), and also agrees
to some extent with the finding in Chapter 6 of this thesis that numbers
of plasma cells tend to increase during the latter part of the cycle
(although this increase is inferred rather than directly observed in
Chapter 6). The function of the cellular infiltrate remains uncertain:
the suggestion that the cells are present to phagocytose desquamated
epithelial cells seems unlikely in view of the finding that budding of
the ductules and subsequent involution do not occur. As discussed in
Chapter 6, the cellular infiltrate may reflect variation in secretion
of a local transmitter produced by the epithelial cells, though this
possibility remains speculative.
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The results therefore suggest that progesterone does have an influence
on the ductule epithelium, but that this influence is not sufficient
to cause budding of the ductules. The observation that a biopsy taken
during the seventh week of pregnancy (Fig 4:4) showed no increase in
numbers of ductules or lobules - but did show increased epithelial
height - supports the conclusion that cyclical changes during the
normal menstrual cycle affect only the epithelium and not the lobules.
4 Influence of other factors
Dieckmann (1925) first suggested that the age of the subject was the
main factor influencing the development of the lobules. This suggestion
receives some support from the present study. In the present study,
it was hoped that any changes would be more readily detected by
subtracting the age at menarche from the subject's age, giving her
"menstrual age", the reason for this being that lobular development does
not begin until puberty. The results show that there is significantly
less lobular density among specimens from women within ten years of the
menarche than among specimens from older women. It seems likely that
this is because lobular development is still taking place during the
years just after the menarche - some of the specimens in the present
study were obtained within a fairly short time (eg. four years) after
the menarche. However, once a certain lobular development has been
attained, no further development occurs, and there is no evidence in
the present study to support Dieckmann's (1925) hypothesis that lobular
development continues to occur during a woman's reproductive life.
On the contrary, the measurement of ductule diameters suggests the
opposite - that a steady decrease in activity occurs during reproductive
life. The progressive decrease in the mean luminal diameter found in
this study, however, is not reflected by a decrease in any other variable,
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and so its significance remains uncertain. It is possible that the
degree of distension of ductule lumina normally depends on a low
level of secretory activity by the epithelial cells, but if this is
the case then the steady decrease of luminal diameter with age might
be expected to be reflected by a decrease in the amount of stainable
secretion or a decrease in epithelial height. Neither was found to
be the case in this study.
Birth interval (ie. the difference between a woman's age at her first
full-term pregnancy and her age at menarche) was studied because of
the importance of this factor in the epidemiology of breast cancer
(MacMahon 1972). However, it did not appear to have any influence at
all on breast histology. This is not particularly surprising, and a
possible explanation of the importance of the birth interval in breast
cancer epidemiology is put forward in Chapter 7.
Breast-feeding history does not appear to influence histology. There
is no evidence in the present study that prolonged breast-feeding is
associated with, for example, incomplete involution. This is in
agreement with clinical findings and with observations on the epidemiology
of breast cancer, which also appear to show no influence of breast¬
feeding history (Chapter 7).
Thus the histology of the breast shows marked variability, but is
significantly influenced by parity. The menstrual cycle has an effect
on the epithelium only, and not on the lobules. Menstrual age had only
a slight effect. The next two chapters describe studies on the function
of the epithelium, and the relevance of the changes attributable to
parity is discussed in detail in the final chapter.
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SUMMARY
Specimens of apparently normal breast tissue were obtained from 174
patients undergoing breast biopsy or mammoplasty. The histology of
the lobules, the ductules and the stroma was examined. There was
marked variation between specimens as far as lobular histology was
concerned. Parous women showed slightly increased numbers of lobules
per sq mm compared with nulliparae, but ductular epithelium showed a
more significant variation between these two groups, with large clear
basal cells being commoner among nulliparae. Gross cyclical changes
in lobular histology with the menstrual cycle were not found: the
influence of the menstrual cycle was limited to a change in the height
of the ductule epithelium and a change in stromal cellularity.
Increased epithelial height and increased cellularity of the intralobular
stroma were found in the luteal phase among both parous women and nulliparae.
Lobular development appeared incomplete soon after the menarche. Ductule
diameters decreased with increasing age, but the patient's age did not
otherwise influence breast histology. Breast feeding history and age at
first pregnancy did not influence breast histology. Cyclical changes in
the appearance of the stroma were minimal.
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The histological studies described in Chapter 4 suggested that the
effects of parity and the menstrual cycle are seen in the epithelial
cells of the ductules, rather than in gross lobular histological
changes. Since histological changes during the cycle involved only
the height of the epithelium, other methods of investigating
epithelial cell activity were explored.
Two methods were used:- one was the assessment of immunoglobulin
synthesis, which is described in Chapter 6, and which gives at best
an indirect assessment of epithelial cell activity. The other method,
described in this chapter, was direct study of epithelial cell activity
in tissue-culture.
Cell turnover occurs to some extent in most tissue of the body. Its
rate can be assessed in vitro by the incorporation of labelled precursors
into the DNA of the cell nuclei as measured by autoradiography. An
in vitro method of examination of mammary tissue was already in use in
the Department of Clinical Surgery of Edinburgh University, for the
study of neoplastic tissue. It had been set up by Dr J R W Masters,
who agreed to collaborate on the study of normal tissue by the same
method. In the results to be described, the preparation of autoradio-
graphs and the counting of labelling indices were carried out by
Dr Masters and his assistant, Miss Katharine Sangster.
B PATIENTS STUDIED
The total number of patients investigated by this method was 47. This
number is smaller than the total number of patients investigated by
histological methods because this part of the project was begun later,
and because material was discarded for a variety of reasons. Tissue
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was discarded if it did not reach the laboratory within an hour of its
removal. A total of 21 specimens was excluded from the series because
the final preparation contained too few epithelial cells for an adequate
count to be made.
In addition, three specimens were not included in the series because
the diagnosis on the original breast lump was carcinoma. Three other
specimens were taken from patients who proved to be post-menopausal.
Age
The age range was 15 - 48, with a mean of 29.8. All patients were
menstruating, and all were Caucasian.
Piagnosis
The diagnoses of the breast lumps biopsied are set out in Table 5:1.
The diagnoses are divided into two groups: Group 1, in which there
was either no breast disease or a localised lump such as a fibroadenoma;
and Group 2, in which the disease, though benign, might not have been
localised to the lump excised. However, all the tissue examined in
this study was histologically normal.
Parity and Stage of the cycle
The parity and stage of the cycle of the patients studied are set out
in Table 5:11. The history was obtained as described in Chapter 4.
Blood was obtained for estimation of concentration of progesterone and
oestradiol-17g, as described in Chapter 4.
TABLE 5:1 Histopathology of the primary condition
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Group 1: Fibroadenoma































The method of removing specimens in the operating theatre was
identical to that described in Chapter 4.
Immediately after excision, specimens approximately 5 x 3 x 2 mm in
size were transferred into Waymouth's MB 752/1 medium (Flow Laboratories,
Irvine), containing 20 mM HEPES (N-2-hydroxyethylpiperazine-N^-2-
ethanesulphonic acid) (Flow Laboratories). Within an hour of excision,
the tissue was cut into 1 mm slices using paired razor blades, and
transferred to 5 ml of fresh medium (pH 7.2) containing 2yCi methyl-
3
H-thymidine / ml (Radiochemical Centre, Amersham; 5 Ci/mmol.) in a
sealed plastic Universal container. After four hours' incubation at
37°C, the tissue was washed three times in Hanks' balanced salt solution
and fixed in formol saline.
The tissue was processed by routine histological procedures, and 5y
paraffin sections were picked up on "subbed" slides. Autoradiographs
were prepared using Kodak AR10 stripping film, and exposed for 14 days
at 4°C. The autoradiographs were developed for 5 minutes in Kodak D19
developer, and fixed for 10 minutes in IIford Hypam: distilled water
(1:5): both processes were carried out at 17°C. The sections were washed,
dried, stained with haematoxylin and eosin, and mounted in DPX.
At least 1000 epithelial cell nuclei were counted in each specimen
(average count 1,446), and the number of labelled nuclei was noted: any
nucleus with more than five grains was scored as positive. The Labelling
Index (LI) was expressed as the number of labelled nuclei per 1000 after
four hours' incubation with tritiated thymidine. Results were statistically




The repeatability of the observations was tested with tissue from
four patients. (Attempts to compare right and left breasts in three
other patients were unsuccessful because no epithelium was present in
one of the samples from each patient).
So as to eliminate observer bias, the specimens were labelled in such
a way that they did not appear to come from the same patient.
The results are given in Table 5:111 below.
TABLE 5:111 Repeatability of observations
Patient number Areas sampled Labelling Indices
JD 74 Right breast 3.0
Right breast 1 .9
JD 110 Left upper inner quad 20.0
ii ii ii ii 22 2
JD 163 Right breast 4.2
Right breast 3.7
Right breast 4.6
JD 168 Left breast 3.0
Right breast 1.8
The correlation coefficient between samples is 0.998
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2 Diagnosis
Patients were divided by diagnosis in the lump biopsied, as shown
in Table 5:1. The mean LI in Group 1 (patients with localised disease
only) was 6.92 + 1.61. The mean LI in Group 2 (patients whose disease
may not have been localised) was 9.44 + 1.40. The difference between
these groups is not statistically significant.
3 Parity
Among the 17 nulliparous women the mean LI was 8.09 + 1.94. This was
not significantly different from the mean LI among the 31 parous women,
which was 8.39 + 1.28. The parity of the parous women ranged from
1 + 0 to 4 + 2, and the number of pregnancies a woman had had did not
effect the LI (Fig 5:1).
4 Stage of the menstrual cycle
The labelling indices were compared with the day of the cycle on which
the biopsy was taken, in both nulliparous and parous women. In Figs
5:2 and 5:3 the day of cycle is taken as the number of days from the
onset of the last period, as recalled by the patient. Among the 14
nulliparous patients there was no sign of a cyclical pattern (Fig 5:2),
and there was no significant difference between mean Li's in the two
phases of the cycle (Table 5:1V).
Among the 31 parous patients, however, there was a biphasic pattern
(Fig 5:3). The Labelling Indices fell steadily after the start of
the cycle to a low point at the time of ovulation, and during luteal
phase they rose again to a maximum just before menstruation. The mean
LI during the follicular phase among parous women was 5.38 + 1.63,
which is significantly different from the LI during the luteal phase
































Fig 5:1 Relationship between epithelial cell Labelling
Index (LI) and parity. The figures for parity
represent completed pregnancies of more than 28
weeks' gestation. "+" means that the patient
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LI v day of cycle in nulliparae.
Squares denote subjects with plasma progesterone greater than
Ing/ml (3.2 nmol/L).
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Fig 5:3 LI v day of cycle in parous women.
Squares denote patients with plasma progesterone
greater than Ing/ml (3.2 nmol/L).
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Because of variation in the length of the cycle the simple method of
dating the cycle used in Fig 5:2 and Fig 5:3 may not be an accurate
reflection of the influence of ovulation and the luteal phase. In
addition, the patient's recollection of the date of her last period
may be inaccurate. For these reasons, Labelling Indices were plotted
against the number of days until the next period (as notified to me by
letter from the patient). The resulting "back plot" is shown in
Fig 5:4.
In Fig 5:4 the parous women show a similar biphasic curve to that seen
in Fig 5:3. However, the most striking feature of the "back plot" is
the steady rise in LI among parous women during the luteal phase - ie.
from 13 days before the next period until three days before the next
period. Among parous women the correlation between LI and the day of
the luteal phase (dated from the onset of the next period) is 0.924.
This correlation is highly significant (P<0.001).
Among nulliparae no biphasic curve is seen in the "back plot", and the
correlation with the day of the luteal phase is not significant (r:0.381).
5 Plasma progesterone and oestradiol 173
Plasma progesterone concentration in the blood sample taken at the time
of operation was compared with LI in both nulliparous and parous women.
Among nulliparae there was no correlation (r: 0.587). Among parous
women, (surprisingly perhaps, in view of the relationship seen in Fig 5:4)
there was no correlation, with a correlation coefficient of 0.077 (Fig 5:5)
Oestradiol 17$ showed no correlation with LI in either nulliparae or
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Nulliparous: plasma progesterone below 1 ng/ml
Parous: plasma progesterone below 1 ng/ml
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Fig 5:4 Epithelial cell Labelling Index (LI) back-plotted
from the first day of the subsequent period, to show
the effect of the luteal phase on LI. Between Day 14
and Day 0 LI rises steadily among parous women, and the





































Fig 5:5 Relationship between epithelial cell Labelling
Index (LI) and plasma progesterone concentration.
There is no significant correlation in either
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plasma oestradiol-17fi (pmol/l)
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a Nulliparous: plasma progesterone below 1 ng/ml
a Parous: plasma progesterone below 1 ng/ml
■ Nulliparous: plasma progesterone above 1 ng/ml
Fig 5:6
□ Parous: plasma progesterone above 1 ng/ml
• Nulliparous: taking oral contraceptive
o Parous: taking oral contraceptive
Relationship between epithelial cell Labelling
Index (LI) and plasma oestradiol-17g concentration.
There is no significant correlation in either parous
or nulliparous women (see text).
TABLE 5:IV Labelling Indices:











(n:3) (n:6) (n:8) (n:7) (n: 10) (n:14)
4.57 8.76 8.90 5.15 5.38* 12.17*
+2.04 +3.17 +3.40 +0.86 +1 .63 +2.21
ALL Nulliparae: 8.09 + 1.93 ALL Parous: 8.39 ± 1.28
* The difference between the proliterative and luteal phases among
parous women is significnat (P<0.05)
TABLE 5:V Labelling Indices:
Influence of breast feeding history among parous women
All
breast-
1-6 wks 8-20 wks 24-36 wks 52-84 wks feeders
Never DURATION OF BREAST FEEDING
breast-fed
(n:14) (n:4) (n:5) (n:4) (n:4) (n:17)
7.44 11.62 5.16 5.27 10.70 8.00
+1.75 +3.4 +3.02 +2.00 +4.50 +1.67
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6 Oral Contraception
Seven parous women and three nulliparae were taking the oral
contraceptive pill during the month in which the biopsy was performed.
Their Li's are in the same range as those of non-Pill users, and are
in the lower part of this range: they do not differ significantly
from those in normally cycling women (Table 5:1V). The Li's are
plotted against the day of the cycle in Fig 5:7. No relationship can
be seen to the day of the cycle, although the numbers of specimens
examined are small.
7 Menstrual Age (ie. Age minus age at menarche)
The menstrual age of the patients is compared with the LI in Fig 5:8.
There is no correlation in either nulliparous or parous women.
8 Birth Interval (ie. Age at first birth minus age at menarche)
The number of years between a parous woman's menarche and her first
full-term pregnancy was compared with her LI. The results are presented
in Fig 5:9. There is a suggestion of a negative correlation. Among
women in the follicular phase of the cycle there is no obvious relation¬
ship, but among women in the luteal phase there is a more obvious negative
correlation, with lower Li's being found among women who had a later
first pregnancy. Over all parous women the relationship is a significant
one, the correlation coefficient between LI and birth interval being
0.531 (P<0.01).
This relationship was analysed further, and a check was first made to
find out whether a coincidental relationship existed between the birth
interval and the stage of the cycle on which the biopsy was taken.
Fig 5:10 illustrates that there is a clear relationship between the birth
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Fig 5:7 Epithelial cell Labelling Index (LI) plotted against
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Fig 5:8 LI v menstrual age
Open symbols - parous subjects
Closed symbols - nulliparous subjects
Squares - plasma progesterone greater than 1 ng/ml
(3.2 nmol/L)
Circles - Pill users
Crosses - mammoplasty specimens





































a Plasma progesterone less than 1 ng/ml





Fig 5:9 Relationship between epithelial cell Labelling
Index (LI) and "birth interval" - ie. the number
of years between the menarche and the first full-
term pregnancy.
Overall there is a significant negative correlation,
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Fig 5:10 Parous women in the luteal phase of the cycle.
Among the patients studied there was a relationship between
the day of the luteal phase (plotted as "number of days until
next period") and the birth interval - ie. the number of
years between the menarche and the first full-term pregnancy.
This has to be taken into account in interpreting the
relationship shown in the previous figure (Fig 5:9).
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in the luteal phase of the cycle (r: 0.581: P<0.05). This relationship
appears to be entirely coincidental, but it complicates the analysis of
the data. This is discussed further in the final section of this chapter.
9 Breast Feeding History (Table 5:V)
Of the 31 parous patients, 14 had never breast-fed. The total duration
of breast-feeding (adding up all the pregnancies) in the remaining 17
women ranged from two weeks to 21 months. Table 5:V shows the effect
of the duration of breast-feeding by dividing breast-feeders into four
groups depending on the total duration of lactation. There are no
significant differences between these four groups, and there is no
difference between breast-feeders and non-breast feeders overall.
DISCUSSION
The labelling index (LI) is an indicator of the level of DNA synthesis,
and indirectly of cell growth. Specific conclusions about cell growth
rates cannot be drawn from the LI alone, but in general an increase
in the number of labelled cells indicates an increase in cell growth.
Munford (1964), in a study of various quantitative methods of assessing
changes in the mammary gland, concluded that changes in DNA are an
indication of histological changes, and that biochemical changes occurred
in the absence of histological changes.
Flaxman and Lasfargues (1973) also used tritiated thymidine incorporation
and autoradiography, but used a different method (Flaxman and van Scott
1972) of in vitro culture of human breast epithelial cells, which involves
the addition of hormones. Flaxman and Lasfargues showed that DNA synthesis
would occur in vitro in epithelial cells of human mammary gland without
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added hormones, but addition of insulin and prolactin caused an increase
in DNA synthesis. No other hormones were tested. In our technique,
no hormones were added, and the changes in LI were due to changes already
brought about by circulating hormone.
Ceriani (1972) also maintained normal human breast tissue in organ culture:
he reported that addition of oestrogen caused 1obuloalveolar development,
as did addition of progesterone. Progesterone stimulation produced small
empty alveoli, and oestrogen stimulation produced large alveoli with
secretion. These effects were enhanced if prolactin and insulin were
added to the medium.
Our results show an increase in LI during the luteal phase among parous
women, with a steady decrease among these women during the follicular
phase. Among nulliparae, no consistent change could be seen: although
the numbers of nulliparae were small, the scatter of results seems to
suggest that the same cyclical pattern does not occur among nulliparae.
Meyer (1977) carried out a similar study to ours, at the same time as
ours. Although he examined 104 specimens, only 49 of these were from
menstruating women in whom the stage of the cycle was known. The stage
of the cycle was assessed by history alone, and no distinction was made
between nulliparous and parous women. Meyer reports that a diurnal
variation has been noted in LI among experimental animals, and that this
was minimised in his study since almost all specimens were obtained
between 8 am and noon. (The same is true for our study, although the
hours were 9 am and 1 pm). Meyer found that the LI was low between days
2 and 15 of the menstrual cycle, and "often elevated" between days 16
and 1. His results are identical to the results we obtained among parous
women (Fig 4:7): he includes six patients taking oral contraceptives
and they appear to follow the same cycle. The parity of his subjects
is not reported. Fibroadenoma tissue appeared to follow a similar
cycle. Two samples from patients in the middle trimester of pregnancy
showed Li's at the upper end of the normal range. He also reports
a negative correlation with age.
In our results, when the Li's among parous women are back-plotted
according to the first day of the subsequent period, a linear relation¬
ship is seen, but when the Li's are plotted against the progesterone
concentration, there is no correlation. This suggests that the duration
of exposure to progesterone is more important than the progesterone
concentration. If this is so, it implies that there is a "threshold
level" of progesterone in the circulation that stimulates the epithelial
cells, rather than a graded response.
It would be interesting to know whether or not the plasma concentration
of progestogen produced by the combined oral contraceptive pill is above
such a postulated "threshold" level. Unfortunately, after exclusions
the number of patients examined was insufficient to allow conclusions
to be drawn. Graph 5:8 suggests that only 10-14 days' exposure to
progestogen is sufficient to raise the LI above 20, while Graph 5:9
suggests that among the few parous women who had been taking the pill
for 9-14 days before their biopsy the LI had not reached a high level
(varying from 2 to 8). Although this suggests that the oral contracepti
pill does not contain enough progestogen to stimulate the epithelial
cells, the numbers of specimens are too small for this to be a firm
conclusion.
The correlation between the number of years of nulliparity and the day
of the luteal phase on which the biopsy was taken is an unfortunate
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coincidence. There cannot possibly be a cause-and-effect relationship
between these two variables, but the fact that they are related in
this series means that one cannot be sure about which is the important
variable governing the amount of DNA synthesis. DNA synthesis correlates
equally well with each. If in fact the important variable is the number
of years of nulliparity, this would imply that the longer the breast
goes before first pregnancy, the less is its ability to respond to
progesterone: one might expect this to be reflected clinically in
poorer breast-feeding among older women, and perhaps even in an
inability to breast-feed beyond a certain age. Since this does not
happen it is perhaps more likely that the important variable is the
stage of the luteal phase. The uncertainty could have been resolved
in our series by obtaining tissue for examination late in the luteal
phase from women who had delayed their first pregnancy until their
thirties - but such patients proved difficult to find.
SUMMARY
DNA synthesis in vitro was studied in specimens of breast tissue from
47 women, by organ culture with tritiated thymidine followed by
autoradiography. Among parous women cyclical variation of labelling
was seen, with highest values during the luteal phase. No cyclical
change was seen among nulliparae. Labelling was not related to plasma
concentrations of progesterone or oestradiol 17B, nor to menstrual age
or breast-feeding history. A negative correlation with birth interval
was noted, which may have been due to a coincidental correlation between
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During lactation the breast secretes large quantities of immuno¬
globulins, but very little is known about the production of immuno¬
globulins by the non-lactating breast. An abstract (Hochwald et al
1964) included "breast" as one of the tissues which produced
globulin in vitro, but otherwise the normal non-lactating gland has
not been examined for immunoglobulin synthesis. Part of the reason,
it has been suggested (Hurliman et al 1976), has been difficulty in
culturing the tissue.
Techniques are now well advanced for the identification of immuno¬
globulins, and they can be studied in a semi-quantitative way. It
is known that milk contains IgA, IgM and IgG, and that colostrum is
particularly rich in immunoglobulins. In early human colostrum the
concentration of total immunoglobulins is 4-5 Gm%, almost 90% being
IgA and IgM (Hanson and Johanson 1970). (The main circulating immuno¬
globulin, by contrast, is IgG).
A system for the identification of immunoglobulins in intestinal
mucosa had been developed by Dr D B L McClelland of the Department of
Therapeutics of the University of Edinburgh. For the reasons given
above, it was felt that the adaptation of this system for the study
of normal breast tissue would be worthwhile. I am most grateful for
the help of Dr McClelland and his colleagues (acknowledged in the
introduction to this thesis).
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II BIOPSY TECHNIQUE
The method of obtaining tissue was identical to that described in
Chapter 4. Apparently normal tissue (as judged by the surgeon) was
removed via the same skin incision as the breast lump being biopsied,
but as far away from the obviously abnormal tissue as possible. The
tissue was transported to the laboratory in normal saline, and was
processed within 1J hours of its being removed from the patient.
III HISTOLOGY OF THE TISSUE STUDIED
Sections cut serially with those used for immunofluorescence (see
below) were stained with haematoxylin and eosin and examined by two
observers, including a pathologist who had no knowledge of the patients.
Any specimens in which pathological lesions were found were excluded
from the study. Sections from the adjacent formalin-fixed blocks were
also examined, and no pathological features were seen, though a few
of these sections showed minor changes (atrophic changes in five
specimens, small cysts in two, ductular dilatation in seven, and
features of fibrosing adenosis in three). No specimens showed epitheliosis.
IV IN VITRO SYNTHESIS OF IMMUNOGLOBULINS
A) Patients studied
80 specimens were taken from 74 women, all of whom were experiencing
regular menstrual cycles. The age range was 15-52, with a mean of 33.
27 were nulliparous and 47 had had at least one full-term pregnancy.
Of these, seven nulliparous subjects and six parous subjects were
taking the oral contraceptive pill at the time of the biopsy.
A further 20 specimens in addition to the 74 were discarded from the
series - either because the breast lump biopsied turned out to be malignant,
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or because the tissue removed for study turned out to be abnormal.
As already described, a full reproductive history was taken from each
patient. She notified me of the date of her subsequent period by letter.
Blood was taken, either at the time of operation or within 24 hours
thereafter, for estimation of plasma progesterone and oestradiol-17g
concentrations.
B) Histopathology of the primary condition
In all cases the lesion biopsied proved to be benign breast disease.
(If the lesion proved to be malignant, the patient was excluded from
the study). The primary diagnosis of all the specimens was checked
by Dr I I Smith of the Department of Pathology, University of Edinburgh.
The diagnosis is shown in Table 6:1.
The patients were divided into two groups. Group 1 consists of cases
in which the disease would be expected to be confined to the excised
lump (eg. fibroadenoma) or in which no disease was present (eg. reduction
mammoplasty specimens): in this group the rest of the breast could be
expected to consist of normal tissue. In Group 2 the diagnosis was
fibrosing adenosis, a term which covers both fibroadenosis and fibro¬
cystic disease: this condition may not necessarily have been localised
to the excised lump, even though the tissue used in this study was
histologically normal.
TABLE 6:1a






42 specimens from 40 women
20 specimens from 19 women
7 specimens from 7 women
1 specimen from 1 woman
Group 2 Fibrosing adenosis (with or
without cyst formation)
42 specimens from 40 women
TOTAL 80 specimens from 74 women
TABLE 6:1b







Fibrosing adenosis (with or
without cyst formation)
8 specimens from 7 women
4 specimens from 2 women
3 specimens from 3 women
1 specimen from 1 woman
18 specimens from 18 women
TOTAL 34 specimens from 31 women
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C) Immunological Methods
80 specimens in all, each weighing 100-150 mg, were finely chopped
with scalpels and cultured for 48 hours at 37°C in a roller tube,
following the method detailed by van Furth et al (1966) and McClelland
et al (1976). The culture medium was 1 ml of modified Eagle's medium
'14 f14
containing 1 yCi/ml C L-lysine and 1 yCi/ml C L-isoleucine
(specific activity more than 270 yCi/mmol: Radiochemical Centre,
Amersham). The medium contained gentamicin (25 yg/ml) and nystatin
(75 yg/ml). After incubation the cultures were frozen and thawed
three times, centrifuged, and the supernatants dialysed against two
changes of phosphate buffer (0.015M: pH 7.6) to remove excess labelled
amino acids. The culture fluids were then freeze-dried and resuspended
in 0.1 ml of distilled water.
1) Immunoelectrophoretic analysis of the culture fluid was performed
using 6yL of the concentrated culture fluid. Because this fluid contains
too little protein to provide good reproducible precipitation lines, a
serum carrier was used. The antigen well was filled once with the
carrier serum. After the serum had penetrated into the agar (3-4 minutes),
the same antigen well was filled three times with the concentrated culture
fluid. After electrophoretic separation, the antiserum trough, at 5 mm
from the antigen well, was filled with equine antiserum against human
serum, or other antisera - see below. The precipitation lines were
developed for 24 hours at room temperature. The slides were washed for
72 hours in phosphate-buffered saline, dried, and stained with 0.5%
Amino Black 10B (Merck).
2) Autoradiography was performed at room temperature with a
sheet film (Kodak Royal-X pan) cut into strips to fit the microscope
slides. The exposure time was 21 days.
During development of the precipitation lines the labelled proteins
from the culture fluid and the proteins from the carrier serum
precipitate together. Labelling of an immunoglobulin line indicates
the synthesis of this protein in vitro. (See Fig 6:1)
3) Evaluation of the intensity of protein synthesis in vitro
The intensity of the autoradiographic lines, which indicates the amount
of protein synthesised (van Furth et al , 1966: Lai A Fat et al, 1976),
was classified according to a scale ranging from:
negative
+ line barely visible
+ line clearly visible
to a maximum of +++ - a very dark line on the autoradiograph. The
grading was done independently by two observers.
4) Antisera Antiserum to whole human serum (raised in the horse)
and antiserum to lgM (raised in rabbits) were obtained from the Central
Laboratory of the Red Cross Blood Transfusion Service, Amsterdam.
Commercial antisera to human IgA were obtained from Hoechst Pharmaceuticals
Ltd, Brentford, Middlesex (raised in rabbits), and from Nordic Laboratories,
Tilburg, the Netherlands (raised in goats). Antiserum against human
serum IgA, provided by Dr J Radl, Institute for Experimental Gerontology,
TNO, Rijswick, the Netherlands, was raised in rabbits against a pool of
human serum IgA proteins and purified by solid phase immunoabsorption
(McClelland et al, 1976). Neither this antiserum nor the two commercial
anti-IgA sera showed any reaction with secretory component.
Immunoglobulin synthesis in vitro detected by
radioimmunoelectrophoresis.
Stained immunoelectrophoresis pattern developed
with anti-IgA serum showing IgA arc. Carrier is
human milk.
Autoradiograph showing labelling if IgA arc.
The antiserum to human secretory component was kindly provided by
Dr P J J van Munster, Department of Paediatrics, University of
Nijmegen, the Netherlands, and its characteristies have" been
reported in detail (van Munster et al 1969). This antiserum
reacts with free secretory component and also with an antigenic
determinant which is specific to secretory component bound to IgA.
It does not react with serum IgA or IgA polymers.
D) Plasma cells
Sections stained with Methyl Green Pyronin (Drury and Wallington
1967, p 160) were examined for the presence of plasma cells, identified
by their characteristic shape and cherry-red cytoplasm. Counts were
made of the number of cells per high-power field within lobules. A
minimum of three fields per specimen was examined, and the mean count
was obtained.
E) Results
Synthesis of IgA was detected in 81% of the 80 specimens and synthesis
of IgG in 45% (Table 6:2). IgA synthesis was "strong" (++ or +++) in
42% of the positive specimens, whereas 94% of the IgG-positive specimens
showed only weak or barely detectable synthesis (+ or +). IgM synthesis
was seen in two specimens, and was barely detectable in both.
1) Repeatability of results Four specimens were taken from different
parts of a single breast at mammoplasty, and coded as separate specimens
none of the observers knew which specimens came from the same patient.
After organ culture IgA synthesis was graded as +++ in two and ++ in
the other two; IgG synthesis as ++ in two and + in two; and IgM as
negative in all four.
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2) Influence of parity and stage of the menstrual cycle (Table 6:3)
When comparison was made between parous and nulliparous women, the
proportions of positive specimens (81% and 77%) were similar. There
was no significant difference between the tissue removed during the
luteal phase of the cycle (as shown by a plasma progesterone concentration
greater than 1 ng/ml (3.2 nmol/1)), and that removed in the remainder
of the cycle. However, when the influence of the stage of the cycle
was examined in parous and nulliparous women separately, cyclical
changes were seen in the parous women but not among the nulliparae
(Table 6:3).
Among parous women, 16 showed strong (++ or +++) IgA synthesis during
the luteal phase, compared with only three in the proliferative phase
(P<0.05). Among nulliparae there was no significant difference between
the phase of the cycle. When patients in the luteal phase of the cycle
were examined, IgA synthesis was more intense among parous women than
among nulliparae, and the difference was highly significant (P<0.005).
The pattern of IgA synthesis was similar among women taking oral
contraceptives to that among normally cycling women. 13 women were
taking oral contraceptives (one parous woman taking oral contraceptives
provided two specimens of tissue)and IgA synthesis was "strong" (++)
in three specimens, and "weak" (+ or + ) in ten specimens.
The relationship of intensity of IgA synthesis to plasma progesterone
concentration and plasma oestradiol concentration is shown in Tables
6:4 and 6:5. There does not appear to be a relationship to the
concentration of either hormone in nulliparous or in parous women.
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TABLE 6:2











IgA 65 (81%) 9 18 24 14
igG 36 (45%) - 2 14 20
igM 2 CO - - - 2
TABLE 6:3













































4) Influence of diagnosis of the primary condition Table 6:6
shows that the number of positive specimens and the pattern of immuno¬
globulin synthesis was similar in Group 1 and Group 2. The proportion
of specimens showing synthesis was greater in Group 2, but the difference
2
was not significant (X : 0.57; P>0.1).
5) Other Factors As in Chapters 4 and 5, comparisons were made
between menstrual age (Table 6:7), birth interval (Table 6:8) and
breast-feeding history (Table 6:9) and IgA synthesis. The tables show
that none of these factors appeared to have an influence on IgA synthesis.
6) Correlation with numbers of plasma cells When adjacent sections
stained with Methyl Green Pyronin were examined, it was found that in
all but two specimens plasma cells were present in larger numbers within
lobules than in the extralobular stroma. Among specimens in which IgA
synthesis had been detected in organ culture the mean number of plasma
cells per high-power field within lobules was 5.4 (+4.3). Among
specimens in which no IgA synthesis had been detected in organ culture,
the mean number of plasma cells per high-power field within lobules was
2.2 (+ 1.9) The difference between these groups is significant (P<0.05).
However, the numbers of plasma cells showed no correlation with the
intensity of synthesis among specimens showing IgA synthesis.
TABLE 6:4 Relationship between IgA synthesis and plasma progesterone
concentration





























TABLE 6:5 Relationship between IgA synthesis and plasma oestradiol
17b concentration
Intensity of IgA synthesis
Nulliparae:-










































Influence of diagnosis of primary condition on immunoglobulin synthes
Histologically normal tissue from patients with localised disease
or no disease (Group 1) (38 specimens)
IgA 27 (71%) 5 9 10 3
IgG 16 (42%) 2 6 8
IgM 1(2%) - 1
Histologically normal tissue from patients with fibrosing adenosis
(Group 2) (42 specimens)
IgA 38 (90%) 4 9 14 11
IgG 20 (48%) - - 8 12
IgM 1(2%) - - 1
TABLE 6:7 Effect of menstrual age on intensity of IgA synthesis
Mean intensity of labelling of
Menstrual age autoradiographs (number of specimens)
+++ ++ + + 0
1 - 9 3 3 2 2 3
10 - 19 3 5 7 7 3
20 - 29 3 6 11 4 6
30 - 0 4 4 1 3
TOTAL: 80 specimens 9 18 24 14 15
TABLE 6:8 Effect of birth interval on intensity of IgA synthesis
Mean intensity of labelling of
Birth interval (yrs) autoradiographs (number of specimens)
+++ ++ + + 0
2 - 5 1 0 1 1 0
6 - 10 2 9 3 4 4
11 - 15 4 3 6 4 4
16 - 20 0 2 1 0 1
TOTAL: 50 specimens 7 14 11 9 9
TABLE 6:9 Effect of breast-feeding history on intensity of IgA synthes
Duration of Mean intensity of labelling of
breast-feeding autoradiographs (number of specimens)
(weeks) +++ ++ + + 0
None 3 3 1_ 5 3
1 - 6 0 5 5 2 1
8 - 20 1 1 2 0 3
24 - 46 1 2 1 0 2
52 - 84 1 3 1 2 0
All breast-feeders 3 11 9 4 6
Total: 48 specimens 6 14 10 9 9
V IMMUNOFLUORESCENT IDENTIFICATION OF IMMUNOGLOBULIN
A) Patients studied
34 specimens were taken from 31 women, all of whom were experiencing
regular menstrual cycles. The age range was 19 - 52, with a mean of
33. 15 were nulliparous and 16 had had at least one full-term pregnancy.
Three nulliparous subjects and two parous subjects were taking the oral
contraceptive pill at the time of the biopsy.
The number of patients studied was limited to 31 because of technical
problems or shortage of tissue. The 31 patients studied were part of
the larger series of 74 women in whom in vitro synthesis of immunoglobuli
was studied. The same exclusions therefore apply - no patient was
suffering from breast cancer, and the tissue studied was in each case
normal. The same information on reproductive history, date of subsequent
period, and plasma progesterone and oestradiol-17f concentrations was
available.
B) Histopathology of the primary condition
The diagnosis of the primary condition is shown in Table 6:1(b).
In all cases the lesion was benign, and the diagnosis was checked by
Dr Smith. Again, the patients were divided into two groups, Group 1
having no disease or localised disease, and Group 2 having fibrosing
adenosis, which might not have been localised to the excised lump, even
though the tissue examined in this study was normal.
C) Immunological Methods
Tissue blocks were processed by the method of Brandtzaeg (1974). The
tissue was washed for 48 hours in cold phosphate-buffered saline to
remove tissue fluid proteins, then fixed in cold 96% alcohol for 18 hours
and absolute alcohol for four hours, transferred to xylene and embedded
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in paraffin. The blocks of embedded tissue were stored at 4°C. Serial
sections (6 ym) were stretched on acetone-cleaned glass slides at 40°C
by means of a small amount of water which was quickly soaked away.
Thereafter the sections were dried at 37°C for 30 minutes and stored at
4°C. Deparaffinisation was carried out the same or the next day at
8-10°C: the slides were finally rinsed briefly in deionised water and
air-dried just before incubation.
Tissue sections were incubated with FITC-conjugated rabbit antisera
to human a, y, and y chains (Hoechst) or with normal rabbit serum as
a control for autofluorescence. The specificity of the conjugated
antisera was checked by demonstrating a single arc on immunoelectro-
phoresis against whole human serum and by showing specificity of
staining of bone marrow specimens obtained from patients with myeloma
of known immunoglobulin class. Control experiments were performed by
blocking with unconjugated antisera and by using absorbed conjugated
antisera. After 30 minutes' incubation at room temperature, the sections
were washed three times in phosphate-buffered saline, mounted in
buffered glycerol and examined using a Zeiss fluorescence microscope,
with an Osram HB200w lamp, a BG2 excitor filter, barrier filters 50
and 53, and incident illumination. All the sections were examined
using a 40x Zeiss objective. Sections were photographed on Kodak Tri-X
film with an exposure time of 60-120 seconds.
Sections stained with fluorescent antibody to IgA, IgG and IgM were
graded from 0, through + to +++ for: (a) the number of fluorescent
plasma cells seen, and (b) the number and intensity of non-cellular
deposits. A separate assessment was made of deposits within the lumina
of ductules, deposits in the intralobular stroma, and those in the
extralobular stroma. Sections in which no lobular tissue could be
identified were excluded from the study.
Fig 6:2 Section of breast lobule stained with FITC conjugated
anti-IgA showing fluorescing plasma cells, (x 3750).
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D) Results
IgA Table 6:10 shows the numbers of specimens which were positive
when sections were examined after staining with fluorescent antibody
to IgA. Plasma cells were seen in 71% of the sections, and the number
of cells was moderate or large in 14 of the 24 positives. In all but
two of the sections the cells were seen in greater numbers in the
intralobular stroma than in the extra-lobular stroma. Fig 6:2 shows
a section graded as +++ for plasma cells.
Deposits of IgA were seen in the lumina of ductules in 88% of the
specimens, and as non-cellular foci in the intralobular stroma in
53%. In only five specimens (15%) were deposits seen outside the
lobules.
IgG IgG-containing cells were seen in only three sections. Non-
cellular deposits of IgG were seen in ten sections (29%), and all were
weakly fluorescent or barely visible (+ or +). More deposits of IgG
were seen in the extralobular stroma than in the lobules or the lumina
of the ductules.
IgM Fluorescent IgM-containing plasma cells were seen in one specimen,
and non-cellular deposits of IgM in three: the IgM deposits showed only
barely detectable fluorescence.
Influence of parity and the menstrual cycle Table 6:11 shows the
influence of parity and stage of the cycle, and of oral contraceptive
use, on two parameters:-
(1) the numbers and intensity of staining of plasma cells in the
intralobular stroma (where they were most numerous), and
(2) the amount and intensity of staining of acellular material in the
lumina of the ductules (where it was most plentiful). There is a trend
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TABLE 6:10
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Plasma cells 3 ( 9%) - -21
(Duct lumen 4 (12%) - - 2 2
Acellular ,, , , _ .
material <Lobule 3 < 9Z> " 3
(Stroma 6 (18%) - - 1 5
IgM
Plasma cells 1 (
(Duct lumen 2(6%) - - 2
Acellular , , O0/.
material (Lobule 1 < 3%) " " 1
(Stroma 1 ( 3%) - - - 1
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towards increased staining of plasma ceils in the luteal phase of the
cycle, but this is not significant. Oral contraceptives did not have
an obvious effect, but the numbers examined were small. There was no
correlation with progesterone or oestradiol 173 concentrations (Tables
6:12 and 6:13).
Other factors Tables 6:14 to 6:17 show the influence of diagnosis,
menstrual age, birth interval and history of breast-feeding. None of
these factors has an obvious effect on the pattern of immunofluorescence,
though the numbers of specimens examined are not high. Numbers are
too small to allow separate analysis of nulliparae and parous women.
Repeatability of results Immunofluorescence was carried out on three
specimens of tissue from the same breast (obtained at reduction mammo-
plasty). Again the specimens were coded as separate specimens, and
none of the observers knew which specimens came from the same patient.
IgA-containing plasma cells were seen in two, and graded as + and + ;
acellular deposits of IgA in the intralobular stroma were graded as
+ in all three, and deposits of IgA within the lumina of ductules were
+ in two and + in one. Neither cells nor deposits of IgA were seen in
the extralobular stroma in any one of the three specimens. No cells
or deposits were seen in any of the sections stained for IgG or IgM.
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TABLE 6:11
Immunofluorescence: Influence of parity and stage of the cycle
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ACELLULAR MATERIAL IN LUMINA
OF DUCTULES
Nulliparae:
Follicular phase (8) 1241
Luteal phase (6) 3 1
Oral contraceptives (3) 2 1
Parous women:
Follicular phase (6) 32 1
Luteal phase (8) 512
Oral contraceptives (3) 1 1
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TABLE 6:12
Relationship between immunofluorescence and plasma progesterone concentration
Intensity of immunofluorescence +++ ++ + ■+ 0
Plasma cells in lobules:
Mean plasma progesterone 8 5 1Q>4 17 13<5 17
concentration (ng/ml)
+ SEM +2.6 +3.7 +4.2 +1.8
Number of specimens 33134
Acellular material in lumina of ductules:
Mean plasma progesterone
_ 8 8 7 0 6>0 17.0
concentration (ng/ml)
+ SEM +1.9 +0.9 +4.2
Number of specimens 08132
TABLE 6:13
Relationship between immunofluorescence and plasma oestradiol 17b
concentration
Intensity of immunofluorescence +++ ++ + +_ 0
Plasma cells in lobules:
Mean plasma oestradiol 17b 753 356 741 472 7q4
concentration
+ SEM +368 +130 +127 +98 +181
Number of specimens 35749
Acellular material in lumina of ductules:
Mean plasma oestradiol 176 70? 562 M2 378 781
concentration (pmol/1)
+ SEM +274 + 94 +180 +8 +214
Number of specimens 6 10 7 2 3
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TABLE 6:14 Relationship between diagnosis of primary condition
and immunofluorescence
Plasma cells in lobules:
Group 1 (16 specimens)
















Acellular material in lumina
of ductules:
Group 1 (16 specimens)
Group 2 (18 specimens)
4 5 3 3 1
2 8 4 2 2
TABLE 6:15 Relationship between menstrual age and immunofluorescence
Intensity of immunofluorescence
(numbers of specimens)
Menstrual age +++ ++ + + 0
Plasma cells in lobules:
1 - 9 0 0 2 2 1
10 - 19 1 2 1 3 4
20 - 29 3 5 1 4
30+ 0 1 2 0 2
Acellular material in lumina
of ductules:
1 - 9 0 1 2 1 1
10 - 19 1 5 1 2 2
20 - 29 3 5 4 1 0
30+ 2 2 0 1 0
TABLE 6:16
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2 - 5 (1 specimen )
6 - 10 (8 specimens)
11 - 15 (6 specimens)
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IgA is the principal immunoglobulin in most human external secretions,
including colostrum and milk. By comparison, the principal circulating
immunoglobulin is IgG. It has been known for many years that the IgA
in salivary and intestinal secretions is synthesised locally by
subepithelial plasma cells (Tomasi and Bienenstock, 1968). During
lactation, many plasma cells are seen in the human breast (Beer et al ,
1974), and it has therefore been assumed that the IgA in human milk
is also locally synthesised. Local synthesis of immunoglobulin has
been shown in several animal species (Lascelles and McDowell, 1974;
Watson and Lascelles, 1973), but as mentioned above, little is known
about immunoglobulin synthesis in the human breast (Hochwald et al, 1964).
It is clear from the results presented above that the non-lactating
breast produces IgA rather than other immunoglobulins. This suggests
that the synthesis of IgA is not a non-specific inflammatory response
but a process associated with secretion. The interpretation that it
is a low-grade secretory process is strengthened by the finding that
plasma cells containing IgA are localised to the lobules rather than
being randomly spread through the gland. Deposits of IgA are also
concentrated in the lobules and particularly in the lumina of the
ductules, again suggesting a process of active secretion of the
immunoglobulin into the ductules. In comparison, the cells containing
IgG are fewer and are randomly distributed throughout the lobules and
the stroma.
Since many of the specimens of breast tissue were obtained from
patients with breast nodules, it is possible that the secretion of
IgA is a reaction to breast disease. However, similar results were
obtained with mammoplasty specimens, and so it appears likely that
IgA synthesis is a property of normal breast tissue.
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It may be that the secretion of IgA into the ductules is a form
of defence against infection (mastitis being very rare in the non-
lactating breast), but it is also possible that it represents a low
level of activity in a gland whose primary function is full lactation.
Amongst primitive human beings the breast was probably lactating
almost continuously, with interruptions only for pregnancy, and it
is therefore possible that humans have not evolved a mechanism to
"switch off" secretion completely.
Synthesis of IgA occurred in both parous and nulliparous women,
but cyclical changes in the amount of synthesis were found only in
parous women. The amount of IgA synthesis increased markedly in
the luteal phase of the cycle, implying that this is due to an effect
of progesterone. The observation that the increase in IgA synthesis
was not seen in nulliparae would suggest that before first pregnancy
the breast is less sensitive to progesterone. This agrees with the
findings in Chapter 5, and will be discussed further in the final
chapter.
The increased amount of IgA synthesis may be due to either increased
numbers of plasma cells or increased activity of the plasma cells
already present. The examination of MGP-stained secretions indicated
that there are increased numbers of plasma cells, but it is difficult
to tell whether or not there is also increased activity. The mechanism
for attracting circulating plasma cells into the mammary gland is
still poorly understood, although this is being investigated. Mattioli
and Tomasi (1973) labelled plasma cells by injecting tritiated
thymidine into neonatal mice, and checked the disappearance of labelled
cells: they estimated the half life of IgA plasma cells from the gut
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at 4.7 days, and the maximum life span as eight weeks. Weisz-Carrington
et al (1978) found that in mice, a combined regimen of progesterone,
oestrogen and prolactin produces development of glandular epithelium
with increased numbers of IgA-secreting plasma cells and increased
intra-epithelial IgA. This appeared to be due to an increased
ability of the gland to attract and/or retain precursors of IgA
plasma cells derived from gut-associated lymphoid tissue.
It is possible that the stimulus for increased IgA synthesis is the
increased secretion of a local transmitter from the breast epithelial
cells, but until such a transmitter can be identified this possibility
will remain unproved. However, since there is no other evidence to
suggest that plasma cells themselves are sensitive to ovarian steroids,
it seems more likely that their increased number in the breast at
certain times in the cycle is due to increased secretion of a transmitter
by the epithelium - ie. that immunoglobulin synthesis is an indirect
indicator of epithelial cell activity.
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SUMMARY
80 specimens of macroscopically and histologically normal breast tissue
were examined by in vitro culture for immunoglobulin synthesis. 34
specimens were examined by immunofluorescence for the presence of
immunoglobulins. Synthesis of IgA was detected in 81% of specimens,
while synthesis of other immunoglobulins was much less intense.
Plasma cells containing IgA were seen in 71% of the specimens
examined by immunofluorescence, and 88% of specimens had deposits
of IgA in the ductules. Nulliparous women showed no cyclical changes,
but among parous women IgA synthesis was more intense during the
luteal phase of the cycle. Other factors did not affect the intensity
of immunoglobulin synthesis.
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The results of the four parts of this study - morphological, histological,
DNA-labelling and immunological - have been discussed in the appropriate
chapters. The purpose of this final chapter is to compare these results
with one another, and to discuss their relevance to theories about
the hormonal control of breast cancer.
This chapter consists of three sections. First, the results of the
research are summarised and compared. Second, the epidemiology of
breast cancer is reviewed and current theories about its hormonal
aetiology are discussed. Finally, a new hypothesis is put forward
based on the results of this work.
1 THE EFFECT OF PARITY AND THE MENSTRUAL CYCLE ON THE BREAST
A Summary of results
In the histological investigation described in Chapter 4, the most
striking positive finding was the difference between parous and
nulliparous women. This difference had not been investigated before.
The difference between the two groups was just significant as far
as lobule density was concerned, but highly significant as far as
types of epithelium were concerned. The finding of a difference in
epithelial types agrees with the broad conclusions of Chapters 5 and
6 - that there is a difference between parous and nulliparous women -
but gives no indication of what the functional difference might be,
since the function of the clear cells (which are commoner among
nulliparae) is unknown.
Cyclical changes with the menstrual cycle (first suggested by
Rosenburg in 1922) were limited to changes in epithelial height, and
these changes were seen among both parous and nulliparae. Budding of
the ductules does not occur. The change in epithelial height draws
attention to the action of ovarian steroids on the epithelium
itself, but the observation that changes occur among both parous
women and nulliparae is in contrast to the cyclical changes noted
in Chapters 5 and 6, which occurred among parous women but not among
nulliparae. Again, the histological picture does not indicate what
functional changes may be occurring, other than a probably generalised
increase in cell activity during the luteal phase of the cycle.
The suggestion by Dieckmann (1925) that the breast changes with
age is not confirmed by the histological study: the mammary gland
is less fully developed soon after the menarche than it is in later
years, but it does not continue to develop all through the reproductive
years. On the contrary, the diameter of the ductules appears to
become less as the woman becomes older.
Despite the observation that histological changes during the cycle
are limited to the epithelium only, the morphological study described
in Chapter 3 demonstrates that cyclical changes in breast volume occur
in nulliparae. It seems likely that similar changes occur also among
parous women, although this has not been investigated. The amount of
the change is of the order of 20%, and it is therefore not due to
changes in the breast lobules - which frequently constitute well
under 20% of the volume of the breast. The volume change is probably
caused by alteration in the fluid content of the stroma, and this
fluid may be intravascular or extravascular, or both. Although no
changes in stromal oedema were detected in the histological examination,
a 20% change might well be undetectable histologically.
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The studies of DNA synthesis (Chapter 5) and immunoglobulin
synthesis (Chapter 6) agree in their conclusions: functional
changes - unlike structural changes - occur during the cycle
among parous women, but not among nulliparae. Both these
parameters are probably indicators of epithelial cell activity.
DNA synthesis is a direct indicator, implying preparation for
cell division - in preparation for either ductule proliteration
or increased cell turnover. (In this context it is interesting
to note that the biopsy taken during the seventh week of pregnancy
showed no pro!iteration of the ductules). Immunoglobulin synthesis
may be an indirect indicator of epithelial cell activity: although
due directly to an increase in the number of plasma cells, this
increased number of plasma cells probably reflects an increased
secretion of a local attractant - perhaps by the epithelial cells
of the ductules. Thus the cyclical changes in immunoglobulin
synthesis may indirectly indicate cyclical changes in the production
of the transmitter by the epithelium.
In both Chapter 5 and Chapter 6 the numbers of nulliparous women
examined were small, and so there exists the possibility that cyclical
changes were not observed among nulliparae because too few specimens
were examined. It is difficult to know how many specimens would have
to be examined before it could be said with certainty that no cyclical
changes existed. Nevertheless, the fact that both chapters agree in
showing cyclical changes among parous women and none among nulliparae
supports the idea that the observations are genuine.
In each of the four parts of the study, the increases that were
observed during the cycle occurred during the luteal phase. Thus
they appear to be a response to increased plasma progesterone
concentration. No other hormone, ovarian or pituitary, increases
at this stage of the cycle to a higher level than at any other stage
(apart, of course, from progesterone derivatives). Oestrogen levels
are highest during the follicular phase of the cycle, when breast
volume, epithelial height, DNA synthesis and IgA synthesis were
lowest. The observation that DNA synthesis and IgA synthesis do
not show cyclical changes among nulliparae therefore indicates that
the epithelium of the ductules among nulliparous women does not
respond to progesterone as completely as that of parous women. The
level of epithelial cell activity among nulliparae (as indicated by
DNA and IgA synthesis) is not uniformly low, and so the cells are
being stimulated to some extent throughout the cycle - but this
stimulation is not regularised as it is among parous women.
B Conclusions
The conclusions of the various studies may be summarised as follows:
1 Histologically, there is a difference between the ductular
epithelium of nulliparous women and that of parous women.
2 Among nulliparous women, the stroma of the breast and the
ductule epithelium appear to be hormone sensitive.
3 Among nulliparous and parous women, a low level of epithelial
cell activity is present throughout the cycle (as shown by DNA and
IgA synthesis).
4 Among parous women, epithelial cell activity varies during the
menstrual cycle, apparently in response to fluctuations in the plasma
progesterone concentration.
5 Among nulliparous women, no cyclical change in epithelial cell
activity occurs in response to fluctuations in plasma progesterone
concentration.
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6 Therefore, although the epithelium of the nulliparous woman
is active and hormone sensitive, it is less sensitive to progesterone
than is the epithelium of the breast of a parous woman.
A change in the hormone sensitivity of the breast as a result of
parity may have a bearing on the breast's susceptibility to malignant
change. Before this is discussed, the epidemiological data relating
to hormones and breast cancer will be reviewed.
II EPIDEMIOLOGY OF BREAST CANCER
A General Factors
The human is the only primate in which breast cancer is common
(Seibold and Wolf 1973), but the reason for this is unknown. In
the human, breast cancer is the commonest malignancy affecting the
female, and its incidence is increasing: in the USA it is now 82.7
per 100,000 woman-years. The results of treatment have changed little
since 1935 (Henderson and Canellos 1980), and the mortality rate has
scarcely improved over the last 40 years - a slight decrease (24.9 to
23.3 per 100,000 woman-years) has been attributed to earlier diagnosis
(Brian et al 1980). During the last 20 years the epidemiology of the
condition has been extensively studied.
1 Geographical factors
Breast cancer is commonest in North America and Western Europe (Levin
and Thomas 1977), and its incidence declines in Eastern Europe and
Asia to a low level in Japan (Doll 1972). Migration from an area of
low incidence to one of high incidence (eg. from Japan to California)
appears to increase an individual's risk of cancer (Buell 1973). The
difference in incidence are therefore not genetic in origin. The
reason for them in unknown. It has been suggested that ingestion of
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dietary fat is a possible environmental factor (Miller 1978; Wynder
1980). In experimental animals high-fat diets promote both the
appearance and the growth of mammary tumours: this effect may be
mediated by prolactin. Breast cancer incidence can be correlated
with fat intake on a national level but a cause-and-effect relationship
is far from proved.
De Waard et al (1977) suggest that part at least of the difference
in incidence between Japan and Holland can be explained by differences
in body weight and height. They found that among Dutch patients with
breast cancer, those with metastases were heavier than those without
nodal involvement. Beer and Billingham (1978) suggested that the
difference in breast cancer incidence between Caucasian and Oriental
women may be due simply to breast size differences: the larger amounts
of adipose tissue in the breasts of Caucasian women might act as
reservoirs and slow-release depots for blood-borne carcinogens.
However, breast size does not differ between breast-cancer patients
and controls (Adami and Rimsten 1978); Petrakis and Ernster 1978).
Petrakis and Ernster point out that blood-borne carcinogens would be
stored and released as effectively by distant fat stores as by the
breasts themselves.
Trichopoulos et al (1980) point out that there are differences in
breast cancer incidence within populations also: higher social
class women have 2-4 times the risk of developing the disease compared
to lower socio-economic groups.
The effects of age on breast cancer incidence have been summarised
by Doll (1972). The condition is extremely rare under the age of 25.
In areas of low incidence the maximum incidence is at age 55, but
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in areas of high incidence such as Great Britain, the incidence of
the disease increases steadily with age, though the rate of increase
is slower after the menopause. The significance of the menopause is
emphasised by a slight decline in incidence between ages 45 and 54,
before the rising pattern is again resumed. There has been a slight
increase in the incidence of breast cancer in this century, particularly
during the last ten years; this is particularly seen in the 55-64
age group (and is therefore not the result of oral contraception).
Brian et al (1980) found a 25% increase in the age-adjusted incidence
rate in Rochester, Minnesota, between 1935 and 1974, most of this
increase occurring in women aged between 45 and 64.
2 Breast-feeding
The influence of breast-feeding on subsequent cancer incidence was
first studied in a controlled way by Lane-Claypon in 1926, though
the first recorded suggestion of a connection was 80 years earlier
(Walshe 1846). Lane-Claypon reported that a history of breast-feeding
was commoner among controls than among cancer patients. More recent
studies have failed to confirm this finding (MacMahon and Feinlieb
1960), though Levin et al (1964) felt that there was some effect of
lactation - with short histories of lactation (up to 17 months)
increasing the risk slightly, and longer histories causing a decrease.
Lilienfeld (1963) noted the conflicting results of different investigations
of this question, and made the point that "if nursing habits played
an important etiologic role in breast cancer, one would expect marked
changes in the incidence" of the disease as a result of different
lactation patterns. He also suggested that the effect of lactation
might be explained not by a positive influence of lactation itself
but rather by the fact that lactation suppresses menstruation, and the
menstrual cycle may have the more important effect.
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The strongest evidence in favour of the possibility that breast¬
feeding in itself affects the incidence of subsequent breast cancer
is seen in a report from Hong Kong (Ing et al 1977). Women in
fishing villages there breast-feed only from the right breast, and
among 73 such women who developed breast cancer, the tumour was
left-sided in 27 of 35 (79.4%) post-menopausal women (ie. women over
55 years old), and left-sided in 48.7% of the 39 pre-menopausal
women. However, McManus (1977) pointed out that many other large
studies of the laterality of breast cancer have also found a pre¬
dominance of left-sided tumours. He also pointed out that the gene
pool of the Tanka women may be significant - it is known from large
surveys that a relative is more likely to be affected in the same
breast only if the presenting case has a left-sided tumour. Finally,
he points out that adeno-carcinoma is for some reason much commoner
on the left. A recent report from Oxford (Kalache et al 1980) found
no relationship between breast-feeding history and breast cancer.
The report compared 707 patients under 50 years of age with 707 matched
controls: no differences were found in the numbers of women breast¬
feeding or the duration of lactation.
3 Pregnancy and menstruation
The importance of parity has long been recognised: a nulliparous
woman has a greater risk than a parous woman of developing breast
cancer. Janerich (1978), reviewing New York State Cancer Registry
data, found that this relationship holds only for older women, and
that breast cancer in younger women is commoner among married women.
To explain this, he pointed out that malignant cells are similar to
fetal cells, and suggested that immunosuppression during pregnancy
allows tumours to grow and that many of these tumours are then
destroyed when the immune system returns to normal after pregnancy:
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if the tumour has become too large, however, its destruction will
be impossible. Doll (1978) pointed out that the figures on which
this theory is based are probably a statistical artefact. However,
the possibility remains that altered immune tolerance during
pregnancy may have some bearing on its effect on breast cancer
incidence.
In a world-wide survey comparing breast cancer patients with controls,
another factor emerged - the age at which a woman has her first
full-term pregnancy (MacMahon et al 1970). If this occurs before a
woman is 20 years old, her risk of subsequent breast cancer is less
than half that of a nulliparous woman. There is a linear relationship
between the age at first birth and the risk of breast cancer, between
the ages of 20 and 33, after which the protective effect of parity
is no longer seen. After the age of 33 a first pregnancy appears
actually to increase the risk of subsequent breast cancer (see Fig 7:1).
The suggestion that late first pregnancy increases the risk of subsequent
breast cancer was cautiously interpreted when the data were first
published (MacMahon et al 1970), and the authors emphasised that the
points lying above the line, denoting increased risk, necessarily
represented small numbers of patients, as few women have their first
pregnancy late in reproductive life. However, the consistency of the
results is striking, and in a later review the authors themselves
appeared more convinced that these data points are significant
(MacMahon et al 1973).
A number of studies, such as that of Levin et al (1964), have confirmed
the suggestion of Lilienfeld (1963) that the total number of menstrual
cycles is related to the risk of breast cancer. Late menarche and
early menopause both have significant protective effects on the risk
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Fig 7:1 Relative risk of developing breast cancer in relation
to the mother's age at the birth of her first child. The
risk in nulliparous women is taken as 1.0.
(From MacMahon et al 1970).
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of subsequent breast cancer (Doll 1975), the effect of the latter
being much greater than that of the former. In fact, an artificial
menopause under the age of 35 reduces the risk to about one-third
of that in women having a natural menopause between the ages of 45
and 55, and a delayed natural menopause after the age of 55 increases
the risk by one-half (Trichopoulos et al 1972; Doll and Smith 1958).
The significance of the age at first birth was confirmed by a large
scale study of 20,000 women in New York (Shapiro et al 1973), and
this study also confirmed the lack of significance of total family
size. It confirmed too the increased risk associated with early
menarche - menarche at ages under 15 was found to be associated with
a 50% increase in relative risk - but did not confirm the importance
of menopausal age: early menopause seemed to have a protective effect,
as reported by others, but the numbers in this series were small and
the effect was not significant.
Farewell (1977), studying the incidence of breast cancer in Guernsey,
concluded that age at menarche, age at first birth, family history
and aetiocholanolone secretion are important risk factors and have
additive effects on breast cancer risk. However, Adami et al (1978),
in a case-control study of 179 consecutive breast cancer patients in
Sweden, were unable to confirm any relationship between breast cancer
risk and age at menarche, age at first birth, age at menopause or
number of children - either in pre- or post-menopausal women.
Miller (1978) was also unable to confirm the significance of age at
first pregnancy or early menarche in a case-control study in four
areas of Canada, but Ravnihar et al (1979) confirmed the significance
of age at first birth in a case-control study in Yugoslavia. A case-
control study of 236 breast cancer patients in Utah (Hunt et al 1980)
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found that a late age at first birth was strongly associated with
breast cancer incidence, and also that risk was correlated with the
age at last delivery.
The effect of age at first birth appears to explain some of the
previous confusion about the influence of parity and lactation.
Women who have their first pregnancy early in life are more likely
to have larger families and therefore are also more likely to
breast-feed for a larger part of their lives. When the age at
first birth is taken into account, however, lactation had no effect
on breast cancer risk - neither the absence or presence of lactation,
nor its average duration, nor its prolongation for more than 24 months
(MacMahon et al 1970). However, the effect of age at first birth
does not fully explain the effect of socio-economic status - social
classes I and II have some 50% greater risk of breast cancer than
social classes IV and V. Nor does it explain the variation in breast
cancer incidence in different countries (MacMahon and Cole 1972) -
though the effect of the age at first birth is seen in all areas of
the world, whether of high or low breast cancer incidence.
4 Other factors
The New York study (Shapiro et al 1973) also confirmed the importance
of a family history of breast cancer - there was a 30% increase in
risk if a mother or sister had the disease. An extensive study of
twins in the Danish Twin Registry did not produce any firm conclusion
on the heritability of breast cancer (Holm et al 1980). These authors
estimated the Genetic Determination of breast cancer is approximately
0.30 - 0.40, but emphasised that this estimate was liable to error,
and concluded that "genetic factors seem to be of some importance
in the development of breast cancer, whereas these factors play no
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major role in the development of cancer of other sites".
Shapiro et al (1973) showed an association between benign breast
conditions and breast cancer - a prior "benign breast lesion" was
associated with a 60-100% increased risk of breast cancer. Previous
investigators had found an association between breast disease and
subsequent breast cancer (Warren 1940; Lewi son and Lyons 1953).
The estimates of the increased risk vary between a doubling of risk
(Davis et al 1964) and a five-fold increase (Black et al 1972), but
the latter figure is based on a search for "atypical characteristics"
within biopsies of benign lesions. The term "benign breast disease"
covers a large number of histological conditions (Davis et al 1964)
and there have been a number of attempts to define the apparently
benign changes which are associated with a higher risk of subsequent
breast cancer (Foote and Stewart 1945; Karpas et al 1965; Wellings
1980). These attempts have been hampered by a lack of consensus
regarding terminology: each survey has had to define its own criteria
for diagnosis of each lesion, and this difficulty not only complicates
comparison of different studies, but also reflects the range of opinion
among pathologists when asked to classify any particular specimen.
However, in a 13-year follow-up of 1441 patients with benign breast
disease, Hutchinson et al (1980) found 66 cases of breast cancer -
an incidence of 3.55 per 1000 woman-years (which is 2.1 times that
in the general population). They found that fibroadenoma alone was
not associated with increased risk, while fibrocystic disease was:
in women with fibrocystic disease increased risk was related to the
presence of epithelial hyperplasia or papillomatosis, especially
if there was calcification. Larger and bilateral lesions carried
increased risk.
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The relationship between low-dose radiation and breast cancer has been
intensively studied (Land 1980) but this is thought not to be a very
important factor in the aetiology of the disease. However, the
observation that radiation may be especially dangerous at adolescence
(as shown by the incidence of breast cancer among survivors of the
atomic bombing in Japan) strengthens the idea that breast cancer
initiation occurs at this time (Cole 1980).
The possibility of a viral aetiology remains open, though it is
now thought unlikely (Cole 1980). However, the identification in
human breast cancer of an antigen similar to mouse mammary tumour
virus has recently been reported (Spiegelman et al 1980).
B Endocrine factors
The observations that both the age at menarche (Stascewski 1971)
and the age at the menopause have an effect on breast cancer risk
point to a connection between endogenous hormone levels and breast
cancer. The total number of years of menstrual activity is related
to breast cancer risk (Levin et al 1964), with a greater risk being
associated with more than 35 years of menstrual activity than with
less than 30 years. It is now generally agreed that ovarian hormones
are implicated in the initiation or promotion of breast cancer, and
most interest so far has centred on the role of oestrogens.
1 Oestrogens
MacMahon and Cole (1972) summarised the evidence for ovarian involvement
in breast cancer. They concluded that "the proportion of human breast
cancer cases that depend on an intact ovary for their development
is at least two-thirds and may be even higher", basing this conclusion
on the effect of early surgical menopause in reducing risk of
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subsequent breast cancer by two-thirds, and on the fact that in dogs
neutering reduces the risk of breast cancer by about 90%. Addressing
the question of whether oestrogens affect tumour induction or promotion,
they point out that the importance of the age at menarche suggests
that ovarian activity has a role in tumour induction. The years
immediately after the menarche may be years of high risk of tumour
induction, and the significance of the age at first birth suggests
that this high-risk period terminates with first pregnancy. They
found little evidence that the ovary also has a role in tumour enhance¬
ment.
MacMahon and Cole developed a theory that the carcinogenic effect
of ovarian activity depends on the type of oestrogens produced by
the ovary: oestriol has not been demonstrated to have the same
carcinogenic effect as oestrone or oestradiol , and MacMahon and Cole
suggest it has a protective effect against the other two oestrogens.
Lemon (1970) postulated that oestriol competes for oestradiol
receptors in breast tissue and thus impedes the oestradiol stimulus
to breast cancer induction. Such a protective role has been demonstrated
in the rat (Terenius 1971). In support of their hypothesis, MacMahon
and Cole have shown, in a study of urinary "oestriol ratios" among
different groups of women, that the ratio of oestriol to the other two
oestrogens is much higher in young Asian women (who have a low risk
of breast cancer) than it is in young American women. Trichopoulos
et al (1980), in a recent study in Athens, correlated urinary oestriol
ratios with social class: the lower socio-economic group (with less
risk of developing breast cancer) had 50% higher oestriol ratios than
the higher socio-economic group.
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The "oestriol hypothesis" has been criticised on various grounds.
Smith and Smith (1970) suggested that the carcinogenic potential of
oestrogens may be indirect, acting through the medium of pituitary
hormones, but they offered little evidence in support of this idea.
Kirschner (1977) reviewed some of the criticisms: a number of
investigators have found increased urinary oestriol excretion among
breast cancer patients; circulating oestriol levels are normally
too low to modulate the action of oestradiol or oestrone; and perhaps
most importantly the excretion of oestriol does not accurately reflect
its production. Longcope and Pratt (1978) compared groups of women
with different urinary oestrogen ratios and found no differences in
the ratios of blood production rates of oestriol, oestrone and oestradiol.
Kirschner (1977) also points out that the hormone profiles in older
women may not reflect the hormone profile at a younger age, when the
cancer was initiated.
Siiteri et al (1974) presented an alternative "oestrone hypothesis":
they suggest that oestrone is the important oestrogen in carcinogenesis
since it is the oestrogen exclusively produced by postmenopausal and
anovulatory women "having constitutional stigmata commonly encountered
in endometrial cancer patients", and is concentrated by breast carcinoma
after superfusion. They point out that oestriol competes more effectively
for receptors with oestrone than with oestradiol, and add that their
hypothesis can be tested by observing the effects of exogenous oestrogens
on breast cancer incidence: if oestrone is indeed the main carcinogen
then the administration of oestradiol and progesterone will decrease
the incidence of cancer.
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Such a decrease has not been observed. Hoover et al (1976) found
that prolonged administration of exogenous oestrogens appeared to
increase the risk of breast cancer, though the effect was not dose-
related. Thus breast cancer appeared to respond to exogenous
oestrogen administration in the same way as endometrial cancer does
(Smith et al 1975); Ziel and Finkle 1975), and although the risk
of breast cancer is apparently not great (and only appears after at
least ten years' exposure to oestrogens), the fact that no decrease
in incidence has occurred appears to weaken the "oestrone hypothesis".
Cohen et al (1978) have suggested that the hyperoestrogenism
associated with breast cancer may be caused by diminished production
of melatonin by the pineal gland. Pineal calcification is apparently
commonest in areas with high breast cancer incidence: melatonin can
act on the ovary and its impaired secretion is believed to trigger
puberty. Melatonin may influence tumour induction in experimental
animals (Karmali et al 1978). The significance of pineal calcification
has been questioned, however, by Tapp (1978), who suggests that hyper-
function of the pineal is associated with breast cancer, through
increased prolactin secretion. Evidence for both these hypotheses
is slender.
Nandi (1978) suggested that the role of oestrogens in carcinogenesis
is synergistic with other carcinogens and is a dual role: first,
the hormones are necessary for the growth of cells transformed by
other carcinogens and second, by increasing the rate of cell division
and shortening the life-span of normal cells, they reduce the ratio
of normal to transformed cells.
7-18
There now appears to be some disenchantment with the numerous theories
proposed on the roles of oestrogens in carcinogenesis. Sherman et al
(1979) found that oestradiol levels during the cycle were normal in
a group of breast cancer patients. Korenman (1980) noted that endocrine
studies have produced inconsistent results and invite scepticism,
and he made the same suggestion as Nandi (1978), that the endocrine
environment influences the breast's susceptibility to other carcinogens.
More interest is now being shown in the role that progesterone may play
in mammary carcinogenesis.
2 Progesterone
Grattarola (1964), in a study of the premenstrual endometrial patterns
of women with breast cancer, found that they had an increased incidence
of anovulatory cycles. He looked at 87 premenopausal women with
breast cancer, and performed endometrial curettage 24-48 hours before
the menstrual period was due: he compared the results with the
examination of 59 women with normal breasts, having a similar age
range. Cycles were ovulatory in 67.7% of the normal women but only
17.2% of the patients with breast cancer. It is of course possible
that since the specimens were obtained just before or just after
mastectomy the psychological stress of the discovery of cancer had
interfered with normal ovulation.
Later evidence on the role of progesterone is not all in agreement.
Trichopoulos et al (1980) found that anovular cycles were indeed less
frequent in a lower socio-economic group of women, at less risk of
breast cancer, but Sherman (1979) found that progesterone production
during the cycle was normal in a group of breast cancer patients.
Wallace et al (1978), in a survey of menstrual cycle patterns, found
that late menarche (which should protect against breast cancer) was
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associated with longer and more variable cycles - though these workers
did not confirm that these variable cycles were anovulatory. Age
at menarche, they found, did not affect fertility, and they also
noted that a long period of irregular cycles usually precedes a
late menopause (which increases the risk of breast cancer).
Sherman and Korenman (1974) suggested that increased frequency of
anovulatory cycles may explain the connection between some well-
recognised risk factors and breast cancer. As well as noting that
menstrual cycles after the menarche and before the menopause are
anovulatory (which may explain the importance of early menarche and
late menopause in increasing breast cancer risk), they point out that
nulliparity (another risk factor) may be due to anovulation; that
obesity (also a risk factor) is associated with anovulation; and
that inadequate corpus luteum function would result in diminished
urinary androgen excretion - another factor associated with increased
risk of breast cancer (Bulbrook et al 1971: see below). Inadequate
production of progesterone would mean that the breast was subjected
to "unopposed" stimulation by oestrogens. Although the nature of
the modification of the action of oestrogen by progesterone is not
understood, it is now being recognised as far as the endometrium
is concerned that unopposed oestrogen stimulation may be carcinogenic -
and that this carcinogenicity may be modified by intermittent exposure
of the endometrium to progesterone.(Sturdee et al 1978; Craft et al
1978; Paterson et al 1980).
Sherman and Korenman's hypothesis has received support from the
Guernsey study (Bulbrook et al 1978); premenopausal women at high
risk of breast cancer have lower plasma progesterone levels during
the luteal phase of the cycle than normal women, although they have
normal oestradiol levels.
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Korenman has recently developed his "inadequate luteal phase" theory
into a so-called "oestrogen-window" hypothesis (Korenman 1980a,b).
He suggests that unopposed oestrogen stimulation at the time of the
menarche and the menopause opens a window to other carcinogens -
a window that is effectively closed at other times by the presence
of progesterone. His hypothesis has five parts:
1) Human breast cancer is induced by environmental carcinogens in
a susceptible breast.
2) Unopposed oestrogen stimulation is the most favourable state for
tumour induction.
3) There is a long latent period between tumour induction and
clinical expression.
4) The duration of the exposure to oestrogens determines risks.
5) Susceptibility to induction ("inducibi1ity")declines with the
establishment of normal luteal phase progesterone secretion and
becomes very low during pregnancy.
In support of his hypothesis, Korenman cites the incidence of breast
cancer among atomic-bomb survivors in Japan: those irradiated at the
age of 10-14 showed the highest incidence of subsequent breast cancer,
but those aged between 30 and 49 at the time of exposure showed no
subsequent effect. According to this hypothesis, the administration
of exogenous post-menopausal oestrogens would extend the second window.
3 Oral Contraceptives
As yet no effect of oral contraceptives on breast cancer incidence
has been shown by epidemiological studies (Arthes et al 1971; Royal
College of General Practitioners 1974; Sartwell et al 1977; Vessey
1978). Lesnick (1971) reported that the incidence of breast cancer
in women taking the Pill was less than expected. No morphological
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differences have been seen in cancers in women taking the oral
contraceptive pill (Fechner 1970c) or oestrogen replacement
therapy (Fechner 1972b). Fechner (1972a) also found no difference
between benign breast disease in women taking post-menopausal
oestrogen replacement therapy. Thomas (1978), summarising nine
case-control studies or oral contraceptives and breast cancer,
comments that their consistency in showing no effect is striking,
considering the numerous methodological differences between the
studies.
However, it has been suggested that the Pill may have some effect
in increasing cancer risk in nulliparous women only (Black and Leis
1972), and that oral contraceptives greatly increase the risk of
breast cancer in women who have had previous benign breast disease
(Fasal and Paffenbarger 1975). Paffenbarger (1977) suggested that
the use of oral contraceptives before first pregnancy may increase
the risk of breast cancer; an effect which may be due to their
delaying the first pregnancy rather than to their effect on the breast.
Recently, however, a Californian case-control study (Pike et al 1981)
of 163 young women aged 32 or less at the time of diagnosis of breast
cancer showed a relationship between cancer risk and the number of
months of taking oral contraceptives before first full-term pregnancy.
The risk was increased 2.2 times at six years of use. By contrast,
oral contraceptive use after first full-term pregnancy was not associated
with any increased risk. The same study suggested that a first-
trimester abortion before first full-term pregnancy was also associated
with increased risk (2.4 fold). This study has been criticised (Royal
College of General Practitioners 1981) because only 163 of an eligible
245 patients were interviewed, and because it is not quite clear
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whether the study controlled for the interval between menarche and
first pregnancy.
Nevertheless, a similar trend is shown by another study (Royal
College of General Practitioners 1981). Although this survey (which
covers 23,000 women using the Pill and 23,000 controls) found no
overall relationship between Pill-use and breast cancer, the risk
ratio in women under 35 years old at diagnosis was 2.81. This ratio
was not significant, but in the age-group 30-34, the ratio did reach
significance, at 3.33. The Oxford-Family Planning Association study
showed no such trend (Vessey et al 1981), but the latter authors
point out that the Oxford study is based mainly on women who were
older and who tended already to have had a full-term pregnancy when
they started taking oral contraceptives. The significance of these
studies is still uncertain, but may become clearer with a longer period
of observation.
There seems to be agreement on the observation that oral contraceptives
decrease the risk of benign breast disease (Fasal and Paffenbarger
1975; Vessey et al 1972). The connection between benign breast
disease and cancer (mentioned above) is not a strong one, and it
seems that the decrease in incidence of benign breast lesions is
not mirrored by a decrease in incidence of carcinoma. There have
been isolated reports of unusual fibroadenomas removed from women
on the Pill (Brown 1970; Goldenberg et al 1967), but no differences
were found in controlled series between lesions from women on oral
contraceptives and controls (Taylor 1971; Fechner 1970a,b). Erb
and Kallenberger (1972) found that oral high-dosed oestrogen-
progesterone combinations tended to produce adenosis, but there
was less cystic disease and no sign of precancerous change.
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In a case-control study in Yugoslavia, Ravnihar et al (1979) confirmed
the finding that oral-contraceptive use is associated with a decreased
incidence of benign breast disease but does not affect the incidence
of breast cancer. LiVolsi et al (1978), in a histopathological study
of 205 premenopausal women, attempted to resolve the apparent
conundrum that the Pill lowers the incidence of benign breast disease
while not affecting the incidence of cancer, despite the fact that
there is normally a correlation between benign breast disease and
cancer (Hutchinson et al 1980). Li Vol si's conclusion was that oral
contraceptives protect only against fibrocystic disease in which
epithelial atypia was minimal or absent, and they do not protect
against premalignant forms of benign breast disease.
4 Androgens
The possibility that androgens have a role in the initiation or
promotion of breast cancer was raised by the work of Bui brook et
al (1971). These investigators set up a prospective study in the
island of Guernsey, measuring urinary androgen and corticosteroid
metabolites in 5000 healthy women. When breast cancer was later
diagnosed in a woman taking part in the study,her urinary excretion
of these steroids was retrospectively compared with that of matched
controls. Bulbrook's group found that the 27 breast cancer patients
had much lower levels of androsterone and aetiocholanolone in the
urine than did 187 matched controls. They do not offer an hypothesis
to explain this, but Kirschner (1977) has suggested two possibilities:
one (that the decreased excretion is the result of nutritional,
thyroidal or other factors) seems unlikely to be correct several
years before the appearance of the disease; and the other is that
androstenedione, which is normally excreted as aetiocholanolone,
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is almost completely converted peripherally to oestrone in women
at high risk of breast cancer. Thus Bulbrook's observations might
be evidence d<n favour of Siiteri's "oestrone hypothesis".
However, Kirschner et al (1978) found that androstenedione and
oestrone production rates were no different in breast cancer patients
than in controls, and that the conversion of androstenedione to
oestrone was not abnormal in women with breast cancer. They also
found that approximately 30% of oestrone in postmenopausal women
with breast cancer comes from sources other than androstenedione,
compared with less than 10% in normal women. Nevertheless, in a
recent report (Wang et al 1979), Bulbrook's group found that plasma
androgens correlated with urinary androgens, and they felt that
urinary androgen levels truly reflected adrenal androgen production,
which therefore, they contended, is low in high-risk women.
Adams (1978) suggested that urinary androgens may be low because
DHEA is metabolised by an alternative pathway, not to oestrone but
to another adnrogen, ADIOL: this androgen has been shown to affect
oestrogen receptors in the rat mammary gland.
Although it is suspected that the abnormalities of androgen metabolism
may reflect in some way an abnormal oestrogen stimulus to the breast,
their significance is far from clear. The picture is further complicated
by the finding (Grattarola 1980) of a weak correlation between
increased urinary testosterone and breast cancer, in study of
ovariectomised patients.
5 Other Hormones
Evidence that prolactin may be involved in the initiation or
promotion of breast cancer comes from the findings of Kwa et al
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(1974) and Henderson et al (1975) that plasma prolactin levels are
raised in the families of patients with breast cancer (though not
in patients themselves). Sherman et al (1979) found normal prolactin
levels during the menstrual cycle in women with breast cancer. In
1974 reports that breast cancer was associated with reserpine use
(Armstrong et al 1974; Heinonen 1974) led to speculation that this
drug may affect the breast by stimulating the release of prolactin.
However, the association between reserpine and breast cancer has
been denied in later investigations (O'Fallon et al 1975).
Suggestions of a connection between hypothyroidism and breast
cancer remain unconfirmed (Kirschner 1977).
Ill HYPOTHESIS: THE MENSTRUAL CYCLE AND THE AETIOLOGY OF BREAST CANCER
The importance of parity is clear from the foregoing review. Although
a woman's total number of children and duration of breast-feeding
are probably not important, the first full-term pregnancy has a
significant effect on the subsequent risk of breast cancer. Before
first full-term pregnancy the epithelial cells are susceptible to
some kind of precancerous change, to which they are less susceptible
after this pregnancy. The importance of the age at menarche (the
earlier the menarche the higher the risk of breast cancer) suggests
that the premalignant influence begins at puberty and continues
until first pregnancy. The longer the interval between menarche and
first pregnancy, the longer the exposure to this premalignant
influence and the higher the risk of subsequent breast cancer.
A A previous hypothesis: the menstrual cycle is harmful to the breast
Short (1974) has suggested that the premalignant influence operating
during this time is the hormonal fluctuation of the menstrual cycle
itself. His hypothesis was that during the interval between menarche
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and first pregnancy, the breast is awaiting the surge of hormones
induced by pregnancy, which will complete the development of the
gland into a fully functional lactating organ. It might be that
the gland which is awaiting this hormonal surge is particularly
sensitive to changes in hormonal concentrations, and becomes
"stable" only after it has fully developed and then involuted.
Thus menstrual cycles before the first full-term pregnancy may
represent a "stress" to the immature breast.
Short's hypothesis would explain the importance of the age at
menarche and the age at first pregnancy as breast cancer risk
factors. The hypothesis would not be incompatible with more
detailed hypotheses such as the "oestrone hypothesis" or the
"oestriol hypothesis", since these oestrogens are present before
the first pregnancy and can act on the breast then. It would
explain why breast cancer appears only in a few species, particularly
the human, since only in humans and domesticated animals is fertility
restricted artificially to produce a long interval between the
beginning of reproductive life and the start of first pregnancy.
When fertility is unrestricted, first pregnancy follows ovulation
fairly quickly, and the breast therefore is subjected to only a few
months of hormonal fluctuation while still in its hypothetical
"hypersusceptible" state. Short's hypothesis would also help to
explain the increased incidence of breast cancer in this country:
although girls are no younger at marriage now than they used to be,
the age at menarche has fallen steadily during this century to a
mean of 13.2 years, at which it now seems to have stabilised
(Tanner 1973; Roberts and Dann 1975). This has increased the length
of time that the menstrual cycle can act on the breast before first
pregnancy.
7-27
Short's hypothesis also has the particular attraction of having
clinical applicability. If the menstrual cycles before first
pregnancy stimulate the breast and those after first pregnancy do
not, the stimulus could be removed by abolishing the monthly
fluctuations of the cycle - for example, by continuous dosage with
the combined oral contraceptive pill. Taking the Pill in a three-
monthly cycle rather than a monthly cycle is acceptable to many
women (Loudon et al 1977), and might even be a surer method of
contraception than allowing hormone levels to fluctuate slightly
each month. Even taking the Pill on a conventional monthly regime
might protect the breast, although such an effect has not yet been
demonstrated epidemiologically.
If in the present study cyclical changes had been found among
nulliparae but not among parous women, this hypothesis would have
been supported. However, the reverse was the case. Before first
pregnancy the breast seems unresponsive to the changes of the menstrual
cycle, and after first pregnancy it shows cyclical changes. It
therefore appears that the cyclical variations in breast epithelial
cell activity are not harmful to the stability of the cells. Indeed,
the reverse seems to be the case: the inabi1ity of the nulliparous
breast to undergo these cyclical changes may be connected to its
susceptibility to malignant change.
B A modified hypothesis: the immature breast is less sensitive
to progesterone
A new hypothesis can therefore be formulated. Before first pregnancy
the breast is an "immature" organ, and it only reaches full maturity
after achieving the full histological and functional development at
the end of pregnancy. While it is "immature" it is susceptible to
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premalignant influences, and the longer the stage of immaturity,
the greater is the risk of premalignant changes occurring. After
full maturity has been reached, the influence of premalignant factors
is much less. The most important aspect of the immaturity of the
breast before first pregnancy is its inability to respond to
progesterone. Although the immature breast will respond to progesterone
if the concentration is high enough, large amounts of the hormone (as
achieved during the middle trimester of pregnancy) are required to
produce an effect on the epithelial cells. On the other hand, after
maturity is reached, the epithelial cells will respond to much smaller
concentrations of progesterone.
It is suggested, then, that the hormonal aetiology of breast cancer
is in some respects similar to that of endometrial cancer - a parallel
that other workers have already suggested (Korenmann 1980a,b). In
fact, much interest is now being shown in the idea that progesterone
protects against breast cancer, or is a marker for a protective
factor (Cole 1980). Possibly progesterone can oppose the carcinogenic
effect of oestrogen both on the endometrium and on breast tissue.
As far as the endometrium is concerned, it is now widely thought that
malignant change can be produced by prolonged exposure to oestrogen
unaccompanied by progesterone. This has been reported to occur with
post-menopausal oestrogen therapy (Ziel and Finkle 1975). Although as
Feinstein and Horwitz (1978) point out, the risk of exogenous oestrogens
causing endometrial cancer may have been exaggerated by bias in
diagnosing the condition, this seems not to have been the case.
Thomas (1978) summarises eight case-control studies, all but two of
which show a strong relationship between exogenous oestrogens and
endometrial cancer. Endometrial cancer is also associated with
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conditions (such as functioning ovarian tumours) in which oestrogen
is produced unaccompanied by progesterone over long periods of time
before the menopause (Siiteri 1978).
It is now thought that the apparently carcinogenic effect of oestrogens
on the endometrium could be modified by progesterone, and this theory
is reflected by modifications of regimes of post-menopausal "hormone
replacement therapy" by the addition of a progestogen, in such a way
as to mimic the production of progesterone during the luteal phase
of the normal cycle (Studd et al 1978). There is now evidence that
this addition of progestogens does decrease the incidence of endo¬
metrial hyperplasia (Sturdee et al 1978); Craft et al 1978), and
may therefore decrease the incidence of endometrial cancer (Paterson
et al 1980).
It is now thought that a similar protective effect of progesterone
may exist for breast epithelium. The molecular basis for this
effect remains unclear, however, and the theory is by no means
substantiated. Nevertheless, alternative theories are proving
disappointing, and the progesterone theory seems at the moment to
be a promising one (Cole 1980; Korenmann 1980a,b), as discussed
earlier in this chapter.
The theory that the breast may have a different sensitivity to
progesterone before and after first pregnancy has not been put
forward before. Taken in conjunction with the progesterone
hypothesis, this theory would explain a number of the observations
about the epidemiology of breast cancer. In particular, it would
explain the importance of the age at menarche and the age at first
full-term pregnancy. After the menarche there are a few months of
anovulatory cycles, but when ovulation begins, progesterone is
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produced regularly during the years between menarche and first
pregnancy, in concentrations similar to those in cycles after
first pregnancy. However, if before the first pregnancy the
breast epithelium is relatively insensitive to progesterone, the
end result will be the same as if there were simply a long series
of anovulatory cycles between menarche and first pregnancy - the
effect of the oestrogen present in the circulation will be "unopposed"
by the progesterone, despite the presence of the latter hormone in
normal concentrations.
The hypothesis explains why studies have not revealed consistent
differences in hormone concentrations between groups of women at
different risks of breast cancer (Kirschner 1979). If the difference
between the groups is due to some extent to the breast's responsiveness
to hormones rather than to their circulating levels, then differences
in urinary excretion or plasma concentrations will not necessarily
be found. Thus two groups of women with exactly similar patterns of
steroid hormones in the circulation could be at different risks
because of variation in the effects of the hormones rather than their
concentration.
Nevertheless, the hypothesis is not incompatible with other hypotheses,
including the "oestrone", the "oestriol" and the "progesterone window"
hypotheses. The present hypothesis offers no opinion on which type
of oestrogen is important in carcinogenesis. Oestrone, oestradiol
or oestriol may be exerting the effect which is unopposed by progesterone.
It seems likely, in fact, that the interaction of these hormones is
more complex than we suspect at the moment: for example, Wotiz et
al (1978), measuring progesterone receptors in the rat, found that
synthesis of progesterone receptor can be induced by oestradiol, but
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this induction is inhibited by oestriol. Progesterone receptors in
human breast tissue remain difficult to measure, and until more is
known about them, speculation about hormone interaction at a molecular
level at the cell membrane will be hard to substantiate or disprove.
The present hypothesis extends, rather than competes with, theories
of the importance of progesterone such as the "inadequate luteal
phase" theory. This theory, it is suggested, is only operative after
the first full-term pregnancy. If ovulation is infrequent after the
first pregnancy, or if only small amounts of progesterone are produced
during the luteal phase, the "unopposed" action of oestrogen will
continue after the first pregnancy, despite the ability of the breast
epithelium to respond to progesterone if present. The inadequate
luteal phase before first pregnancy is irrelevant, according to the
present hypothesis. There are, however, two possibilities for the
inadequate luteal phase before first pregnancy having an effect on
breast cancer risk. One is that anovulation will be associated with
infertility, and therefore women with low progesterone concentrations
will have delayed first pregnancies, thus increasing their risk. The
other is that the breast's insensitivity to progesterone may be
partial rather than complete before first pregnancy, so that a
protective effect of progesterone may be present, though much diminished
compared with its effect after first pregnancy.
A recent observation which affects the present hypothesis is the
finding that oral contraception may influence breast cancer risk
before first full-term pregnancy but not after it (Pike et al 1981;
Royal College of General Practitioners 1981). The present hypothesis
does not permit any conclusions to be drawn about the role of the Pill
in influeencing breast cancer risk. If the breast before first pregnancy
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is insensitive to progesterone it will almost certainly be insensitive
to progestogens in oral contraceptives. Therefore the question as to
whether or not oral contraceptives influence the risk of breast cancer
becomes a question of whether exogenous oestrogen as provided by the
Pill is more, or less, carcinogenic than endogenous oestrogen from a
woman's own ovaries. Since the nature of the carcinogenic effect of
oestrogens is still not understood, this question is impossible to
answer on theoretical grounds, and the answer will have to await a
prolonged period of observation of women taking exogenous oestrogens.
However, the present indications that the Pill may have different
effects among parous and nulliparous women (though as yet these
indications remain unconfirmed) support the present hypothesis to
the extent of indicating that the hormone sensitivity of the breast,
as far as carcinogenesis is concerned, may be different before and
after first pregnancy.
The present hypothesis does not explain all epidemiological
observations regarding breast cancer, which may be a disease with
several causative factors. It does not, for example, explain racial
or geographical variations. Although the decrease of the age at
menarche would allow the hypothesis to explain the increasing incidence
of the disease over recent years, this will probably not be confirmed
until another 40 years have passed, when the present levelling off
of the fall in the age at menarche may be reflected by a levelling off
of the increase in breast cancer incidence.
The present hypothesis draws attention to the response of the breast
epithelium to hormones. Much attention has been focused on the levels
of hormones in plasma and urine as indicators of risk of breast cancer,
but it may be that attention would be better concentrated on the breast
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epithelium itself. The relevance of the hypothesis to clinical
practice and future research will be outlined in the final section.
C Clinical relevance and future prospects
To test any hypothesis on the causation of breast cancer is difficult
because of the probable long interval between cancer initiation and
the presentation of the disease. Because several factors may be
involved, large numbers of women have to be studied. Nevertheless,
the present hypothesis should be capable of being proved or disproved
within the foreseeable future. As methods improve further information
on the response of normal breast tissue to endogenous hormones should
become available. For example, refinements are to be expected in
methods of detecting steroid receptors - and progesterone receptors
will be of particular interest - and of detecting milk-specific
proteins such as casein or a-lactalbumin. Such investigations will
eventually confirm or refute the hypothesis that before the first
full-term pregnancy the breast is "immature" functionally, and
relatively insensitive to progesterone.
If such investigations support the present hypothesis, it will
indicate possible methods of prevention of breast cancer, although
in the short term the prospects for preventing the disease seem as
distant as ever. If initiation of a precancerous process is
inseparable from functional immaturity of the gland, it is difficult
to see how the process can be prevented without the occurrence of a
full-term pregnancy soon after the menarche. Possibly in the future
methods will be developed of perhaps inducing the synthesis of receptor
proteins, but this prospect is a distant one.
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Nevertheless, the hypothesis, if correct, will indicate the direction
which should be taken by research into contraception. It appears
inevitable that women will in general wish to continue the present
pattern of childbearing, with a relatively long interval between
menarche and first pregnancy. If anything, it seems likely that
this interval will become longer rather than shorter. At present
the method of contraception used to delay first pregnancy is usually
the oral contraceptive. Already doubts are being raised about the
effect of the oral contraceptive on breast cancer risk, and whether
or not these fears are well-founded, it already seems likely that
the oral contraceptive is not protective against breast cancer.
The ideal contraceptive, as Short (1979) has pointed out, will have
positive effects on health, rather than merely minimal ill-effects.
If the present hypothesis is correct, then a contraceptive method
which provides exogenous oestrogen will continue to initiate pre¬
cancerous change, even though progestogen is also provided. Therefore
research should be directed at suppressing ovarian activity without
providing exogenous oestrogen. Baird (1976) has suggested that it
ought to be possible to develop a contraceptive which suppresses the
hypothalamic-pituitary-ovarian axis without adminstering oestrogen -
for example, it could be achieved by mimicking the increased hypothalamic
sensitivity to oestrogens which is the normal condition throughout
chiIdhood.
The idea of decreasing the interval between menarche and first
pregnancy by attempting to re-create the premenarcheal endocrine status
may seem fanciful and is certainly not immediately feasible. Nevertheless,
if oral contraceptive use before first pregnancy does prove to increase
the risk of breast cancer, young women are going to stop taking the
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Pill, and pressure will increase for alternative methods to be developed.
There is a need, therefore, for further work in two areas: first to
examine in more detail the effects of oestrogen and progesterone on
the mammary epithelium of nulliparous women (and to accumulate further
evidence for or against the hypothesis outlined here); and second,
to develop contraceptive methods which will avoid the administration
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Changes in breast volume during normal menstrual cycle
ind after oral contraceptives
MILLIGAN, J O DRIFE, R V SHORT
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Limmary
he volume of the left and right breasts was measured
lily in four nulliparous women during normal mens-
ual cycles and after the use of oral contraceptives,
reast volume increased significantly in the second half
'
both normal and contraceptive-controlled cycles. The
iean total change in volume throughout the cycle was
•0 ml under natural conditions and 66 ml on oral
intraceptives.
Production
he human breast seems to be uniquely sensitive to ovarian
:roids. Man is the only primate in which gross morphological
east development is completed at puberty; in all other
imates the mammary gland develops only as a consequence of
e more profound hormonal changes that accompany preg-
incy.
Not surprisingly, therefore, many women report breast
langes during the normal menstrual cycle, with a feeling of
llness and a tingling sensation immediately before menstrua-
m.1 Women taking oral contraceptives also seem to experience
nilar breast symptoms.2 It has been claimed that there are
so pronounced changes in breast volume during the normal
enstrual cycle, with maximum values occurring in the week
Tore menstruation.3 No attempt has been made, however, to
udy changes in breast volume in women on oral contra-
ptives. We therefore decided to obtain accurate quantitative
formation on the nature and extent of breast volume changes
nulliparous women during the course of normal and contra-
ptive-controlled cycles.
ubjects and methods
Four healthy nulliparous women, all aged 21 years, were studied
r three months.
Case 1—Before the study this woman had been taking mestranol 50 ug
as norethisterone 1 mg (Norinyl 1) daily in 21-day cycles which were each
[lowed by seven tablet-free days. Observations were begun during the
:ond normal cycle (21 days) after she had stopped taking the contraceptive,
the next cycle she again took Norinyl 1.
Case 2—This woman had been taking mestranol 50 ug plus norethisterone
mg (Ortho-Novin 1/50) daily in 21-day cycles (followed by seven days of
treatment), and observations were begun on the sixth cycle. This was
ilowed by a normal ovulatory cycle (32 days) and then another contra-
ptive-controlled cycle.
Case 3—This woman was observed during three consecutive contraceptive-
ntrolled cycles. She was taking ethinyloestradiol 50 ug plus norethisterone
etate 3 mg (Gynovlar 21) daily in 21-day cycles followed by seven tablet-
;e days.
Case 4—This woman was not taking oral contraceptives and she was
idied for one normal 29-day cycle.
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These observations provided data on three complete normal cycles
and six complete contraceptive-controlled cycles. In one woman
(case 2) the occurrence of ovulation during the normal cycle was
confirmed by serial progesterone determinations.
Volume measurement technique—A glass mixing bowl 7 inches
(17-8 cm) in diameter standing inside a container on the floor was
filled to the brim with water. The woman, kneeling on the floor,
lowered one breast into the bowl, thus displacing water into the
surrounding container. The volume of water displaced was measured
in a 1-litre graduated cylinder. Variability due to postural changes was
controlled by marking positions for the container, hands, knees, and
elbows on a sheet of plastic. Each woman made three consecutive
measurements on each breast every day at the same time, using water
of about the same temperature. Repeated measurements were also
taken from one woman throughout one day, and the results related to
previous posture. A series of consecutive measurements was also made
over 40 minutes on the right breast of one woman at water temperature
ranging from 45-15 C.
Results
Reliability of technique—A measure of the precision of the tech¬
nique was obtained from the correlation between measurements made
on left and right breasts for each day of the cycle. The correlation
coefficient was highly significant (P <0-001) for all individual cycles
(table I). The "error" in the method was calculated by expressing the
variation between consecutive measurements made on one breast on
any one day as a percentage of the total change in volume during the
cycle. Table I shows the error for each subject expressed as a co¬
efficient of variation. Results of experiments to show the effects of
previous posture and temperature on breast volume are given in tables
II and III. There was a significant change in volume with posture
(P<0-001) and a significant decrease in volume with decreasing water
temperature (0-05> P>0-02).
table i—Correlation between measurements on left and right breasts, shotting
precision of technique
Case No Correlation coefficient between measurements
on left and right breasts
Overall coefficient
of variation
1 0 859 21
2 0-728 8-5
3 0-865 3 2
4 0-889 5 4
table ii—Variation in breast volume after consecutive changes in posture
Horizontal for: Vertical for:
4 hours 11 5 hours 4 hours 11 5 hours
Right breast (ml) 523 552 532 562
Left breast (ml) 530 588 543 600
table hi—Variation in breast volume with consecutive decreases lit water
temperature
Temperature ( C) 45 40 35 30 25 20 15
Breast volume (ml) 542 564 571 514 525 505 518
Cyclical changes—Breast volume increased significantly during the
second half of normal and contraceptive-controlled menstrual cycles
(P <0-001; fig 1), although there was no consistent difference in total
COPYRIGHT © 1975 All rights of reproduction of this rfprint are reserved in all countries of the world413/75
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volume change between normal and contraceptive-controlled cycles
(figs 2 and 3). The pattern of volume change seemed to be different
within one woman under different hormonal conditions (see fig 1). In
the normal ovulatory cycle the smaller breast volumes were found on















- mestranol + -
i 5 9 13 17 21 25 29 i 5 9 13 17 21 25 i 5
Days
fig i—Case 2. Absolute volume changes with time throu ghout normal cycle
and subsequent contraceptive-controlled cycle.
decrease up to and during the menses. In the contraceptive-controlled
cycle breast volumes rose steadily throughout the 21 days of steroid
treatment, reaching a peak 4 days after completion of the course and
dropping rapidly during the period of withdrawal bleeding.
Although the decrease in breast volume in contraceptive-controlled
cycles started on different days in different women, in every case the
main decrease occurred during the week when the pill was not taken.
Breast volumes increased again with the start of a new course of
steroid treatment (fig 3). Minimum volumes occurred about a week
earlier in contraceptive-controlled cycles than in normal menstrual
cycles. The pattern of breast volume changes in normal cycles (fig 2)
followed closely the incidence of subjective feelings of tenderness and





fig 2—Volume changes throughout all complete normal cycles expressed as





fig 3—Volume changes throughout all complete contraceptive-controll
cycles expressed as percentages of mean volume for each cycle and plotti
backwards from first day of menses.
Discussion
Others have attempted to measure changes in human brea
volume during the normal menstrual cycle by planimetr
measurements of breast radiographs4 or a water displacemei
technique.6 The most detailed study is that of Ingleby,3 wl
made weekly plaster casts of the breasts and then weighed tl
wax impressions made from these casts. She found the smalle
breast volumes in the follicular plase of the cycle in seven oi
of nine women, with an 8-44% increase above minimum valu<
during the second half of the cycle.
Masters and Johnson6 reported a 20-25% increase in brea
volume during intense sexual excitement, which they attributt
to deep vasocongestion; they do not make clear, howeve
whether these changes were objective measurements or mere
subjective assessments. Hytten7 measured breast volun
changes during pregnancy in 11 women by a water displacemei
technique. He found that the breasts had often attained the
maximum volume by the end of the second trimester. Even i
nullipara there was no significant relation between initial brea
size and the degree of enlargement, which might exceed 100"
but there was a highly significant correlation between the degrt
of enlargement and the subsequent milk yield.
Our findings confirm and extend these earlier observatioi
on cyclic changes and provide the first information available o
the effects of the contraceptive pill. The mean total change i
natural cycles was 100 ml while the mean total change for a
contraceptive-controlled cycles was 66 ml, and the pattern i
change during normal and contraceptive-controlled cycles w;
broadly similar (see figs 2 and 3). The high correlation coefficien
obtained by each woman for measurements on her left and rigl
breasts gives some indication of the reliability of this techniqi
of measurement.
The fact that a considerable degree of histological8 an
morphological9 breast development occurs in girls'before tl
menarche is perhaps the strongest argument for believing thi
this development is oestrogen dependent. Subsequent changi
in volume during the menstrual cycle might be a result t
hormonally controlled vascular and lymphatic changes10 (
structural changes in the intralobular stroma11 and alveok
epithelium21. In the rhesus monkey13 alveolar and lobular enlargt
ment occurs only in the second half of ovulatory cycles,3 whic
suggests that this is specifically a progestational change.
496
There is circumstantial evidence to suggest that a repeated
ccession of menstrual cycles before the first pregnancy may
en be harmful to the breast14; recent epidemiological evidence
ows that the risk of breast cancer increases with time elapsed
>m menarche to first pregnancy.15 16 Such considerations
ghlight the importance of a fuller understanding of the changes
cing place in the breast during the normal menstrual cycle and
:er the use of oral contraceptives.
We thank those women who generously volunteered to take part in
is study and are grateful to Dr C S Corker and Mr R Sharpe for
itistical advice.
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SYNOPSIS
In order to understand the aetiology of mammary cancer, it is first necessary to have a clear
understanding of the physiology of normal mammary development and lactation. The
species with the highest spontaneous incidence of mammary cancer are man, the laboratory
rat and mouse, and the domestic dog and cat. Mammary cancer is relatively uncommon in
primates, even when kept in captivity, and virtually unknown in the cow, which has
nevertheless been selected for large udder size and high milk yield for many generations.
Why should this be so?
Part of the answer may lie in the fact that mammary cancer is most common in those
species that have been ordained by man to spend the greater part of their reproductive lives
in the non-pregnant state, undergoing a succession of regular oestrous or menstrual cycles.
Another part of the answer may lie in species differences in the hormonal sensitivity of the
mammary gland itself. For example, the human breast is unquestionably the most
oestrogen-sensitive of all the primates, since it becomes fully developed anatomically at the
time of puberty, well in advance of the first ovulation or the first pregnancy. This is not the
case in any other primate. The aetiological factors known to predispose to breast cancer in
women include early age atmenarche, late age at first pregnancy, and late age atmenopause.
This suggests that it may be harmful to the breasts to be exposed to a succession of menstrual
cycles, with high oestrogen levels in the follicular phase unopposed by the protective effect of
progesterone.
Absence of pregnancy is also a major aetiological factor in the rat and cat, but is of less
importance in the dog. This could be explained by species differences in the endocrinology
of the oestrous cycle.
INTRODUCTION
All the epidemiological evidence points to a major role of steroid hor¬
mones in the development of mammary cancer; witness for example the
low incidence in males, and the protective effect of ovariectomy in
females. Although genetical predisposition, infectious agents and chemi¬
cal carcinogens are also important, especially for the experimental induc¬
tion of mammary tumours in laboratory animals, the object of this paper
Present address: Eastern General Hospital, Edinburgh, Scotland.
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is to review the hormonal factors that might be involved in the aetiology of
the condition.
Before we can begin to appreciate the abnormal, it is first necessary to
have a clear understanding of the physiology of normal mammary
development and lactation. This may help us to understand why it is that
spontaneously occurring mammary tumours are very common in women
(cumulative risk, one woman in 20 by the age of 70 in Britain; Doll, 1975),
but rare in all other primates (Seibold & Wolf, 1973; Appleby, Keymer &
Hime, 1974), very common in dogs (Schneider, 1970), fairly common in
cats (Dorn, Taylor, Schneider, Hibbard & Klauber, 1968), and yet virtu¬
ally unknown in horses and cattle (Priester 8c Mantel, 1971) (see Figs 1
and 2). At first sight there is no obvious explanation to account for such
marked differences in incidence rates between the various species.
2000
20(1) 40(6) 60(11) 80(16)
30(3j) 50(8j) 70(l3j) 90(l8j)
Human age (dog oge) at diagnosis in years
Fig. 1. Annual age-specific incidence rates for human and canine mammary cancer. From
Schneider (1970).
Although trite, it is nevertheless necessary to remind ourselves that the
mammary gland has been specifically designed by evolution to succour
the newborn young. Evolution has also always operated to maximize
fertility; pregnancy therefore followed hard on the heels of puberty, and
the mammary gland became a functional organ soon after the commence¬
ment of an animal's reproductive life. It is interesting that man has chosen
to suppress this reproductive potential in only a few selected species: his
wife, his domestic pets, the cat and dog, and his laboratory animals. In his
farm animals on the other hand, fertility has always been at a premium in
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Fig. 2. Annual age-specific incidence rates for canine and feline mammary cancer. From
Dorn el al. (1968).
order to achieve maximal production of milk or offspring. Could the high
incidence of mammary cancer in some species be related to man's self-
imposed infertility, resulting in the exposure of the mammary glands to
an increased number of sterile oestrous or menstrual cycles before they
achieve their ultimate developmental goal of lactation?
Cancer of the mammary gland during the reproductive years would
place an individual at a severe disadvantage in evolutionary terms,
whereas if the same fate were to befall the individual after reproduction
had ceased, it would be beyond the reach of natural selection, and of no
significance for the survival of the species. It is therefore interesting to
remember that we are the only species in which the female undergoes a
true menopause, and the peak incidence of breast cancer is in the
post-menopausal years (see Fig. 1).
If we are to attempt to analyse possible endocrine factors that could
account for the marked species differences in mammary cancer incidence
rates, it is essential to take into account the major differences that are
known to occur between species in the hormonal control of mammary
development and lactation. These have received scant attention in the
past from cancer epidemiologists: for example, Schneider (1970) states
that "one event common to man and dog is the same reproductive cycle in
the female". Yet an appreciation of these differences must form the basis
for any comparative epidemiological study, or any attempt to develop an
animal model for human breast cancer. It therefore seems desirable to
divide the species up into a number of different lactational categories
before attempting to analyse the role of endocrine factors in the genesis of
mammary cancer.
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THE SIMPLEST SITUATION: MAMMARY DEVELOPMENT AND
LACTATION OCCUR AT PUBERTY, AND ARE INDEPENDENT OF
PREGNANCY
The most striking examples of this situation are seen amongst the marsu¬
pials, of which the red kangaroo (Megaleia rufa) will serve as an approp¬
riate case in point.
Male red kangaroos have no pouch and no teats. The four teats first
become apparent in the pouch of the female at the time of puberty
(Sharman & Calaby, 1964). The length of the oestrous cycle (35 days) is
slightly longer than the length of pregnancy (33 days); all the evidence
suggests that the hormonal changes during the cycle are identical to those
of pregnancy itself, so there has been no need to develop any endocrine
mechanism for the maternal recognition of pregnancy (Sharman, 1970).
Therefore it is hardly surprising to find that it is unnecessary for female
red kangaroos to mate and become pregnant in order to lactate. Sharman
& Calaby (1964) successfully removed a newborn joey less than one day
old from the teat in its mother's pouch and transferred it to the teat of a
virgin, unmated foster mother three days before she herself was due to
return to oestrus. The foster mother apparently lactated normally, since
the joey had a normal growth rate throughout the duration of its pouch
life.
These observations on marsupials may seem a far cry from the
aetiology of mammary cancer, especially since there are no reports of
such tumours in marsupials. However, the point is made that in some
species lactation is normally initiated by the hormonal changes of the
oestrous cycle, and no additional endocrine stimulus of a pregnancy is
required.
Amongst the eutherian mammals, the domestic dog (Canis familiaris)
and the ferret (Mustela furo) appear to have a pattern of mammary
development that is very similar to that of the marsupials. The bitch is a
spontaneous ovulator and has a gestation length of about 60 days; she
normally comes into oestrus twice a year. The lifespan and secretory
activity of the corpora lutea of pseudopregnancy are very similar to those
of pregnancy (Jones, Boyns, Cameron, Bell, Christie & Parkes, 1973),
suggesting that once again there has been no need for the maternal
recognition of pregnancy, and hence no need for the placenta to develop
an endocrine function. Thus in any unmated bitch, oestrus is invariabh
followed by ovulation and the formation of corpora lutea of pseudopreg¬
nancy, which persist for about 60 days. During the course of the first
pseudopregnancy the mammary glands of the virgin bitch begin to
develop and at the end of the pseudopregnancy she may lactate copioush
(Asdell, 1964).
Much confusion has arisen in the literature over the misuse of the term
"pseudopregnancy" in the bitch. It has tended to lose its scientific conno¬
tation (an extended luteal phase in the absence of pregnancy), and has
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become a subjective description of the animal's behaviour following
oestrus. Thus pseudopregnancy may be described as "mild", "moderate"
or "severe", depending on the degree of mammary enlargement noticed
by the owner. In "severe" cases, the virgin bitch may even go so far as to
make a nest and retrieve and "mother" some inanimate object, whilst
lactating profusely.
If the endocrine changes of pregnancy in the bitch are so similar to
those of pseudopregnancy, we might expect to find little difference in the
mammary cancer incidence rates between mated and unmated animals.
This still seems to be a point of some dispute. On the one hand, Uberreiter
(1966) stated that pregnancy inhibited the growth of mammary tumours
while pesudopregnancy stimulated it, and Andersen (1965 and pers.
comm.), in a lifespan study of 354 female beagles, reported that about
50-60% of the unmated animals had developed clinical signs of mam¬
mary tumours by the age of ten, whereas only 10% of the parous animals
had developed tumours. However, in a carefully executed retrospective
case-control study, Schneider, Dorn & Taylor (1969) failed to find any
association between pseudopregnancy and mammary cancer risk. Parous
females were neither over- nor under-represented in the 93 animals with
malignant mammary tumours, nor did there appear to be any effect
of age at birth of the first litter, litter number, litter size, or total number of
offspring per female. In another careful case-control study, Fidler, Abt &
Brodey (1967) even reported that tumour-bearing bitches had signific¬
antly fewer episodes of pseudopregnancy than controls.
Further research will be required to resolve this point. In view of the
human evidence (see below), itmay be the time elapsed to first pregnancy,
rather than the total number of pseudopregnancies or pregnancies, that
is the critical determinant of the mammary cancer incidence rate in the
bitch. From the evidence to date, all that can be said is that there is some
suggestion that nulliparous bitches are more likely to develop mammary
cancer than their parous counterparts.
In contrast to this somewhat equivocal situation there is excellent
evidence to show that early ovariectomy of the bitch has a most pro¬
nounced sparing effect on the subsequent likelihood of developing mam¬
mary cancer. Schneider et al. (1969) showed that bitches that were
ovariectomized before their first oestrus had only 0-5% of the mammary
cancer risk of intact bitches. If ovariectomy was delayed until after the first
oestrus the risk increased to 8%, whereas animals that had two or more
oestrous cycles before ovariectomy had 26% of the risk of intact controls.
Within this latter group, animals ovariectomized before the age of 2-5
years had a much lower risk than animals ovariectomized after 2-5 years.
This evidence would all suggest that mammary cancer is predetermined
by the time a bitch is approximately 2'5 years old, and ovarian hormones
are crucially important; there is clearly a time-lag of several years between
sensitisation and turnout development. Once the tumour is established,
however, ovariectomy appears to have no effect on the subsequent course
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of the disease. As to which ovarian hormones are the culprits, and how
they are implicated, this must remain a matter of speculation until some
definitive experimental evidence is forthcoming. Although it is fashion¬
able to implicate oestrogens, Jabara (1962) failed to induce mammary
tumours in bitches given large doses of diethylstilboestrol, although this
treatment did give a high incidence of ovarian tumours; perhaps the
animals were not kept for long enough for mammary tumours to become
apparent. The beagle bitch has also become notorious with the drug
regulatory agencies for producing benign mammary tumours when
treated chronically with synthetic progestagens (Nelson, Weikel & Reno,
1973).
Since the majority of mammary cancers in dogs, as in women, are
adenocarcinomas (Schneider, 1970), and since the two species show very
similar age-specific incidence rates when their ages are adjusted for
differences in absolute lifespan (see Fig. 1), it has often been suggested
that the dog is the most appropriate animal model for the study of human
breast cancer. The great differences in the hormonal control of mammary
development between the two species, to say nothing of the profound
endocrine differences during the cycle and pregnancy, should make one
cautious about making such a naive assumption. Nothing seems to be
known about the spontaneous incidence ofmammary cancer in the ferret.
Since its reproductive cycle is so similar to that of the dog, it would be
worth exploring as a possible experimental animal for mammary cancer
studies.
THE INTERMEDIATE SITUATION: MAMMARY DEVELOPMENT
AND LACTATION DEPENDENT ON COPULATION
The domestic rabbit (Oryclolagus cuniculus) is perhaps the best example
of a species in which mammary development is dependent on copulation.
The unmated f emale rabbit is almost constantly in oestrus or sub-oestrus,
but there is no mammary development or lactation. Following a sterile
mating, ovulation is induced, and this is followed by a pseudopregnancy
of about 16 days (the gestation period is 29 days) and mammary develop¬
ment; at the end of pseudopregnancy, when the corpora lutea are
beginning to regress, the doe plucks her hair to make a nest, and starts to
lactate (Asdell, 1974). The fact that pseudopregnancy is of shorter
duration than pregnancy suggests that the placenta does exert some
endocrine influence on the mother, although this is clearly not essential
for mammary development. Mammary cancer appears to be a rare event
in the rabbit, so it is necessary to look at other animals in this group in
order to obtain epidemiological evidence about mammary cancer inci¬
dence rates.
The domestic cat (Felis catus) is a good case in point. The female is an
induced ovulator, and in the absence of copulation, the female will
undergo a succession of 10-day periods of oestrus every two to three
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weeks from the spring to the autumn. Ovulation does not occur, so no
corpora lutea are formed, and mammary development does not take
place. However, a sterile mating is followed by ovulation and a pseudo-
pregnancy which does not last as long as pregnancy itself (30 v. 63 days;
Asdell, 1964). This, together with the fact that ovariectomy late in
pregnancy does not result in abortion (Asdell, 1964), suggests that the
placenta has begun to develop an endocrine function towards the end of
gestation in the cat. The mammary glands are also said to develop during
pseudopregnancy, and lactation may occur when the corpora lutea
regress (E. C. Amoroso, pers. comm.).
There is good epidemiological evidence from a retrospective case-
control study to show that ovariectomy reduces the risk of mammary
cancer in cats about sevenfold (Dorn et al., 1968). In a most extensive
uncontrolled investigation, Weijer, Head, Misdorp & Hampe (1972)
examined mammary tumours, mostly adenocarcinomas, from 156 cats, of
which 114 were intact females, 40 ovariectomized females and two
castrated males; the average age of spaying was 5-8 years. One most
interesting point was that only 35 of the 114 intact females had ever had
kittens.
11 is tempting to try and relate these findings to the different endocrine
status of the animals. As in the dog, the protective effect of ovariectomy
suggests that ovarian steroids are implicated in the aetiology of feline
mammary cancer, and it would be interesting to know whether the
protective effect is greater the earlier the operation is performed. Nor¬
mally there are very few opportunities for a cat to become pseudopreg-
nant, since most matings are likely to be fertile. However, there will be a
small group of cats that are so jealously guarded by their owners, that
although they come into heat regularly, they are never given the oppor¬
tunity to mate, and so they seldom if ever ovulate. These would appear to
be the animals that are most likely to develop mammary cancer. It would
require a careful case-control study to establish the point, but it seems
possible that in the cat, it is repeated cycles of oestrogenic stimulation of
the nulliparous mammary gland that is one of the main endocrine factors
predisposing to mammary cancer. It would be particularly interesting to
be able to compare the incidence of spontaneous mammary tumours, and
the structure of the mammary gland, in three groups of cats, namely those
which were never mated, those that had repeated pseudopregnancies
following sterile matings, and those that had repeated pregnancies.
In contrast to the rabbit and the cat, the laboratory rat (Rattus nor-
vegicus) is a spontaneous ovulator. However, the stimulus of copulation is
necessary to activate the corpus lutem and produce a pseudopregnancy.
In the absence of mating, the rat will undergo four-day oestrous cycles,
and the corpora lutea formed after ovulation secrete very little proges¬
terone for only two days. Following a sterile mating, the corpora lutea are
much more active and last for 12 days, whilst following a fertile mating the
corpora lutea are fully active and persist for the duration of pregnancy:
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22 days (Hashimoto, Henricks, Anderson 8c Melampy, 1968). At the time
of puberty, ovarian oestrogen secretion results in rapid growth of the duct
system within the mammary gland. However, alveolar development
requires the additional stimulus of pregnancy, and the rat's placenta is
known to produce both luteotrophic and mammotrophic hormones
(Cowie 8c Tindal, 1971). There seems to be little information about the
degree of mammary development produced by pseudopregnancy.
The reproductive cycle of the mouse (Mus musculus) is very similar to
that of the rat. In addition to the oestrogen-induced ductular prolifera¬
tion of the mammary gland at puberty, Faulkin 8c DeOme (1960) made
the interesting observation that the stroma of the mammary gland had an
important regulatory action on ductular development.
There is an enormous literature on the genetic, viral and carcinogenic
factors that influence the incidence of mammary tumours in rats and
mice, and Welsch & Meites (1974) have recently reviewed the literature on
the hormonal control of mammary tumours in these two species. There is
abundant evidence to show that chronic oestrogen administration
increases the incidence of spontaneous mammary tumours, and ovariec¬
tomy diminishes it. Similarly, hypophysectomy decreases tumour inci¬
dence, whilst multiple pituitary transplantation increases it. It seems
reasonable to conclude that oestrogen exerts its carcinogenic effects both
by a direct action on the mammary gland, and indirectly by stimulating
the secretion of prolactin from the pituitary. But in spite of all this
experimental work, few investigators have addressed themselves to the
important question of determining how the animal's own reproductive
state (repeated oestrous cycles, repeated pseudopregnancies or repeated
pregnancies) influences the incidence of mammary tumours. Howell 8c
Mandl (1961) obtained spectacular results by keeping a group of nullipar-
ous rats until they become senile or died; they found a 100% incidence of
mammary tumours. A comparable control group, housed with males and
hence allowed to become pregnant on every possible occasion, only had a
4% incidence of mammary tumours. It would have been interesting to
know the tumour incidence rate in a group undergoing repeated
pseudopregnancies.
Although the evidence is admittedly very incomplete, it does seem that
in those species in which mammary development and lactation are
dependent on copulation, the risk of developing mammary cancer is
highest in animals subjected to repeated oestrous cycles in the absence of
an ensuing luteal phase. Whether an initial pregnancy, or even a
pseudopregnancy, by temporarily transforming the mammary gland into
a secretory structure, can reduce the incidence of mammary cancer even
though the animal reverts to a succession of oestrous cycles, remains to be
determined. Experiments of this nature should be simple and cheap to
perform, particularly in rats and mice, and they could yield much
valuable information about the stage of mammary development that is
most susceptible to neoplastic change following oestrogen exposure. This
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might be much more relevant to an understanding of the aetiology of
human breast cancer, than all the experiments on "triply operated"
rodents (ovariectomized, adrenalectomized and hypophysectomized)
given pharmacological doses of exogenous hormones and carcinogenic
agents.
THE USUAL SITUATION: MAMMARY DEVELOPMENT AND
LACTATION DEPENDENT ON PREGNANCY
Most mammals with which we are familiar fall into this category. They are
all, by definition, spontaneous ovulators. The duration of the luteal phase
of the oestrous or menstrual cycle is much shorter than the duration of
pregnancy, and is seldom referred to as a pseudopregnancy. The
extended life of the corpus luteum during pregnancy can be attributed to
an endocrine role of the placenta, which may produce a whole variety of
hormones. In species like the horse, cow, sheep, goat, pig and guinea-pig,
where the life of the corpus luteum is prematurely cut short at the end of
the oestrous cycle by the luteolytic action of prostag!andin-F2a secreted
from the uterus, the placenta has to exert an initial anti-luteolytic action in
order to save the life of the corpus luteum and maintain the pregnancy. In
primates, on the other hand, where there is no evidence for a uterine
luteolysin, prolongation of luteal life in pregnancy is brought about by the
secretion of chorionic gonadotrophin and maybe other luteotrophins
from the placenta (Short, 1969). The placenta may also produce a
mammotrophic hormone (see the chapter by Forsyth, this volume) and a
variety of steroid hormones, including oestrogens and progesterone.
These may be manufactured in sufficient quantity to take over the
endocrine maintenance of pregnancy, so that ovariectomy of the mother
no longer results in abortion.
Thus it can be seen that pregnancy involves major endocrine changes,
and it is hardly surprising that nature seems to have used these, rather
than the more modest hormonal changes of the shortened oestrous cycle,
to initiate lactation. The increased ovarian oestrogen secretion at puberty
initiates ductular growth within the mammary gland, but the two- to
three-week luteal phase of the oestrous cycle common to all members of
this group is barely sufficient to initiate alveolar development; this is well
illustrated by the guinea-pig (Turner & Gomez, 1933). If the life of the
guinea-pig's corpora lutea is prolonged by hysterectomy, then mammary
development occurs and the animal may lactate (Loeb, 1927). If preg¬
nancy is terminated prior to mid-gestation, this is followed by mammary-
involution, but termination after mid-gestation will initiate lactation
(Loeb & Hesselberg, 1917).
The rhesus monkey, Macaco, mulatto, another member of this group,
shows more pronounced mammary changes during the menstrual cycle.
Speert (1941, 1948) carried out a most thorough histological investigation
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of the mammary gland, and noted that variations between individuals at a
given stage of the menstrual cycle were greater than those within an
individual at different stages of the cycle; thus it was essential to study
serial biopsies from the same animal. When this was done, there was clear
evidence of histological changes during ovular cycles. These changes took
the form of lobular enlargement, hyperaemia and alveolar dilatation dur¬
ing the luteal phase, with regression following menstruation. During
pregnancy, there was little histological change in the mammary gland
from the luteal state for the first two months, but by the third month the
lobules had become markedly hypertrophied and the alveoli were
enlarged and full of secretion; these changes became even more pro¬
nounced with advancing gestation. When abortion was induced on the
36th day of pregnancy, it was followed by mammary regression, but
abortion on day 60 resulted in immediate although transitory lactation.
Speert (1948) also obtained some most interesting results on mam¬
mary involution following ovariectomy; this produced generalized
atrophy of the mammary gland and the appearance of discrete hyperplas¬
tic nodules which disappeared following oestrogen or progesterone
therapy. He also carried out one of the few detailed ihvestigations of
mammary involution following parturition, and showed that this was
arrested or even reversed in those animals that started to ovulate again
soon after delivery. Finally, Speert studied the effects of chronic adminis¬
tration of large doses of oestrogen or progesterone to intact and castrated
monkeys. Depending on the dosage, oestrogen took about a month to
produce duct, lobule and alveolar development, although it did not
initiate secretory activity. This hypertrophied state could be maintained
for the duration of treatment (up to 30 months) with no evidence of
spontaneous involution. No mammary tumours were produced in any of
these animals, perhaps because they were not kept for long enough,
although some showed benign metaplastic changes of the alveolar
epithelium. Progesterone was also capable of stimulating alveolar growth
and development in castrated animals; it is of interest that a ductal
carcinoma has recently been described in one out of six rhesus monkeys
given physiological doses of an oral contraceptive (Kirschstein, Rabson &
Rusten, 1972).
It would be most exciting if one could begin to relate all this histologi¬
cal information to the aetiology of spontaneously occurring mammary
cancer in animals within this group. However, such tumours are exceed¬
ingly rare in herbivores (Priester & Mantel, 1971) and sub-human pri¬
mates (Seibold & Wolf, 1973; Appleby et al., 1974), and perhaps we
should be seeking an explanation for this fact. It could be argued that in
members of this group the oestrogenic phase of the oestrous ormenstrual
cycle is followed by an abbreviated although fully-functional luteal phase,
which might in some way counteract the effects of repeated oestrogenic
stimulation of the mammary gland without producing full alveolar
development.
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THE HUMAN SITUATION: MAMMARY DEVELOPMENT OCCURS
AT PUBERTY, BUT LACTATION IS STILL DEPENDENT ON
PREGNANCY
We are the only primate in which the breasts undergo a major anatomical
development at the time of puberty. Breast enlargement is in fact the first
external sign of impending puberty in girls (Marshall & Tanner, 1974),
and the breast can achieve its adult size before the first ovulation, which is
usually a year or two after menarche (Short, 1976). The reason is not
far to seek; breasts are regarded as erotic in most human societies (Ford &
Beach, 1952), and it makes obvious sense to develop the organs of sexual
attraction before conception occurs. In contrast, the breasts appear to be
devoid of erotic significance in all other primates. Much of this pubertal
breast growth is due to stromal development, and the fact that the human
breast can respond to the minute amounts of oestrogen secreted by the
ovaries at the commencement of puberty suggests that this stromal tissue
has become extremely sensitive to oestrogen. Since the stromal tissue of
the mouse mammary gland has an important regulatory action on ductal
growth (Faulkin & DeOme, 1960), it would be interesting to know if the
same was true of human breast stroma.
The development of mammary ducts in women at the time of puberty
has been described by Dawson (1934) and Haagensen (1971). Coincident
with the stromal development of puberty there is a lengthening and
branching of the ductular tree, which is rudimentary in the pre-pubertal
girl, and the formation of lobules. Following these initial pubertal
changes, the amount of glandular tissue shows wide variations between
individuals, and indeed between different areas of the same breast (Foote
& Stewart, 1945), and this heterogeneity has bedevilled all attempts to
analyse the histological changes in the normal human breast.
Rosenburg (1922) claimed that there was budding of the ductal
epithelium in the pre-menstrual phase, with the subsequent disappear¬
ance of the acini formed from this proliferation after menstruation had
occurred. However, Dieckmann (1925) reanalysed Rosenburg's material,
and concluded that the differences he had found were due to the patient's
age, rather than to the stage of the menstrual cycle. Foote & Stewart
(1945) also concluded that the number of lobules increased with age, but
in addition they claimed that the number and size of the alveoli increased
prior to menstruation.
Curiously, none of these early workers took into account the parity of
the subjects they studied, so there exists no information in the literature
about possible changes in breast histology as a result of pregnancy. We
have attempted to remedy this deficiency.
Several surgical units in Edinburgh have co-operated to provide us
with tissue from 170 women of reproductive age undergoing reduction
mammoplasty, or breast biopsy for benign disease. Any subjects who were
shown to have histological evidence of malignant breast disease were
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excluded from the study. A full reproductive and menstrual history was
taken from each subject, and blood was collected for plasma progesterone
assay. Each woman was asked to notify us of the date of her next
menstrual period.
In the case of mammoplasty, a piece of tissue was taken at random
from the specimen removed by the surgeon; in the case of biopsy, a piece
of apparently normal tissue was removed through the same incision as the
biopsy, but as far away as possible from the abnormal area. The tissue was
immediately fixed in 4% neutral buffered formaldehyde, and 5 /am-
thickness paraffin-embedded sections were stained and examined.
As in previous studies, we found wide variations within a single breast
in the number of lobules per unit area, the number of acini per lobule,
and the area of the specimen occupied by lobules; however, the variations
between individuals were much greater than those within an individual.
The proportion of glandular tissue varied at random from 0-3% to
29-0% of the area of the section; epithelial height and epithelial cell size
were also determined, and an objective assessment was made of the
degree of oedema of the intralobular stroma. However, none of these
variables showed consistent variations with the stage of the menstrual
cycle in either nulliparous or parous women.
The only histological structures that did appear to show a difference
between nulliparous and parous women were the vacuolated cells in the
basal layer of the alveolar epithelium, as described by Dieckmann (1925)
and Bassler (1970). There was a tendency for these cells to be more
numerous in nulliparous women, suggesting that the epithelium of the
breast might undergo a structural change after the first pregnancy.
Even though histological changes may not be readily apparent in the
human breast during the course of the menstrual cycle, structural and
functional changes undoubtedly do occur. For example, there are pro¬
nounced changes in the total breast volume; nulliparous girls had maxi¬
mal breast volumes at about the time of menstruation, decreasing by as
much as 20% during the early follicular phase of the ensuing cycle; there
is even a suggestion that women on the combined oestrogen +
progestagen contraceptive pill may show a different pattern of change to
women having normal menstrual cycles (Milligan, Drife 8c Short, 1975).
At a functional level, we have found increased IgA synthesis in tissue
cultures of human breast during the luteal phase of the cycle in parous
women, but not in nullipara (Drife, McClelland, Pryde, Roberts 8c Smith.
1976), and there are similar changes in DNA synthesis in organ cultures
of breast tissue as assessed by the incorporation of tritiated thymidine
(Masters, Drife 8c Scarisbrick, 1977). It seems safe to conclude, from
several different lines of evidence, that structural and functional differ¬
ences do exist between the breasts of nulliparous and parous women.
If the initial growth of the human breast at the time of puberty is for
purposes of sexual advertisement only, one would not necessarily expect
the volume of the resting breast to give any indication of its potential
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functional capacity during lactation. Hytten (1954) in fact showed that
there was no correlation between initial breast size at the beginning of
pregnancy and subsequent lactational performance, whereas there was a
good correlation between the degree of secondary breast enlargement
during pregnancy and subsequent milk yield.
How can we begin to relate all this fragmentary evidence about the
physiology of the human breast to the epidemiology of human breast
cancer? We have many tantalizing clues, but little hard proof of cause-
and-effect relationships. Thus it has been known for over two centuries
that breast cancer is particularly common in nuns (Doll, 1975) and it is
now an established fact that nulliparous women, such as nuns, have a
much higher incidence of the disease than parous women (Taylor, Carroll
8c Lloyd, 1959). The evidence initially suggested that the more pregnan¬
cies a women had, the less likely she was to develop breast cancer.
However, MacMahon and his colleagues (MacMahon, Cole, Lin, Lowe,
Mirra, Ravnihar, Salber, Valaoras & Yuasa, 1970) were able to show in five
different areas of the world that it was the age of the mother at the birth of
her first full-term infant that determined the risk throughout the rest of
her life (Fig. 3). Women who gave birth to their first child before the age of
18 had about one-third the breast cancer risk of those whose first birth was
delayed until 35 or later. Indeed, women whose first birth was after the
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Fig. 3. The relative risk of developing breast cancer in relation to the mother's age at the
birth of her first child. The risk in nulliparous women is taken as one. Pregnancy before the
age of 35 reduces the risk, and after 35 increases it. From MacMahon, Cole & Brown (1973).
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actual number of pregnancies was irrelevant, nor did it matter whether
the children were breast or bottle fed. The previous correlation between
low cancer incidence and high parity could be explained simply by the fact
that the mothers of large families inevitably started reproducing early in
life. MacMahon's observations have been confirmed in a large-scale
prospective study carried out in New York city (Shapiro, Goldberg, Venet
& Strax, 1973), and in a retrospective case-control study in New York
State (Lilienfield, Coombs, Bross & Chamberlain, 1975).
The message from MacMahon's work is clear and simple; early first
pregnancy protects, whereas late first pregnancy exacerbates. It
emphasizes the point that the predisposing factors act early in a woman's
reproductive life, but that a pregnancy can protect the breast against these
influences. Late first pregnancy may be harmful because it activates a
pre-cancerous state that already exists.
Another important factor that has been shown to influence the breast
cancer incidence rate is the age of menarche; women with an early
menarche have an increased risk (MacMahon, Cole & Brown, 1973;
Shapiro el al., 1973). It is well known that the age of menarche varies
markedly in different areas of the world, being most advanced in the most
developed countries, and most retarded in the poorest (Marshall &
Tanner, 1974), whereas the reverse is true for the age at first pregnancy,
with the affluent nations having the motivation and the means to defer the
birth of the first child, whilst the deprived nations have neither (Short,
1976). It therefore seems significant that the breast cancer incidence rates
are highest in the developed countries (MacMahon, Cole & Brown, 1973),
which have the longest period of time between menarche and first
pregnancy, whereas they are lowest in the developing countries, where
the period between these events is the shortest (Fig. 4). Although Mac¬
Mahon himself rejects it as an explanation, it still seems plausible to
imagine that the nulliparous breast may be stressed by a repeated succes¬
sion of menstrual cycles, whereas following the first pregnancy there is a
structural and functional transformation of the breast which protects it
from further precancerous change.
It would be fascinating to know the breast cancer incidence rates of
women ovariectomized at various ages before and after the onset of
puberty, but this information is never likely to become available. How¬
ever, there is a mass of evidence to show that ovarian hormones do have a
major part to play in the genesis of human breast cancer. The classical
work of Beatson (1898) showed that ovariectomy could occasionally cause
remission of breast cancer in pre-menopausal women. He was led to
perform the operation because, he believed, "lactation is at one point
perilously near becoming a cancerous process if it is at all arrested", and
he asked himself the simple question, "Is cancer of the mamma due to
some ovarian initiation, as from some defective steps in the cycle of
ovarian changes; and if so, would the cell proliferation be brought to a
stand-still ... were the ovaries to be removed?" There is now abundant
MAMMARY CANCER IN MAN AND ANIMALS 225
Age
Fig. 4. Age-specific incidence rates of breast cancer in five different areas of the world. Care
must be taken in interpreting these data, as there could be "cohort effects" with progressive
declines in the age atmenarche in the last century. From MacMahon, Cole & Brown (1973).
clinical evidence to show that ovariectomy prior to the menopause
reduces the breast cancer risk for the rest of life, and the earlier the
operation is performed, the greater the reduction (Trichopoulos, Mac¬
Mahon & Cole, 1972; MacMahon, Cole & Brown, 1973); ovariectomy
before the age of 35 reduces the risk to about a third of that in women
having a normal menopause at 45-54, whereas women with a late natural
menopause, after 55, have the risk increased by half.
Other aetiological clues are provided by racial differences in breast
cancer incidence rates; the Japanese have one of the lowest rates in the
world, and yet if Japanese migrate to the United States, their children
have incidence rates very similar to those of native Americans (Buell,
1973). This suggests a major influence of environmental factors. There is
evidence to suggest that in the early part of this century, Japanese women
were probably experiencing a very late menarche and an early first
pregnancy, which could account for the low incidence of the disease in
Japan in recent decades, whereas American-born Japanese would be
expected to conform more to the reproductive norms for the United
States, with early menarche and late first birth. Other evidence that also
points to a major influence of environmental factors comes from a review
of published breast cancer incidence rates in monozygotic and dizygotic
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Table I
The incidence of malignant breast tumours in female monozygotic and dizygotic twins
Monozygotic twins Dizygotic twins
One twin Both twins One twin Both twins
affected affected affected affected
No. of cases reported in literature 4 4 3 3
Data from Macklin (1940).
twins (Macklin, 1940). These results are summarized in Table I. In spite
of the small numbers, and the biases inherent in any survey of the
published literature, the 50% non-concordance in monozygotic and also
in dizygotic twins would suggest that the environment is much more
important than the genotype. For the future, it would be fascinating to see
whether differences in reproductive life history could account for these
differences between monozygotic twins. However, it is only fair to point
out that the female relatives of women with breast cancer are said to have a
two- to three-fold increased risk (MacMahon, Cole & Brown, 1973),
indicating that genetic predisposition may be quite important. Once
again, it would be necessary to establish that this apparent familial trend
was not due to a familial similarity in reproductive life histories.
Although all the epidemiological evidence about human breast cancer
points to an involvement of the ovaries, it does not tell us which ovarian
hormone is likely to be the culprit. Now thatmanymillions of women have
been exposed to a combined oestrogen + progestagen oral contraceptive
for up to a decade, and many thousands of women have been taking
oestrogens in the form of post-menopausal hormone replacement
therapy for an even longer period of time, we are beginning to get some
answers.
There is general agreement that the combined oral contraceptive has
not led to an increased incidence of breast cancer (Arthes, Sartwell &
Lewison, 1971; Vessey, Doll & Sutton, 1971, 1972; Boston Collaborative
Drug Surveillance Programme, 1973; Royal College of General Prac¬
titioners, 1974), although Fasal & Paffenbarger (1975) have suggested
that oral contraceptives may hasten the development of pre-existing
cancer. However, all the above studies have shown that oral contracep¬
tives do reduce the incidence of benign lesions of the breast. Since women
with benign breast lesions have an increased likelihood of subsequently
developing a malignant tumour (Davis, Simons & Davis, 1964; Black.
Barclay, Cutler, Hankey 8c Asire, 1972; MacMahon, Cole & Brown.
1973), it is reasonable to hope that the oral contraceptive may ultimately
be shown to reduce the incidence of malignant breast disease. We shall
have to wait for several more years before women who took the oral
contraceptive early in their reproductive years enter the high breast
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cancer incidence age group. When they do, it will be particularly interest¬
ing to know whether taking "the pill" for an extended period of time in the
sensitizing years prior to first pregnancy has had a greater sparing effect
than when taken after the first pregnancy. Since the pill contains both an
oestrogen and a progestagen, it prevents the breast tissue from being
exposed to oestrogen alone, whereas during the first half of the normal
menstrual cycle, the ovaries are secreting oestrogen and little or no
progesterone.
It is only very recently that reliable evidence has become available
about breast cancer incidence rates in post-menopausal women on oes¬
trogen replacement therapy (Hoover, Gray, Cole & MacMahon, 1976).
The risk of developing breast cancer is increased by this therapy, particu¬
larly 10 years or more after first exposure; 15 years after the start of
treatment, the risk was doubled. Furthermore, this oestrogen replace¬
ment therapy appear-; to cancel out the normal protective effects of
multiparity and oophorectomy, and enhance the chance of malignancy in
those with benign breast disease.
All this evidence leaves one with the strong impression that oestrogens
may be involved in the genesis of human mammary cancer, and that the
breast is in a particularly vulnerable state in the period between menarche
and first pregnancy. If we could discover more about the functional
changes that the breast undergoes during this time, we might come much
closer to an understanding of how breast cancer is caused. Since it seems
likely that we shall be using steroid hormones on an ever-increasing scale
to regulate human reproduction, it would be comforting to think that we
knew enough to use them judiciously. They might enable us to prevent
not only pregnancy, but breast cancer as well.
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NOTE ADDED IN PROOF
Recent evidence suggests that lactation itself may have a cancer-sparing
effect on the human breast. Ing, Ho 8c Petrakis (1977) studied a group of
Chinese women in Hong Kong who traditionally only fed their babies
from one breast. They found that cancer developed only in the unsuckled
breast in 79% of such women when postmenopausal, a significantly
different distribution from that seen in the normal Chinese population in
Hong Kong.
Ing. R., Ho, J. H. C. & Petrakis, N. L. (1977). Unilateral breast feeding and breast cancer.
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1.tviutiwn,i], i.n,,,ii,,11.11 11uiCddi CiNICCI/
VOLUME
Fig.1.Breastvolumech ngesduringt eyclinthnulliparouswo n.Vol m sr expressedaperc ntagesofthem nvolumef rachcy l ,alott db kw r srth firstdayofmenses.F omMilliganl[1975],withp rmission. stromalchanges.However,manyo ehohavbornchildr nsti lexperi ce asubjectivefeelingoffulln ssthebr a teform nstruation,soi ms likelythatestromar mainss nsitivethorm nesaft rpreg ancy. B.HistologicChangesDuringthycl Asmentionedab ve,variousinvestigatorsh vclaimedth tcha g soccuri thebreastlobul sduringtcycle.Ingen ral,th sechang srs idoinv v increasedepith lialgrowthtowar sthendfcycle,longid ma
jurne
thelobul s,andincreasc llularinfilt tionfthintral bul rstr ma.Foo e andStewart[1945]illustrateinvolutionfthlob lebeginn gafttheo s ofmenstruation—accordi gtheseworke s,taci icollap ,thce lsbe¬ comepyknotic,andtheintralobularstrombecomesd sandinfiltra ewith lymphocytes.T eystatth"reactivation" ccursbo td y15fthecy le, withlooseningfthstroma,mul iplicatioftheacini,ndsecre iointth ductulelumina—changesofsuchaobvio sn turethonewo dersythere hasbeennycontroversyaboutt m.Bec useoftfa tthparondnulli- parouswomenern texamineds arat ly,thhistologicw rkasrepe ted inourproject. Breastbiopsieswerobtain dfr m187wund rgoingbreasts rgery eitherforcosmeticr asonsf rbi psyfalum .(Patientwhsubsequently turnedouthavbreastcanc rwerexcludedfromtst dy.)Tti sfo examinationwasobtai edfranreawhichthsurgeonconsid r dmacroscopi- callynormal,asf wapossiblefromthe"lump."Af llmenstrualand reproductivehist rywastakenfromeachp ti ntandbloowastakenforestima- ■•tionofstero dhormonelevels.Thbiop iw reprocessedyn ahistol gic methodsanw restai eihematoxylinandcosi . Estimateswermadofthizelobul s,thenu b rflobulesperun t area,thnumberofaciniperlob l ,thsizeftacini,ndthem u tf infiltrationoftheintra obularstr m—fact sw ichprev ouworke sh d reportedasvaryingduringthecycle.Mark dvari tionswerefoundbetweenspeci¬ menstak nfromdiffer ntpartsfthsbre st,andev nm rev iation wasfoundbet eenrightandl ftbr asts,wheresuchspecime sw ravail bl . Itprovedimpossibletc nfirmheprevi usclaimsth tlobulsizeandco ¬ plexityvarieddur ngthcycle,oth tt esizflobulesincreaseds adily duringawoman'sreproductivelifeti ,assomew rke shavcl imed.Lobules "typical"ofthevariousst g sfheycle,sdescrib dbea lierinv tigato s, couldinfactbeoundaltogetheriths mebre st,andwc mthecon¬ clusionthathistologicc an esduringthecy len toc r,ieitherparous ornulliparouswomen.ItisfinterestthatHaag sen[1971]ltemptedto confirmtheexistenceocyclicalchang sinthbrea tlobules,andalsfa l d. Themainaimoft shist logicstudy,howev r,stident fdifferences betweenthreastsofparouandnulliparo swomen.Des tthdifficulty posedbythmarkedvariabilityintheappearanceofthlobul sfroa yn individual,onetre ddidemerg .Twotyp sofc llhavbe ndescrib dint epitheliumofthductul st ebreast—onwi hpi kcy oplasmfollo ing stainingwithhematoxylandeosin,ando ewithcl arcytoplasm.Tpink cellsaresituat dne rthlum noftd ctule,w lthecle rorvacu la edcel arebasalinposition,ndretherefo eoftenth ughtbmyoepith lialcells [Hamperl,1970].Howev r,thfactthaclearcellsresometimepres ntin largernumbersthanothepi helialcells(willustratedbyHaagensen[1971])
castssomedoubtnthir le[Ba s r,1970].Wh tevertrufunctionof thesecells,ithabe nsuggested[Dieckma n,1925]th tvacuolizationoft basallayericharacteristicofthpremenstrualph ftcycl—suggestion thatHaagensen[1971]founddifficulttoc nfirm. Inourst dy,epitheliawerecategorizedinthryp sa co d ngt completenessfthbasallayerofvacuo t dcells:Thet rtyperil us¬ trateddiag ammaticallynFi ure2.Es imat swem dofthfrequencyf thesetypesofepitheliainachbio y,yanbserv rwhounawarfth historiesfthpatientfromwhomt yeob ain d.Iw sfoundt ty1 epitheliumwasfoundmorefrequentlyamongnulli ar uswom ,andtyp3 morefrequentlyamongpar uswo e—th tisy,ecleaovacuolated cellsaremorenumerousithbreastefotf stpregnancy.Thist d, illustratednFigur3,statis icallysignificant.De piteieckm nn'sla m[1925] wedidnotfithavacuolatedce lsw rmonum r uatnyparticular stageofthecycle. Althought issignificanttre dwafou ,istillnmorethanre d,and itwasnotpossiblelo katbiopsyndswithcert nthai mefr parousornullipa ouwoman—justasitsmpos ibletestimatethestageof thecycleatwhichbiopsyh deentake . Tosumup:heresultft ishist logicst dywaconf rth tbreas involutesc mpletelyafterpregnancy(withorw thoutlact i n)andth lobulesdoinde dreturnth ioriginalh st logicsta .Tmenstr alcycle doesnotcausethech ngesfpregnancyiminiatur ,eithernullip rouso TYPE12TYPE3 Fig.2.Diagrammaticrepresent tionofth ey sepitheliumfoundint cini stainingwithhematoxylinndeosin.Intype1th riain erla rofc llwithpink- taini g cytoplasmandcom ete(oral oscomp )u erlayefclearrva uol t dcel s.In type2hetwocelltypesarin ermingleda ddon tfoiscretlay s.It p3,thcl r cellsarebsent.
I -Nullipara -ParousWomen
TYPEITYPE2TYPE3 seenonlys en
I'ig.3.Histogramshowst efrequ ncywithhichthet r eyp sofpit eliums owni Figure2weres nn187biopsiesfnormalbrea ttissue.Typ1epith liumw sseenai lyinnulliparouswomen,andtyp3e itheliumwasslightlyc mmonerpar uswo n. V parouswomen.However,th risuggestionthatpitheliumofthd ctulesislightlyalteredbythexperienceofpr gnancy,asshownbt rel tivenum¬ bersofdifferentc lltypes. C.FunctionalChangesDuringhCyc e 1.Immunoglobulinsynthesis.Ic ntrastt esev ralr ports—conflictingthoughtheymab —ontheistologyfther stingbr ast,lmosnothingi knownfitsfunction.Theassumptionhasbe nthatiaso e:Ib en assumedthatglandularctivityi bsenbetweenpubertyandpr g ancy,switches onatthee dfpr gnancy,a dswitchesoffag inaft rl cta ionisover.How ver, smalla ountsofsecre ionanbaspiratedfromo e75%frestingb s [Petrakisetl,1975],ndthenatureoft issecretionionlybegi ningo investigated. Colostrumandmilkcontaingeamou tsfi munoglobulin,swedec d d tocheckt eimmunoglobulinconte tfrbr astbi psies,u ingmm no¬ fluorescencet chnique.Also,u ingatechn queofti sc lt rewithl b l d aminoacids,followedbyrad o mmunoelectrophoresis,wtestedthabilityf80freshlyobtainedbre stbi psi stosynthesizeimmu oglobulins[Drifta ,1976].Wefoundthat81%oft sespecimensshoweddemonstrableynthesis ofIgA,while45%s owedIgGsynthesisan ly3IgMsynthesis.IgAit principalimmu oglobulinfmi kandotherl n ularsecretions,whileIgG foundigreaterquan itiesithblood.Thsyn hesisfIgAwafmuchg ater intensityhanaofIgGrI M. Whent eimmunoglobulinco te tf34tiss elic swas diedbyimmuno¬ fluorescence,muchgreaterq a iti sofI Awerefo ndthanofIgGrM:71%
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ofthecyclewasde in dbythpla maprogesteroneconcentration:Proliferative,l ssh n
1ng/ml;luteal,moreh n1ng/ml.Inte sityfsy thesiswaass sedbinten ityofb lingofautoradiographs.M ifiedf mDr fcetl[1976],wi hp rmission. ofspecimenshadplasmaellsont iningIgA,and88%hd positsfIgAwith¬
intheductules.Plasmac llsont iningtherimmunoglobulinsw ef u di muchsmallern mbersandw edistri ut dthroughst omafthebreast withoutanyconcentrationi elobul s.Fr edepositsfIgAw res enmostfrequentlyinthlumi aofthed ctules,lessfr qu ntlyiths romaofhelobulesthemselves,anduchl sfrequ ntlyithint rlobularstroma:Dep sits oftheotherimmunoglobulinswerefe erandw remov nlydist ibuted.Itappears,herefore,thatminimall veofimmun globulinsynthesiscon¬ tinuesithso-calledr tingbre st.Thiswasf undibo hp rousdulli¬ parouswomen,butwhenthe eogroupsw rel k dats parately,iwas foundthatamongp r uswomenIgAsynthesiswaoreinte edur nglutealph seofecycle,wh r ast iseffectwnonamongnulliparous women.TableIshowst at"str ng"I Asynthesisase ni16p rouswomeninthelutealph seofecycle,butinonlynul iparouswomanithel t l phase—st tisticallysignificantdifference.Aimilarr dw souwhenh numbersofplasmacellw reexa inedinthi munofluor scencespecimens.Thust efunctionalabilityfthebr astse mstoaveb enlteredsomehowbytheexperienceofnefull-t rmpr gnancy.Wfou docorrelationb twee theabilitytosynthesizeIgAandttotalnumberofpregnancieswomandhad,orthehistoryofl ctation,theimelapsedsincehmenarche,lasmalevelofestradiol. Synthesisofimmunoglobulinsicarriedtbythplasmacellsithetroma ofthelobules,andthmechanismoftransportft ei munoglobulinsi totheductlumenisunknown.Plasmaellsarek nt igratei togl dsfromh circulation,bthefa tort tattractsth mnthelobulesfhb ea tisl o unknown.Itmaybeaproductfthepithelialc ls,ndsot evariationit e
numbersofplasmacellduringthycleip rouswo nybtr s ltf variationinthemou toft ispostulatedttr cta .How v r,byne s certainthateactivityoftpl smac llsisnindic orfthefun tio lactivity oftheglandularepithelium,ndv nis,tndicationonlyi d r cte. Wethereforeatt mpt dtinvestigatehepith liumselfm rdir c ly,by studyingDNAsynthes sithepit elialcell . 2.DNAsynthesisithepithelialcells.Usingati sueult ret c n que, amountofDNAsynthesisithepit lialcelwaasses edbyincuba ingfr h tissueslic swithlabeledthym dineanestimatingthincorporationflab ly autoradiography.Countswe emadfthenumb rlabel dcleii epithelium,andtle st1,000e it lialnucleiwerecoun dieachspe im n [Mastersetl,1977].The"l b ingindex"(LI)waexpressedat numb rof labelednucleip r1,000. Therewere52specimensexamin dfro47ti ts,anddupli atespec ns fromthesamebre strf thstsconfirm dt rep atabilityf results.WefoundthatDNAsy thesis,likimmunoglobulins nthow d

















Fig.4.InvitroDNAsynthesisbynormalbrea ttissuefrpa uswo en:Rel ti n hip betweenepith lialc llabl ngind cesandd yofhcyc e.Tri ngl sotespe imensfr womenithaplasmaprogest ronelev lstha1ng/ml;squaresdenott owherh levelwasover1ng/ml,si nifyingthpr sencecorpusluteu .FrMastertl[1977], withpermission.1.1 100028—j 26- 24 22- 20 18 16- 14- 12- 10 8- 6" 4- 2




lig.5InvitroDNAsynthesisbynormalbrea ttissuef nullip rouswomen:Rel tion¬ shipbetweenepith lialc llab ingindicesa dd yofeycle.Tria gl sd otespecimensfromwo enithaplasmaprog steronelev lstha1ng/ml;quaresd notet swh re thelev lwasover1ng/ml.Crossesdenotep cimensobtainedatreductionm moplasty.FromMastersetl[1977J,wi hp rmission.
thelutealphase.Th risevidenceofaslighth st l icdiffer ncebetw nth breastsofnulliparousandparouwomen. I suggestthatbreasoft enulliparouswom nshouldbregardeda "immature"organ,andthatlyftertf rstfull-t mp g ancdo sth breastreachitsfin lmaturest ge.Duringthimmaturest gebe we nme rch andfirstpregnancytheepitheliumiso lyp rtiallysensitivetst ro dhormones: Thecellsrequiretstim luoftrelativelyhighst roidlev lsinpregnancy beforetheycanre chth irfullunctionalmaturity,wi hthabi itorespond tosteroidhorm nes.Bythendofpregnancyprofoust ucturalandfunc i nal changeshavebeenproducedinthbr ast,ndaft rtbre sth e ch dt i stage—whetherlactationisuppressedorno—inev rreve tcom l t lyti immaturestate. Ithaslreadybeenpointedout(Sectio)thuntilisce urytimma ur stageofdevelopmentw sarelativ lyshortone.Inthcircumstancesu derw ich thebreastoriginallyevolved,i sdevel pmentfrotherstbuddi gatpuber yt fulllactationwouldhavebeenrelativelysmo hp ocess,beginni gb fort cmenarche—whicouldbfollow dquicklyythfirstpregnancy.Itisnl nowadaysth twehavbeguntoldebr astinthp rti lldevel pedst foradecademore.Thepossiblhar fulffectsothiwillbfurth rcon¬ sideredinSectionIV,butthnextse tionwilltakeupnoth rv ryrecentin¬ fluencethataffe tstbreas-softhr lcontr ceptivepill. E.ffectsofOralContraceptive Oralcontraceptivesan wwide yusedthroughoutwo l ,byothnull¬ iparousndparouwomen.Th yar th rm rsuitablfotheyo ngeag groups,andtebthecontrac ptivemeth dofchoi efawombef re herfirstpregnancy.Acarefulwatchhabe ,ndisei g,koth ipossible abilitytocausebrea tdis ,utotherwi eth ireff ctntr st ngbrea tha hardlybeenexamined.Th r fore,ineachotinvestig tionsmention dabove, wealsoinclud dwom ntaki goralc ntraceptives. Inthestudyofbreastv lumech ng s,threevolunteermea uredthcha g inbreastvolumeduringcoursesfthecombinedoralco tracept vepill.Th resultsareshowninFigu6.Thpatternofvolumech ngw sbroadlys mi r tohatduringeno malcycle,withasteadyincreaseduringth21daysof treatmentandquickdecreaseuringthw ek"off'tPill.Thamountf changew sagainoftherder20%.W athappensifwom ncontinuestake thePillwithoutabreak?Tvolumeincr sdon tcontin ein efi i ly:I onetrialinwhichrcontraceptivesweretakfothremo hscon inuously [Loudonetal,1977],3%fthesubjectscomplainedofbreastdiscomfort,which becamel sstroublesomathi lprogressed.Iw ulda p ar,ther for ,t t thestromahasonlylimi edabilittrespo dtcontinuousexpos rt steroids.
VOLUME fig.6Breastvolumech ngesthr ughoutsixmpletontracept ve-c ntrolledcycl si threenulliparouswom n.Volarexpressedpercentagesfmvolumf ach cycle,andplottedba kwar sfromthirstd yfmens .FroMilligane[1975]•, withpermission. Whenthistologyofebreastwasx mined,nff cralcontraceptives couldbedemonstrated.Sepa teex minationswermadfaterialfrnulli¬ parousanduswomen,counterma flobulel l a,aci i perlobule,sizofacinindcellu arinfiltratio :Th rwasndic tioneithe
groupofadiffe enceb tweenom nnhPilla dnormalsubjects.T rew noevidencethatt eusfthPille therst mulatedruppr ssedthg andular componentfthbreas . Inourtissuecultureinve tigations,pati ntsothP llw relsoexamined,a d theresultsforb thimmunoglobulinynthesisandDNAsy the isw rescatt red withinthenormalrangefou disubjectswhoereotonP l .T rewas nosignthatcyclicalch ngeso curredduringtmonththPi le herulli- parousorparousw men. Theeff ctsoft ePillnthr stingbrea tappear,t refore,tolimit d twoareas.Fi stth reistimulationfthst oma,analogoushechanges n
inthenormalcycle,andsecondth reiab litionfthnormalyc ical responseoftheglandularcomponentfthbreasp rousw man.C ld eitherortheseeffectsbharmful—ov nb neficia ?N itherpos ibilitys ems likelyatthemoment,invi wfthf ctt atinc dencefbr stdis a e hardlyalteredbythPil[Vess ,1978],uttheff ctsofralcont acep ives onbreastdisea ewilleconsid redb low. III.EPIDEMIOLOGYOFBREASTCANCER A.HazardofPr longedNulliparity Itiswellknownthatbre stcanceriscommonerongnulliparouswomen, butthereasonremainsobscure.Mu hinv stigationb ec r edouty epidemiologiststclarifyhexactn tureftconnec ionb twparitynd cancerrisk,butitremainedcontroversialntthl rgsurv ysfMa Mahon etal[1973]ndShapiroetl[1 3].Bothfthesesurveysexaminedwid rangeofpossibleri kfactors:S mprov dth oconnectionwithbreast cancer,whilsome—uchsgttmenarche,ea lyoopho ectomy—w re indeedshowntbrelatedbr stcancerrisk.O ftmorestrikingfind¬ ingswastherel tionshipbetw enthri kofsubsequentbreaca cera dthg atwhichwomanhaserfirstull-termpr gnancy.T isi u tr tedFigur7, thegrapht twasfirspublis edbyMacMa onln1970. Thelinearr lationshipbetweenstc ncerriskdgfib rt ,shown inFigure7,holdsf rdiffe entracesndsnaff ctedbythumberofs bse¬ quentpregna cies.Itisalsoclearfromths eurvey( w llf oth r work)thatane rlymena cheincr sestheisfbr stcanc rl t riif [MacMahonandCole,1972].Therefore,alt ughotheriskf c s,sucsra arelsoimportant,onesig ifica tf ct rideterminingthskfl rbr st canceristhlengthoftimeathbre stremainsitm turestb for thefirstfull-termpr gnancy.Oncethmassiveho onsti ulusofp egnancy bringsaboutfulldevelopmentfthglandularc po entt isarticularriski removed,nmatt rhowlongthbreastremainsit stings efterm u ityhasbeenreached.
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Fig.7.Relativeriskofdevelopingbr astcancert rf ,relationwoma 'saget thebirthofIterf stchild.T erisknnulliparouswomeniaks1.0.F omMacMahon ctal(1970],withpermission. Epidemiologiceviden ehasnotind cat dthn ureftcarcinogenictimu¬ lusduringtheyearsbeforethfi stfull-termpr gnancy.P h pst emmaturityoftheglandits lf,withoutnyotheroutsideinfl ence,ie oughca sei st ¬ bilityoftheep thelialc ls,leadingtocancerousch ge—es mewayt t theincompletelydevelopedundesc n edt isiliabltomalignantha ge.However,thesignificanceofthagtmena chem kestvid ntthatpr ¬ cancerousprocessbeginatpuberty,notbir handthisob ervationharaised thesuspicionthatov rianhormo eproductionisi pl catedthprecancerous process.Est genshaveoft nbeca tintherolefc rci ogens[MacMahonandCole,1972],andth ycertainlyappeartobrimesusp cts,sincepub rtye m tomarkhestartfexposuretc rcinogenwhichco tinuesta ttilth glandre chesmaturity. Analternativeexpl nationforhsignificanceofthegtme archesh t pubertyitselfproducesachangeintcells,rwhichth iint in icimmaturity
makesthemmoreunstablendsusceptibletpr anc rouschange.H w v r, pubertydoesnotinvolveasudd nsurgefhormo eproductionb tag adual buildupofestrogenconcentrationsu ilthmaturel v lfhreproductive yearsarer ached.Itse msunlikelythatslowbuil upw uldproducedra a¬ ticonce-and-for-allhangeit egl du arcells.Wl ftwiththstrong possibilitythatexposuretrogenindeedthcarcinogenicinflu nce. B.PreviousTheoriesfHormonalCausationfBrea tCancer Aconnectionbetw eestrogensandbreastcancerhl gb nsusp ctedf anumberofreasons,includingthf ctae rlyoophorectomyprotectsgain t thedisease.Thmechanismbyw ichthovaryactsnt ebr a tr mained obscure,however,andthepossibilityhab nrai dthatdiffer ntyp sof estrogenmayhavdifferingp tentialsf rcarci ogenesis[MacMahondC ,1972;Kirschner,19 7]. Itwasfoundth tpatientswithbreastcancerexcre er lativelyl e tr olh n estradiolorestrone,andi ceestriolil spotentes og nibioa sayyst ms thantheoth rwo,i assuggestedt ttmightpr tectbr astfromth highercarcinogenicityoftwom epot testrog ns.Excretionfs riol amonggroupsofw menvaryingn ti nalitiesvaryingriskfbre stca cer wasfoundtov ryin er elywiththationalincidenceftdiseas .How ver, this"estriolhypothesis"in tuniversallyacc pted,pa lbecaustot factcertainth tstr olile sarcinogenicthtoth restr gens(seKi sch er [1977]forreview).Siit rital[19 4]h vepr sentedr asonsforsusp ctingha thecarcinogenisestroneatherthaestradiol,nth yvfo mul ted alternative"est onhypothesis." Therehasbeenl sint stnthrolefprog st roneithd velopmentf breastc ncer,althoughprogesteronen rmallya tsnestrog -p imedt tissues.Grattarola[1964]fo ndthatbre stcancerp tien shighin id ce ofanovulatorycyclesthanormalwomen,andShe anKore ma[1974] suggestedthatinadequatecorpuslut mf nc ionmaybv rommon g breastcancerp tients.The eobs rvationspointtths ibilitytproge terone hassomeprotectiveeffectnthbreast—possiblycount ractingtomext n thecarcinogeniceff ctofstrogen.Ithpr t ctiveeff tfpro es eronei deficient,thchancesofbreasncerdevelopingrh gh r. Suchaprotectiveleforprogest ronewouldbinke pingwithob rvations onendometrialcancer,whi hisc monerongpatie tsw thex sses gen production(eg,bygranul sacelltumorsfheovary)ndmongpatientsi whomtheeff ctofstrogeniun pposedbypr gest rone:U d rsuchcircum¬ stancesestrogenproduceshype pla iafhendometrium,whichm ybfol¬ lowedbyfrankcancer.Thpossibilityh l ob enraisedthatunopp sed exogenousestrogens,takenv rp riodfy ars,m yhaveca ci ogeniceff ct ontheendometrium[Zi landFi k e,1975].Isowbeli v dthatp ssible
carcinogeniceffectofxog ousestrogensthend metriumcanbmodi ied bytheadditionofprogesteronetestrog ntherapy[S udetal,1978].Hoov r etal[1976]havesuggestedthasimilarc rcino niceff ctofunopposed exogenousestrogensmi hte istfobr a tcanc r,utthpos bili yfaboli hing thiseffectbytadditionofprogesteronetest ogtherapyr mainsb investigated. C.EffectsofOralContrac ptives Whenoralcontraceptiveswerefirsintroduc dtherwefearst atcontin d useofpotentsteroidsmightincrea ethincid ncofbreasancer.Otherhop d thatesuppressionofendogenoushorm npr d ctionmightact allydecrea e theincidenceofthdiseas .S udi sofarh v tjustif edei rthhop sr thefears[Vess y,1978;Startwelltl,197 ].Ihbe ntenta iv lysuggested thatuseoft ePillbeforefirstchildbirthm yass c atedwithnincr er k ofbreastcancer[Pfaffenb rg rtl,1977],busuchincrease(itexist all)mustbeonlyslightandainfactduthdel yi goft ewoman's firstpregnancy.Otheoth rhand,thot atP llm ydecreast e incidenceofbreastancerhabek ptal veythefind gth tbenignre st disease(whichhalimiteda soci tionithbre sc n er)israth rleco mon amongwomenonthePill. Itis,ofcourse,tillt oea ya seswithcer ainttheffectofr lc n¬ traceptivesonbreastcanc r,sincethfi su rftPillaro lyn wbegin i g toreachtheagetwhicht yrg eat striskofbre scancer.Howev r,th indicationsatprese trthhewillnobdramaticc ngeincidence attributabletohePill. IV.MENSTRUATIONA DBREASCA CER A.TheNatureoftConnection Theresultspr entedinSectioIIpointhconclusiot attme strual cyclehasdifferenteffe tsonthbre stfp rouandnullipa owomen.Am g parouswomen,anincreasetheactivityoftgl ndulart ssuduringhse ond halfothecyclereflectststimu ationfthbre sprogesteronefrot corpusluteum.Amongnulliparouswomen,th sincreasesabsent.Thpla ma concentrationsfprogeste oneinthlutealp a(a dofest di l)w rfo d inourst dytbeod fferentinullipar usa dparouswom ,sthconcl si n isthateglandularti sueofbre stinotr sponsivtno pregnantlevelof progesteroneun ilaft rthfirspreg ancy.T im ansthbeforetfirst pregnancytheestrogenpres tfomostfthcycliseff tively"unopposed" byprogesterone,despitthlatterhormone'presenceinthbl odi dequate concentration.On ethhorm nalstimulusfthefir tp egna cyhasbroughtt
glandulartissueofullm turity,circulatingpro e teronecaaonthep th lial cellstoopposeestrogen.Ifestrogenaind dcarcin enic,in wwide y believed,thisphenomenonprovid sasatisfactoryx la atioothprec ncer us stimulusactingbetweenmenarchedfirpregnancy. Theobservationthatstromafbreasial ohormone-sen itivey beofsomerel vancethishypoth sis.Iftherearest g nrec ptorint breaststromatheywillindtho m ne,em vingifrthci culationand retaininginhigherconcentrationthla dul repith li m. This"progesteroneblock"hypoth siextendutdnohallenget theoriesofhorm nalcarcinogenicactieferredtabov(Secti111).Sh r an andKorenman'ssuggestion[1974]thainad quatelut lphasespredisposet breastcancerisnotch llenged:Ifinad quatlut lph seso c rftthf r t pregnancy,estrogeactionw llofcoursbunopp sedyprogestero eath t time,inspitofthefactabre stissuei ythencapablofres onding progesteronewhp esent.Itisevpos iblethatinad qualut lpha sbefor thefirstpregnancymayhavneff c—ithmmaturebre st'sins n i ivi yto
_progesteroneisnotcompl ebuonlypartial.Howev r,rre ultssugge tth theblocktactionfproges er nenthimm turbre tscompl te,since cyclicalactivitywascompletelabsentinnulliparouwo n,andthereforI suggestthatitmmaterialwheth rtlu e lp sebeforfirr gnancyis adequateornot. Thishypothe isdoenotirec lychallengethes rioltestronhypo¬ theses.Tnatureoftcirc latingestrog n—w theripr domina tly estrone,t adiol,oes ri l—andther la ivec rci ogenicityfe ch,a e irrelevanttohehypothesisthatyarllcti gwithoutto p si g modulatingeffectofprogest rone. Finally,thishypothe isfitstobservationthaPillhanc angedt incidenceofbreastcancer.WhwomantakhPillh re d ge ouestr gen productissuppressedbythexogenouse trogen—th ritheref rstillcirculat¬ ingestrogenacti gonthebreast.This,fc urs ,alp og stogenit combinedPill,butifthew ansnull parous,herbreastw linsen itiveto this,andeeresultfartpr cancero socessiscon ern ,willb unchanged. B.ClinicalRelevance Thehypothesisoutlinedabovemighttfirssig ta peartofferlittlhop offindingawaytdecreasetheincid ncobr stancer.Not ingbdo atpresenttochangehpr per iesofte ithelialc llthemselvandmak themmoreresp nsivetoprogesterone.Tamenarcheisnund rou control.Thereisunlikelytbareversaloftsocialtrendtow rdsdelayi g firstpregnancyuntilawomanhestablishedc r erandhom .Ifthepr ¬
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clic Variation of DNA Synthesis in Human Breast Epithelium1
R. W. Masters,2 3 J. 0. Drife,4 and J. J. Scarisbrick5 6
5TRACT—DNA synthesis in normal breast epithelium from
menopausal women was assessed by use of autoradiogra-
. In parous women the labeling indexes decreased during the
cular phase of the menstrual cycle and increased to a sign if i-
tly higher level during the luteal phase.—J Natl Cancer Inst
1263-1265, 1977.
Tie risk of breast cancer is three times greater among
men whose first full-term pregnancy is delayed until
35 or over than among those who bear their first
Id before the age of 19 (7). A possible explanation for
; observation is that the breast epithelium responds to
hormone fluctuations of the menstrual cycle and
t this response is altered following first pregnancy,
support of this hypothesis is the report that the ability
ireast tissue to synthesize immunoglobulins is differ-
in parous and nulliparous women (2). This is the
t study to report cyclic variation of DNA synthesis in
ast epithelium during the menstrual cycle.
rERIALS AND METHODS
he specimens of normal breast tissue were obtained
m reduction mammoplasties or at biopsy from an
a regarded by the surgeon as normal tissue, follow-
removal of abnormal tissue. In all cases the breast
ue was histologically confirmed as normal. The 52
cimens were obtained from 47 patients; a further 21
cimens were discarded because insufficient epithelial
s were present. The nature of the abnormal area,
ermined by routine histopathology, was in all cases
ign¬
ite specimens, approximately 5x3x2 mm, were im-
fiately transferred to Waymouth's MB752/1 medium
taining 20 ium HEPES7 (Plow Laboratories, Irvine,
tland). Within half an hour of surgery the tissue was
into 1-mm slices with paired razor blades and trans-
ed to 5 ml of fresh medium (pH 7.2) containing 2
i [me^>'/-3H]thymidine/ml (Radiochemical Centre,
ersham, Buckinghamshire, England; 5 Ci/mmole) in
aled plastic Universal container. After 4 hours' incu-
on at 37° C, the tissue was washed three times in
tks' balanced salt solution and fixed in formol saline,
"he tissue was processed by routine histologic proce-
es, and 5-/jl paraffin sections were picked up on
ted slides. Autoradiographs were prepared with Ko-
AR10 stripping film and exposed for 14 days at
L They were placed for 5 minutes in Kodak D19
eloper and fixed for 10 minutes in Ilford Hy-
t:distilled water (1:5); both processes were carried
at 17° C. The sections were washed, dried, stained
t hematoxylin and eosin, and mounted in DePex.
t least 1,000 epithelial cell nuclei were counted in
i specimen (average count: 1,446), and the number
abeled nuclei were noted; any nucleus with more
i 5 grains was scored as positive. The LI was ex-
5sed as the number of labeled nuclei per 1,000 after 4
hours' incubation with tritiated thymidine. The results
were statistically analyzed by the Wilcoxon rank sum
test.
A 10-ml venous blood sample was collected from each
patient within 24 hours before or at the time of opera¬
tion, and the plasma was stored at —20° C. The concen¬
trations of progesterone (ng/ml) and 17/3-estradiol (pg/
liter) were determined by radioimmunoassay (3, 4).
Women were classified as being in the luteal phase if the
progesterone concentration exceeded 1 ng/ml. Details
of parity, first day of last menstrual period, and number
of years since menarche were obtained from each pa¬
tient.
The repeatability of the results was tested with tissues
from 4 patients. The results were: 1) right and left
breasts, LI: 3.0 and 1.9; 2) right and left breasts, LI: 3.0
and 1.8; 3) two specimens from the same breast, LI: 20.0
and 22.2; and 4) three specimens from the same breast,
LI: 4.2, 3.7, and 4.6. These results indicated that differ¬
ent specimens obtained from the same or contralateral
breast showed comparable LI.
RESULTS
The results are summarized in table 1. In parous
women the LI of the breast epithelium decreased dur¬
ing the follicular phase and then increased to a signifi¬
cantly higher level (T* <0.05) during the luteal phase of
the menstrual cycle (text-fig. 1). No significant differ¬
ence was observed in the menstrual ages (yr since men¬
arche) between these two groups. In the nulliparous
group cyclic variation was not demonstrated, although
the number of specimens in the group was small (text-
fig. 2).
No cyclic variation was observed in the LI of breast
epithelium from women using oral contraceptives, and
the LI were uniformly low (table 1). The LI of the
parous group using oral contraceptives were similar to
those of the parous follicular group, although no signifi-
Abbreviation used: I.I = labeling index(es).
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Table 1.—Epithelial cell LI of normal breast tissues and the menstrual ages of 47 women"
Normal breast tissue from patients







Fibroadenoma or mammary dysplasia Parous Follicular 10 0.8-17.1 14-33
Luteal 14 1.6-27.4 11-32
Oral contraceptive 7 2.0-7.0 4-25
















Oral contraceptive 2 1.3 7.5
8.3 10
Reduction mammoplasty Nulliparous Follicular 1 2.5 9
Luteal 3 1.9; 3.0 8
8.5 5
25.2 6
Oral contraceptive 1 4.2; 3.7; 4.6 15















a a a d
1 I I I I I I I I I I I I I I I
2 4 6 8 10 12 K 16 18 20 22 24 26 28 30 32
day of cycle
Text-figure 1.—Relationship between epithelial cell LI and day of
cycle in specimens of normal breast tissues from parous women in
the follicular (A) and luteal (□) phases of the menstrual cycle. The
specimens were obtained from premenopausal women undergoing
surgery for benign breast lumps.
1 1 1 1 1 1 T7 1 1 1 ? 1 1 1 1 1
2 4 6 8 10 12 U 16 18 20 22 24 26 28 30 3;
day of cycle
Text-figure 2.—Relationship between the epithelial cell LI and <
of cycle in specimens of normal breast tissues from nullipar
women in the follicular (A) and luteal (■) phases of the menstr
cycle. The specimens were obtained from premenopausal won
undergoing surgery for benign breast lumps or reduction mamr
plasty (X).
cant difference was seen between the LI of the former
group and those of the parous luteal group.
The LI were compared with the plasma 17/3-estradiol
concentrations and the menstrual age, but no associa¬
tions were apparent.
DISCUSSION
Changes in total breast volume (5, 6), amount of
intralobular stroma (7, 8), and the size of the alveoli
have been reported to occur during the menstrual cycle.
This study has investigated the level of DNA synthesis in
normal human breast epithelium; although specific con¬
clusions regarding cell growth rates cannot be made
from LI alone, alterations in the number of labeled cells
do indicate a change in the pattern of growth. In parous
women the LI of the breast epithelium decreased di
ing the follicular phase and increased during the luf
phase of the menstrual cycle. Increased labeling duri
the luteal phase concurs with previous histologic obs<
vations (7), which suggest greater activity during t
phase. Material was insufficient to determine whetl
similar cyclic changes occur in the breast epithelium
nulliparous women; therefore, further investigation v
be necessary to determine whether differences in t
growth rates of breast epithelium exist between pare
and nulliparous women. Nevertheless, the presc
study is the first to demonstrate quantitative changes
the behavior of human breast epithelium during t
menstrual cycle. This finding is particularly signifies
because the epithelial cells are the most common site
malignant change.
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Summary
Nulliparous women have a greater risk of developing
breast cancer than women who have borne children,
but so far no functional differences in breast tissue have
been reported between parous women and nulliparae.
Macroscopically and histologically normal breast tissue
was obtained from 74 women of reproductive age during
biopsy of benign breast lesions and was examined for the
presence of plasma cells by immunofluorescence. Im¬
munoglobulin synthesis was detected by an in-vitro
culture technique.
Synthesis of IgA was detected in 81% of specimens,
of IgG in 45%, and of IgM in 3%. IgA synthesis was much
more intense than IgG or IgM synthesis. Plasma cells
containing IgA were seen in 71 % of the specimens exam¬
ined, and 88% of specimens had deposit of IgA in the
ductules. The findings were not significantly influenced
by the nature of the condition necessitating biopsy or
by oral contraception. Nulliparous women showed no
cyclical changes, but among parous women IgA synthesis
was more intense during the luteal phase of the menstrual
cycle. This suggests that after the first pregnancy the
breast is more sensitive to progesterone.
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Introduction
The term "resting breast" is often applied to the human mam¬
mary gland that is not secreting milk, implying that the gland
is metabolically inactive. Small amounts of secretion can be
aspirated from at least 75°0 of non-lactating breasts,1 however,
and changes in breast volume during the menstrual cycle suggest
that the non-lactating breast responds to fluctuating levels of
ovarian hormones.2
Although milk-specific proteins and large amounts of immuno¬
globulin3 are secreted in milk, there is little information about
the ability of the non-lactating breast to produce these proteins.
The purpose of our study, which was part of a wider investiga¬
tion of the effects of parity and the menstrual cycle on the
breast, was to determine whether the resting breast produces a
milk protein (IgA) and whether such synthesis varies with the
stage of the menstrual cycle.
We therefore studied immunoglobulin production in the
non-lactating human breast using an in-vitro organ culture
technique and also examined the distribution of immuno¬
globulins by immunofluorescence.
Patients and methods
We studied 74 women of reproductive age (mean age 33 years;
range 15-52) with regular menstrual cycles. They had been admitted
to hospital for diagnostic biopsy of a breast lump or for reduction
mammoplasty. Before surgery each patient was invited to participate
in the study, and a full reproductive and menstrual history was taken.
To ascertain the time of ovulation venous blood was taken at the time
of surgery for progesterone assay, and the patient was asked to notify
us of her next menstrual period. Patients whose biopsies showed
malignant disease of the breast were excluded from the study.
BIOPSY TECHNIQUE
After the clinically abnormal lump was removed a piece of macro-
scopically normal breast tissue was removed through the same incision
from a site as far away as possible from the abnormal area. Reduction
mammoplasty specimens were randomly selected from the excised
tissue. The tissues were transported in normal saline and prepared
for culture and histological examination within one and a half hours.
Adjacent blocks were fixed in 4"„ neutral buffered formaldehyde.
IMMUNOLOGICAL METHODS
In-vitro synthesis of immunoglobulins—Eighty specimens, each
weighing 100-150 mg, were cultured for 48 hours in medium con¬
taining 14C-labelled lysine and isoleucine.4 The cultures were tested
for the presence of newly synthesised immunoglobulins and secretory
component by radioimmunoelectrophoresis as described.3 The degree
->
of immunoglobulin synthesis was assessed semi-quantitatively by
grading the intensity of the autoradiographic image from ± (line
barely visible) to + + + (a strong black line on the autoradiograph)
(see fig 1). The grading was done independently by two observers.
Immunofluorescent detection of immunoglobulin in tissues—Tissue
blocks were processed by the method of Brandtzaeg," fixed in ethanol
at 4"C, and embedded in paraffin. Sections were stained by direct
immunofluorescence using fluorescein-conjugated rabbit antisera
against human oc-, y-, and ,u-chains (Hoechst Pharmaceuticals),
whose specificity has been described.7 Control experiments were
performed by blocking with unconjugated antisera and by using
absorbed conjugated antisera. The sections were examined by incident
ultraviolet illumination. Sections stained with fluorescent antibody to
IgA, IgG, and IgM were graded from ± to + + + both for the
number of fluorescent plasma cells and for the number and intensity
of fluorescence of non-cellular deposits. A separate assessment was
made of deposits within the lumina of ductules, deposits in the intra¬
lobular stroma, and those in the extralobular stroma.
HISTOLOGY OF TISSUE STUDIED
Sections cut serially with those used for immunofluorescence were
stained with haematoxylin and eosin and examined by two observers,
including a pathologist who had no knowledge of the patients. Any
specimens in which pathological lesions were found were excluded
from the study. Sections from the adjacent formalin-fixed blocks
were also examined, and no frank pathological features were seen,
though a few showed minor changes (atrophic changes in five speci¬
mens, small cysts in two, ductular dilatation in seven, and features of
fibrosing adenosis in three). No specimens showed epitheliosis.
HISTOPATHOLOGY OF PRIMARY CONDITION
Patients included in the study had either benign breast lesions
(biopsy cases) or no disease (mammoplasty cases). The histological
findings on the clinically abnormal tissue are shown in table I.
Group 1 consisted of patients in whom the disease would be expected
to be confined to the excised lump—for example, fibroadenoma—with
the remainder of the breast consisting of normal tissue. In group 2
the diagnosis was fibrosing adenosis, which may not necessarily have
been localised to the lump excised, even though the tissue used in our
study was histologically normal.
TABLE I—Histopathological diagnosis of breast lesions in patients from whom
normal breast tissue was obtained for in-vitro culture
No of specimens No of specimens
Diagnosis for in-vitro also studied by
culture immunofluorescence
Group 1 Fibroadenoma* 20 8
Mammoplasty* 10 4
No abnormal tissue 7 3
Lipoma 1 1




*Some patients in these groups provided more than one specimen: 74 patients
provided specimens for culture and 31 for immunofluorescence.
3
STEROID ASSAYS
Plasma progesterone levels were determined by a modification of
the radioimmunoassay developed by Neal et aland oestradiol-17,3
levels by a modification of the radioimmunoassay of Cameron et a!."
Results
IN-VITRO SYNTHESIS OF IMMUNOGLOBULINS
Synthesis of IgA was detected in 81% of the 80 specimens (fig 1)
and synthesis of IgG in 45% (table II). IgA synthesis was strong
(^-r- or + 4- +) in 42% of the positive specimens, whereas 94%
of the IgG-positive specimens showed only weak or barely detectable
synthesis (+ or ±). IgM synthesis was seen in two specimens and
was barely detectable in both.
FIG 1—Immunoglobulin synthesis in vitro detected by radio-
immunoelectrophoresis. Above: stained immunoelectrophoresis
pattern developed with anti-IgA serum showing IgA arc. Carrier
is human milk. Below: autoradiograph showing labelling of IgA
arc.
Influence of diagnosis—The number of positive specimens and the
pattern of synthesis was similar in groups 1 and 2. The proportion of
positive specimens was greater in group 2 (see table II), but the
difference was nor significant by the /- test (0-5>P>01).
Influence ofparity and stage ofmenstrual cycle-—Similar comparisons
were made between the parous and nulliparous patients, and the
proportions of positive specimens (81 "X. and 77% respectively) were
not significantly different. There was no significant difference between
tissue removed during the luteal phase of the cycle (as shown by a
plasma progesterone concentration greater than 3-2 nmol/1 (1 ng'ml) ),
+
4




Mean intensity of labelling of
autoradiographs (No of specimens)
4- + + +■ + +
All pecimens {n = 80)
IgA 65 (81) 9 18 24 14
IgG 36 (45) 2 14 20
IgM 2 (3) 2
Histologically normal tissue from group 1 (n = 38)
IgA 27 (71) 5 9 10 3
IgG 16 (42) 2 6 8
IgM 1 (3) 1
Histologically normal tissue from group 2 (n = 42)
IgA 38 (91) 4 9 14 11
IgG 20 (48) 8 12
IgM 1 (2) 1
and the rest of the cycle. When the influence of the stage of the cycle
was examined in parous and nulliparous women separately, however,
cyclical changes were seen in the parous group but not in the nulliparae
(table III). Sixteen parous women showed strong (++ or + 4- +)
synthesis in the luteal phase, compared with three in the proliferative
phase (P<0-05). Among nulliparae there was no significant difference
between the phases of the cycle. When patients in the luteal phase were
examined synthesis was significantly greater among parous women
than among nulliparae (P<0 05). In neither parous nor nulliparous
women did the amount of IgA synthesis correlate with plasma
oestradiol levels. There was no significant difference between the
groups of parous and nulliparous women in average age, time since
menarche, or plasma progesterone or oestradiol levels.













+ + + + + +
Nulliparous patients Proliferative (n = 12) 11 (92) 2 2 7
(n = 22) Luteal (n = 10) 6 (60) 1 4
'
1
Parous patients Proliferative (n = 17) 12 (71) 1 2 5 4
(n = 43) Luteal (n = 26) 23 (89) 6 10 3 4
Influence of oral contraceptives—Thirteen patients were taking oral
contraceptives, and IgA synthesis was detected in 12 of them. This
proportion (92%) was not significantly different from the overall total.
IMMUNOFLUORESCENT IDENTIFICATION OF IMMUNOGLOBULIN
IgA—Table IV shows the numbers of specimens that were positive
5
when sections were examined after staining with fluorescent antibody
to IgA. Plasma cells were seen in 71 °0 of the sections and the number
of cells was moderate or large in 14 of the 24 positive specimens.
In all but two of the sections the cells were seen in greater numbers
in the intralobular stroma than in the extralobular stroma. Fig 2
shows a section graded as + + + for plasma cells. Deposits of IgA
were seen in the lumina of ductules in 88% of the specimens and as
non-cellular foci in the intralobular stroma in 53%. In only five
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fig 2—Section of breast lobule stained with FITC conjugated anti-IgA
showing fluorescing plasma cells. ( 1910.)






Mean intensity of labelling
of positive specimens
(No of specimens)
+ + + + + + ±
Plasma cells . . 24 (71) 4 10 5 5
( Duct lumen 30 (88) 6 13 7 4
Non-cellular material ■{ Lobule 18 (53) 2 13 3
^Stroma . . 5 (15) 1 2 2
IgG—IgG-containing cells were seen in only three sections. Non-
cellular deposits of IgG were seen in 10 sections (29%)> and all were
weakly fluorescent or barely visible (+ or ±). More deposits of IgG
were seen in the extralobular stroma than in the lobules or the lumina
of the ductules.
IgM—Fluorescent IgM-containing plasma cells were seen in one
specimen and non-cellular deposits of IgM in three. The IgM deposits
showed only barely detectable fluorescence.
Comparison of results classified according to parity, stage of cycle,
6
contraceptive use, and diagnosis showed no significant differences
between groups in terms of numbers of positive sections or pattern of
fluorescence. In those patients in the luteal phase of the cycle, more
IgA-positive specimens were again found in the parous group (70"o)
than among the nulliparae (50°„), but the difference was not significant.
The total number of specimens examined by immunofluorescence
was limited to 34 because of technical problems or shortage of tissue.
Also sections in which no lobular tissue could be identified were
excluded. Despite this selection there was good overall agreement in
the proportion of specimens found to be positive by the fluorescence
and organ culture methods.
REPEATABILITY OF RESULTS
Four specimens were taken from different parts of a single breast
at mammoplasty and coded as separate specimens. None of the obser¬
vers knew which specimens came from the same patient. After organ
culture IgA synthesis was graded as + + + in two and + + in the
other two; IgG synthesis as + + in two and + in two; and IgM
negative in all four. Immunofluorescence was done on three of these
specimens. IgA-containing plasma cells were seen in two and graded as
+ and ±; non-cellular deposits of IgA in the intralobular stroma
were graded as + in all three; and IgA deposits within the lumina of
ductules were + in two and ± in one. Neither cells nor deposits of
IgA were seen in the extralobular stroma in any of the three specimens.
No cells or deposits were seen in the sections stained for IgG or IgM.
Discussion
IgA is the principal immunoglobulin in most human external
secretions, including colostrum and milk. IgA in salivary and
intestinal secretions is known to be synthesised locally by
subepithelial plasma cells.1" Many plasma cells are seen in the
lactating human breast,3 and this has led to the assumption
that the IgA in human milk is also locally synthesised. Local
synthesis of immunoglobulin by mammary tissue has been
shown in several animal species," 12 but there is only one brief
report of such a study in the human breast.13
Our observation that the non-lactating breast produces IgA
rather than other immunoglobulins suggests that this synthesis
is not a non-specific inflammatory response but a process
associated with secretion. This interpretation is supported by
the localisation of IgA in plasma cells associated with the
lobules. Deposits of IgA are also concentrated in the lobules
and particularly in the lumina of ductules, whereas IgG-positive
cells are randomly distributed throughout the lobules and
stroma.
Many of our biopsy specimens were taken from women who
had breast nodules and were therefore not truly "normal."
Mammoplasty specimens gave similar results, however, and we
therefore conclude that IgA synthesis is not a reaction to benign
breast disease but a property of normal breast tissue.
7
The secretion of IgA into the ductules may represent a form
of defence against the entry of infection, but it seems more likely
that the IgA secretion is simply a basal level of activity in an
organ whose primary function is full lactation. In our primitive
ancestors the breast was probably lactating almost continuously
during the reproductive years," and it is unlikely that mechan¬
isms adapted specifically for the non-lactating state have had
time to evolve.
IgA synthesis occurs in both parous and nulliparous patients,
but the observation that cyclical changes in IgA synthesis occur
only in parous women implies some functional difference in the
breast after the first pregnancy. The increase in IgA synthesis
in the luteal phase of the cycle among parous women suggests
that after the first pregnancy the breast is more sensitive to
progesterone. A study of DNA synthesis by human breast
epithelium in vitro1"' has also shown cyclical variation in tissue
from parous women and no cyclical variation among nulliparae.
The nulliparous breast is more susceptible to cancer, and
the risk of subsequent breast cancer increases with increasing
time elapsed between menarche and first pregnancy.1" 17 The
suggestion in our results that the nulliparous breast is less
responsive to progesterone than the parous breast may sirnply be
a reflection of the "immaturity" of the nulliparous breast, but
the difference in hormonal sensitivity of breast tissue may have
a direct bearing on its susceptibility to malignant change. It
has been suggested that "unopposed" oestrogen stimulation
can lead to neoplastic changes1": if the nulliparous breast is
relatively insensitive to progesterone this might mean that
oestrogen stimulation during the menstrual cycle is inadequately
"opposed" by progesterone.
We» have no evidence that oral contraceptives produce
abnormal stimulation of breast tissue. Our results suggest that
the nulliparous breast will be relatively insensitive to the
progestogen component of the combined oral contraceptive;
the effect of the oestrogen component remains a matter for
conjecture.
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For Debate . . .
Breast cancer, pregnancy, and the pill
[AMES OW EN DRIFE
["here is still no satisfactory explanation for the effect of preg-
tancy on the risk of breast cancer. Breast cancer is commoner
imong women who have never borne children than among parous
vomen, and the longer a woman delays her first pregnancy the
nore she increases her risk of developing the disease.1 - Recently
t has been suggested3 that prolonged use of oral contraceptives
>efore first full-term pregnancy may increase the risk of breast
:ancer, although after this pregnancy the risk is probably
inaffected by taking the pill.
Clearly the first full-term pregnancy does something to alter
woman's risk of developing breast cancer. Before this pregnancy
he breast is at greater risk of precancerous change: afterwards
he risk diminishes. Whether or not a woman breast-feeds is
irobably irrelevant4: so far as the breast is concerned the
mportant thing is that a full-term pregnancy has occurred,
["here are three possible explanations for this. One is that a
toman's hormonal state is permanently altered by her first
iregnancy. This has been investigated but no consistent answer
las emerged.5 8 A second possibility is that during the first
iregnancy cells that have undergone precancerous change are
lestroyed, immunologically or otherwise. There is no evidence
hat this occurs, and indeed since pregnancy is a period of
ncreased immunological tolerance such a phenomenon seems
inlikely. The third explanation is that the breast epithelium
cself is permanently changed by pregnancy. There is good evi-
lence that such a change occurs.
Iffect of parity on the breast
Early in pregnancy little change occurs in the breast lobules,
iut during the second trimester they undergo proliferation.7
tfter pregnancy (or at the endof breast-feeding) involution occurs,
ntil the histological structure of the breast is similar to that of
nulliparous woman's breast. Recently, however, it has been
hown" that the epithelium of the ductules remains slightly but
nportantly altered: "clear" cells are less numerous after first
regnancy than in the ductules of nulliparous women. More
triking than this histological change, however, is the physio-
sgical change in the epithelium, shown by its altered response
3 hormones.
Synthesis of DNA in vitro by specimens of normal breast
ssue from parous women shows a clear cyclical pattern accord-
tg to the day of the menstrual cycle on which tissue was ob-
lined9 (fig). Synthesis is maximum during the luteal phase of the
ycle and increases rapidly with the appearance of progesterone
l the circulation. By contrast, among nulliparous women no
yclical pattern is seen. In another study10 in-vitro synthesis of
diversity Department of Obstetrics and Gynaecology, Bristol
Maternity Hospital, Bristol BS2 8EG
\MES OWEN DRIFE, esc, mrcog, lecturer
immunoglobulins showed a similar phenomenon: among parous
women there was a pronounced increase in IgA synthesis during
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Day of cycle
In-vitro DNA synthesis by normal breast tissue from parous
women: relationship between epithelial cell labelling indices
and day of cycle. O denotes specimens from women with a
plasma progesterone concentration under 1 ng/ml; • denotes those
where concentration was over 1 ng/ml, signifying presence of a
corpus luteum. (From Masters el al9 with permission.)
In both these studies the plasma concentrations of proges¬
terone and oestrogen were similar in nulliparous and parous
women. The difference between these two groups of women
lay not in the state of their hormones but in the ability of the
breast tissue to respond to these endogenous hormones. That is to
say, pregnancy permanently altered the hormone responsiveness
of the epithelium. How this effect is brought about is not clear:
possibly the high progesterone concentrations of late pregnancy
induce progesterone receptors. We can conclude, however, that
after a single full-term pregnancy the breast epithelium becomes
capable of responding to circulating progesterone at the rela¬
tively low concentrations present during the normal menstrual
cycle. Until the first full-term pregnancy has occurred, it cannot
respond to progesterone at these concentrations.
Carcinogenesis and the pill
Exposure to oestrogen "unopposed" by progesterone is now
recognised as a carcinogenic influence on the endometrium."
In recent years regimens of so-called "hormone replacement
therapy" for postmenopausal women have been altered by
adding a progestogen in the hope that this will prevent the de-
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opment of endometrial carcinoma.12 The incidence of breast
icer has also increased among women receiving prolonged
itment with unopposed oestrogen,13 and so it is possible—
>ut it no more strongly—that unopposed oestrogen has a simi-
carcinogenic effect on the breast.14
rhe importance of an inadequate response to progesterone
v becomes clear. If before first pregnancy the breast has
dequate progesterone receptors and cannot respond to
!ogenous progesterone, then during the normal cycle it will in
ct be exposed to "unopposed" oestrogen—despite the pre-
ce of normal concentrations of progesterone in the circulation.
:refore it does not matter whether a young woman has ovu-
ry cycles before her first pregnancy, because even if proges-
ine is present it will be unable to modify the effect of her
ogenous oestrogen. By contrast, after her first pregnancy the
dence of anovulatory cycles matters a great deal,15*" since
gesterone, if present, will now be capable of "opposing" the
ct of oestrogen.
low does this hypothesis affect the risk to women who take
i contraceptives ? Firstly, it implies that the effects of the pill
' be different among nulliparous and parous women—as is
' being suggested by epidemiological surveys.3 1319 The
ibined oral contraceptive provides oestrogen balanced by
gestogen, but if the breast of the nulliparous woman cannot
>ond to the progestogen component, then a young girl
ng an oral contraceptive is effectively exposing her breast
helium to "unopposed" oestrogen. On the other hand, by
ng the pill she is suppressing the production of oestrogen by
own ovaries. What we need to know is whether exposure to
;enous oestrogen at the steady low concentration provided
he pill is any more dangerous than endogenous oestrogen
le higher fluctuating concentrations supplied by the ovary.
5 question has not yet been answered.
he hypothesis summarised here explains the importance of
iparity and delayed first pregnancy as risk factors for subse-
lt breast cancer. It also explains the importance of early
arche,2 20 since the sooner the menstrual cycles begin the
ler the "unopposed" oestrogen begins to act on the breast
relium. (The importance of a late menopause is explained
he fact that late in a woman's reproductive life her cycles are
tly anovular,21 and so a woman with a late menopause
xiences more oestrogen-only cycles, although her breast
telium could respond to progesterone if it were present.)
hypothesis could perhaps also explain the recent uncon-
:d observation3 that an early miscarriage before first full-
pregnancy is another risk factor: concentrations of both
ogen and progesterone increase in early pregnancy, but in
luliiparous woman only the oestrogen will affect the breast,
te hypothesis does not attempt to explain the racial and
raphical variations in the incidence of breast cancer.22
does it offer an opinion on whether one particular oestrogen
i as oestradiol23 or oestrone24) is less carcinogenic than an-
:. What seems clear above all is that future study should con-
ate less on women's hormonal profiles and more on the
ts of the hormones on the breast itself.
is hypothesis is based on work done while I was an MRC clinical
ch fellow at the MRC Unit of Reproductive Biology, Edinburgh.
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Does endometriosis occur more often in sterilised than in unsterilised
women ?
Endometriosis after salpingectomy or tubal sterilisation was first
reported in 1930.' This has recently been confirmed2; the condition
may also occur after tubal coagulation and may begin within a few
months of operation. The endometriosis may be painful2 and may
spread several centimetres from the tubal stump.1 The original
recommendation for its prevention after salpingectomy was that
hysterectomy should be performed in preference whenever possible,1
but now it is thought that excision of a wedge of tubal uterine cornu is
sufficient.2 It is not clear, however, how to prevent its occurrence after
other forms of tubal occlusion. The frequency of the condition after
tubal sterilisation is unknown. In one study,3 fistula formation with
endometriosis was found in six out of 20 patients with failed sterilisa¬
tion, and so a search was made for the condition among patients with
successful sterilisation: microscopic evidence of endometriosis was
found in 63% of patients with successful tubal cautery but in only
28";, of patients with successful Pomeroy sterilisation. The process
occurs within one to four years of operation, and the incidence is lower
if the proximal tubal stump measures over 4 cm. It must be emphasised
that in this study3 endometriosis was specifically sought and was
mainly microscopic. The risk of painful clinical endometriosis to a
woman undergoing laparoscopic sterilisation with clips or rings is
unknown, but must be very low indeed.
1 Sampson JA. Postsalpingectomv endometriosis (endosalpingiosis). Am J Obstei
Gynecol 1930;20:443-80.
1 Ranncv B. Ktiology, prevention and inhibition of endometriosis. Clin Obstei
Gynecol 1980:23:875-83.
5 Rock JA, Parmley TH, King TM, Laufc L.17., Su BC. Endometriosis and the
development of tuboperitoneai fistulas after tubal ligation. Fern! Scerii 1981 ;35:
16-20.
